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SUMMARY 
Yersinia pseudotuberculosis is a human pathogen that causes acute intestinal and 
systemic diseases. This study investigated the link between pathogenic traits and the 
metabolic core machinery of Y. pseudotuberculosis using a systems biology 
approach: the integration of gene expression profiles with metabolic pathway fluxes 
in the wild type and virulence regulator mutants. The absence of specific virulence 
regulators particularly perturbed fluxes and gene expression of pyruvate metabolism 
and tricarboxylic acid cycle, suggesting an involvement of this metabolic node in the 
virulence management system. Mutants, genetically perturbed in regulators of this 
metabolic branch point and one of its central enzymes, showed a significant 
reduction of virulence in an oral mouse infection model. This revealed the pyruvate-
TCA cycle node as a focal point for controlling host colonization. Flux rerouting was 
also identified as response to applied antibiotic therapies. The examination of 
Yersinia’s fine-tuned adaptation was expanded to temperature, an important infection 
parameter, using a continuous culture with advanced temperature control to mimic 
the infection process. The virulence regulator RovA, known to respond to 
temperature and to control metabolic, stress, and virulence genes, was quantified by 
Western blot analysis and fluorescence-activated cell sorting. RovA showed a 
bistable behavior that generally maximizes survival by heterogeneity. 
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ZUSAMMENFASSUNG 
Das humanpathogene Bakterium Yersinia pseudotuberculosis verursacht ernsthafte 
intestinale und systemische Erkrankungen. In dieser Arbeit wurde die Verknüpfung 
von Pathogenität und Metabolismus in Yersinia pseudotuberculosis unter 
Verwendung von Transkriptom- und metabolischen 13C-Stoffflussanalysen 
untersucht. Virulenz-Regulator-Mutanten wiesen im Vergleich zum Wildtyp starke 
Veränderungen im Pyruvatmetabolismus und im Zitratzyklus auf. Die gezielte 
genetische Deregulation dieses Stoffwechselknotenpunktes führte zu Mutanten mit 
stark reduzierter Virulenz im Mausmodell. Der Pyruvat-Zitronensäure-Knoten konnte 
demnach als ein zentraler Punkt der Virulenzregulation identifiziert werden. Der 
Einfluss verschiedener Antibiotika auf die Stoffflussverteilung wies darüber hinaus 
auf einen komplexen Zusammenhang von Metabolismus und inhärenter Resistenz 
hin. Die feinregulierte Anpassung des Organismus während der Infektion wurde 
weiterführend anhand des temperaturabhängigen Transkriptionsregulators RovA 
untersucht, der Gene des Metabolismus, der Stressantwort und des 
Virulenzprogramms der Zelle kontrolliert. Der Infektionsprozess wurde dazu in einer 
kontinuierlichen Kultur mit präziser Temperaturführung simuliert. Western Blot 
Analysen und fluoreszenzgestützte Durchflusszytometrie zeigten bistabiles Verhalten 
des Proteins RovA. Die daraus hervorgehende Heterogenität der Population kann die 
Überlebenswahrscheinlichkeit der Gesamtpopulation erhöhen. 
 
 
  
   
 
 
  
  INTRODUCTION 
 
1 
1 INTRODUCTION 
In 2010, approximately 10 million people died worldwide through infectious diseases, 
accounting for about 20% of all death cases. More than half of such fatal infections 
are related to common diseases like diarrhea, lower respiratory infections, or 
meningitis (Lozano et al, 2012). Favorably, intensive research has decreased the 
danger and death cases of infections. However, in terms of the number of victims, 
infectious diseases are still a significant burden for public health and further deserve 
intensive investigation. This is complicated by the emergence of new threats. New 
pathogens are constantly released from animal reservoirs and from human-adapted 
agents, respectively, by virulence gene transfer and mutation (Morens & Fauci, 
2013). As an example, the emergence of Yersinia pestis from the zoonotic bacterium 
Yersinia pseudotuberculosis is responsible for one of the most fatal pandemics in 
human history resulting in 50 million deaths (Morens et al, 2008). Although 
genetically almost identical, Y. pseudotuberculosis and Y. pestis differ significantly in 
terms of host entry and process of infection. Y. pseudotuberculosis enters the host 
via oral uptake and subsequent adhesion to and translocation through intestinal cells 
(Grützkau et al, 1990; Isberg & Leong, 1990) leading finally to diarrhea, enteritis, and 
colitis (Figure 1). In contrast, Y. pestis is transmitted via flea bites (Achtman et al, 
1999) and causes severe septicemia that mostly leads to death, if it remains 
untreated (Bosio et al, 2012). Yersinia enterocolitica, the third pathogenic yersiniae 
member, is phylogenetically more distant to Y. pseudotuberculosis, but causes a 
rather similar infection process (Wren, 2003). At the intersection of two different 
pathogenic life styles, the analysis of Y. pseudotuberculosis provides the opportunity 
to gain an in-depth understanding of virulence. The infection process of yersiniae is 
accompanied by constantly changing environmental conditions and the immune 
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defense mechanisms of the host. Y. pseudotuberculosis, e.g., passes the acidic 
stomach and then enters the different parts of the intestine. Here, Yersinia competes 
with the indigenous microbiota. Every member of this microbial community is 
perfectly coordinated with one another and inhabits a specific niche (Njoroge et al, 
2012).  
 
Figure 1. Raster electron micrograph of Yersinia pseudotuberculosis on Caco-2 cells 
(Picture by Manfred Rohde, Department of Molecular mechanisms of streptococci, Helmholtz 
Centre for Infection Research, Braunschweig, Germany). 
Hence, Y. pseudotuberculosis faces strong competition for carbon and energy 
sources and has to defense against the immune system of the host. Thus, a 
successful colonization relies on accurate adjustment of virulence gene expression to 
use scarce resources effectively (Njoroge et al, 2012). In this context, the question 
arises, whether virulence factors are controlled by available trigger substances 
(Lawhon et al, 2002) or even by specific metabolic phenotypes as consequence of an 
integrated output of impact factors. Since systems-wide approaches have been 
proven useful to find relations between so far unassociated microbial behaviors, their 
application to pathogenic bacteria promises enhanced understanding of such 
complex systems. 
  OBJECTIVES 
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2 OBJECTIVES 
The main object of the present work aims at understanding the role of metabolism in 
virulence control of the pathogenic model bacterium Y. pseudotuberculosis. In 
anticipation of the complexity of the involved metabolic and regulatory networks, a 
systems biology approach using state-of-the-art 13C-based fluxome and array-based 
transcriptome analysis should be developed and applied. As such analyses require 
high reproducibility and accuracy, a convenient cultivation strategy for 
Y. pseudotuberculosis should be developed first. The established cultivation set-up 
should subsequently be used to analyze defined gene deletion mutants lacking major 
virulence regulators with different hierarchical positions within the virulence control 
cascade. The determined metabolic phenotype, i.e., the fluxome, should then be 
integrated with transcriptome data to correlate metabolic states with virulence control. 
The integration should provide new insights into the life style of 
Y. pseudotuberculosis. In addition, the contribution of the core metabolism of 
Y. pseudotuberculosis should be investigated in context of its defense role against 
external threats like antimicrobial agents. At best, promising novel targets, identified 
from the systems biology analysis and related to virulence control, should be 
characterized through profiling of second generation mutants, including mouse 
infection studies to investigate their relevance in vivo. Finally, selective studies 
should also explore the dynamic of metabolic and regulatory networks of 
Yersinia pseudotuberculosis. 
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3 THEORETICAL BACKGROUND 
3.1 Clinical relevance of Yersinia pseudotuberculosis 
In mammals, including humans, Yersinia pseudotuberculosis causes gut-associated 
diseases, such as diarrhea, enteritis, and colitis. The threat of Yersinia 
pseudotuberculosis is underdetermined by the fact that it causes severe bloodstream 
infections with a death probability up to 75% (Mandell et al, 2009; Kaasch et al, 
2012). Several recent foodborne outbreaks in industrial countries like Finland or 
Japan further indicate an on-going impact of this Gram-negative pathogen on society 
(Nakano et al, 1989; Hannu et al, 2003; Jalava et al, 2006; Rimhanen-Finne et al, 
2009). Obviously, Yersinia remains a serious threat for foodborne infections. Due to 
its wide-spread distribution among sheep, deer, pig, hare, and even birds, 
contamination of vegetable fields by an animal reservoir seems likely (Tauxe, 2004). 
In addition to its clinical relevance, Y. pseudotuberculosis is important as an 
evolutionary ancestor of Y. pestis, the agent of plague (Achtman et al, 1999). 
Y. pestis evolved just 1,500 – 20,000 years ago and shows an almost identical 
genetic background. There seems to be only one exclusive determinant that 
significantly enhances infection by Y. pestis as compared to Y. pseudotuberculosis: a 
plasmid encoded phospholipase D homolog (Achtman et al, 1999). Acquisition of 
plasmid pFra, coding for the phospholipase D homolog, appears sufficient for 
Y. pseudotuberculosis to evolve to one of the world’s worst pathogen. Due to this, the 
investigation of the life style and the infection process of Y. pseudotuberculosis, as 
aimed in this work, is important towards understanding of two human pathogenic 
bacteria.   
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3.2 Yersinia pseudotuberculosis - Life style and infection process 
The typical infection route of Y. pseudotuberculosis occurs via oral uptake and 
binding to the intestinal epithelium (Isberg & Leong, 1990). Contact and invasion of 
the epithelia is mediated by invasin. It recognizes β1 chain integrins that are 
exclusively provided by microfold cells (M cells). After translocation, Yersinia attaches 
to phagocytic cells located within the encountered region between epithelium and 
Peyer’s patches, the subepithelial dome. The immune response is then paralyzed by 
several Yersinia outer proteins (Yop) that are channeled through a type III secretion 
apparatus into immune cells (Isberg & Barnes, 2001). Subsequently, the pathogen 
spreads into the lymphatic system, where it rapidly multiplies and colonizes deeper 
tissues, such as mesenteric lymph nodes, liver, and spleen (Figure 2) (Dube, 2009).  
 
Figure 2. Process of infection. After attachment, internalization, and translocation of 
microfold cells (M cells), Yersinia reaches the subepithelial dome. Here, attachment to 
dendritic cells and inactivation of the immune defense occurs. Paralyzed dendritic cells then 
carry the pathogen into the Peyer’s patches, where it rapidly multiplies and disseminates into 
deeper tissues. The figure is adapted from (Mowat, 2003) and (Isberg & Barnes, 2001). 
In order to promote its pathogenic life style, Y. pseudotuberculosis has developed 
global regulatory cascades that coordinate physiological processes and virulence 
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factors and initiate infection by expression of the major invasive factor: invasin. 
Several regulators of these cascades suggest a link between virulence and core 
metabolism of the pathogen. Over the last few years, it has become evident that the 
catabolite repressor protein (Crp) and the carbon storage regulator A (CsrA) are 
involved in virulence management in addition to their well-known function as 
metabolic regulators (Figure 3) (Heroven et al, 2012a; Heroven et al, 2012b). CsrA is 
a RNA-binding regulator protein, which itself is controlled by the small non-coding 
RNAs CsrB and CsrC. CsrA is also involved in controlling the major transcriptional 
regulator of virulence (RovA) and its transcriptional repressor (RovM). In the absence 
of CsrA, expression of RovM is reduced, and lower levels of the repressor then lead 
to higher amounts of RovA (Heroven et al, 2008) and subsequent expression of 
invasin, thus mediating attachment to and entry into the intestinal epithelium (Figure 
2) (Nagel et al, 2001). The Crp protein influences the expression of rovA through 
counter-regulation of the Csr RNAs either directly or through the UvrY response 
regulator (Figure 3). Crp and CsrA are pivotal for a successful Yersinia infection 
(Heroven et al, 2012b). Crp also affects the virulence and metabolism of Y. pestis 
(Zhan et al, 2008). In addition to the coordinated expression of virulence factors, the 
ability to efficiently compete for nutrients is crucial for a successful infection, i.e., the 
bacteria must outcompete the gut microbiota and persist long-term within the 
intestinal tract (Chang et al, 2004; Hofreuter et al, 2008). As described above, the 
expression of RovA is crucial for the scheduled provision of invasin. In addition to 
concerted regulation of RovA by Crp, CsrA, and RovM (Figure 3), RovA abundance 
varies with temperature, osmolarity, pH, growth phase, and nutrient status. Maximum 
levels are found at ambient temperature (20 - 28°C) and in stationary growth phase. 
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Figure 3. Regulatory network of the virulence genes of Y. pseudotuberculosis. The 
interactions involve activation (arrows) and repression (dashed lines). The impact of the 
catabolite repressor protein (Crp), the carbon storage regulator protein A (CsrA), and the 
regulator of virulence A (RovA) on central metabolism was investigated in this work. The 
corresponding regulators are displayed in grey boxes. This figure is adapted from (Heroven 
et al, 2012b). 
During batch culture, rovA expression emerges within the mid-log phase and then 
increases continuously (Nagel et al, 2001). An osmolarity level equal to the 
physiological value of the gut (Sleisenger, 1981) is favorable for rovA expression. In 
contrast, pH lower than seven results in drastic decrease of RovA. Host temperature 
significantly reduces RovA abundance, independent of further parameters (Herbst et 
al, 2009). Nutrient rich media favor rovA expression, whereas minimal media 
stimulate rovA expression only weakly. Additionally, rovA expression is auto-
regulated (Figure 4) (Nagel et al, 2001). 
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Figure 4. Factors that influence the expression of RovA (regulator of virulence A) in Yersinia 
pseudotuberculosis. Expression is reduced at high osmolarity, low pH values, low nutrient 
availability (Nagel et al, 2001), and at 37°C (Herbst et al, 2009). The nucleoid-associated 
protein (H-NS) binds with high affinity to the promoter region of rovA and, thus, inhibits 
positive autoregulation (Heroven et al, 2004). At ambient temperature, RovA shows higher 
affinity and is able to suppress H-NS. Given plots schematically illustrate the tendency of 
RovA activity as function of the individual parameters. 
Taken together, temperature has a prominent impact on virulence control of Yersinia 
pseudotuberculosis. Therefore, further studies have investigated temperature 
dependence of RovA in more detail. At host temperature, a reversible conformational 
change occurs, which leads to reduced promoter affinity to target genes and 
increased susceptibility to degradation (Herbst et al, 2009). Furthermore, the 
nucleoid-associated protein H-NS binds with high affinity to the promoter of rovA, and 
hence, prevents transcription. At 25°C, a drastically increased promoter affinity of 
RovA suppresses H-NS binding and leads to readmission of rovA expression 
(Figure 4) (Heroven et al, 2004). To date, the temperature dependence of RovA was 
mainly described qualitatively. A more precise quantitative correlation of RovA levels 
with temperature would allow the construction of kinetic models towards better 
understanding of the underlying interaction. 
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3.3 Virulence promoting metabolism of Yersinia pseudotuberculosis 
One of the key questions that arise from our current knowledge of Yersinia’s 
virulence revolves around the metabolic core machinery of the cell. A first cross-view 
on Yersinia’s metabolic repertoire can be obtained from its genome annotation (Kyoto 
Encyclopedia of Genes and Genomes) (Figure 5). Y. pseudotuberculosis harbors 
phosphotransferase systems (PTS) for uptake of carbohydrates, such as glucose. 
Glycolytic conversion of glucose 6-phosphate occurs via the Embden-Meyerhof-
Parnas (EMP) pathway and the Entner-Doudoroff (ED) pathway, respectively. 
However, the major role of the ED pathway seems to be related to catabolism of 
specific carbohydrates, like gluconate (Conway, 1992). In accordance with its close 
relative Escherichia coli, a complete pentose phosphate (PP) pathway for NADPH 
supply by glucose 6-phosphate dehydrogenase and by 6-phosphogluconate 
dehydrogenase, respectively, is present in Y. pseudotuberculosis. The pyruvate 
metabolism encompasses anaplerotic PEP (phosphoenolpyruvate) carboxylase, 
gluconeogenetic PEP carboxykinase, and NADP-dependent malic enzyme. For 
maintaining appropriate NAD/NADH ratios at substrate overflow, Yersinia possesses 
lactate and acetaldehyde/alcohol dehydrogenases. A quinone-reducing pyruvate 
dehydrogenase delivers quinol as alternative reducing equivalent. Acetyl-CoA can 
either be metabolized via the tricarboxylic acid (TCA) cycle or via the glyoxylate shunt 
(Figure 5). Although metabolic regulators are directly involved in the control of crucial 
infection determinants, metabolic requirements of Yersinia for adapting to and 
surviving in different host niches are largely unknown. 
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◄Figure 5. Central carbon metabolism of Yersinia pseudotuberculosis (YPIII). The reaction 
arrows point towards the physiological direction (glucose as sole carbon source, fully aerobic 
growth). In Yersinia, a wide set of pathways is available: Embden-Meyerhof-Parnas (EMP) 
pathway, Entner-Doudoroff (ED) pathway, pentose phosphate (PP) pathway, tricarboxylic 
acid (TCA) cycle and glyoxylate shunt. Pyruvate metabolism encompasses conversion by 
anaplerotic phosphoenolpyruvate (PEP) carboxylase (ppc) and by gluconeogenetic PEP 
carboxykinase (pckA). For maintaining appropriate NAD/NADH ratios at substrate overflow, 
Yersinia possesses lactate and acetaldehyde/alcohol dehydrogenase (ldh, adhE). NADPH is 
provided by glucose 6-phosphate dehydrogenase (zwf), 6-phosphogluconate dehydrogenase 
(gnd), malic enzyme (maeB) and isocitrate dehydrogenase (icdA). Furthermore, reducing 
equivalents are supplied by glyceraldehyde 3-phosphate dehydrogenase (gapA), pyruvate 
dehydrogenase (aceEF, lpdA), α-ketoglutarate dehydrogenase (sucAB), succinate 
dehydrogenase (sdhABCD), malate dehydrogenase (mdh, sfcA) and quinone-reducing 
pyruvate dehydrogenase (poxB). Substrate-level phosphorylation is catalyzed by 
phosphoglyceratekinase (pgk), by pyruvate kinase (pykAF), by succinyl-CoA synthetase 
(sucCD) and by acetate kinase (ackA). Intermediary metabolites serving as biomass 
precursors are given in black letters. Data are taken from genome annotation (Kyoto 
Encyclopedia of Genes and Genomes). 
First studies indicate a highly complex network of interactions, e.g., insufficient supply 
of PTS-sugars activate adenylate cyclase (Escalante et al, 2012), which then 
activates Crp and subsequent virulence regulatory cascades (Heroven et al, 2012b). 
It remains to be elucidated, how metabolism and pathogenic habits are intertwined in 
Y. pseudotuberculosis. Further evidence on close connections between metabolism 
and pathogenicity comes from studies that investigated resistance in pathogenic 
bacteria. Recent exometabolome profiling of Staphylococcus aureus, treated with 
antibiotics, revealed an accumulation of pyruvate and fermentation products 
(Birkenstock et al, 2012). Genomic studies further identified selected enzymes of 
central carbon metabolism to support persistence under antibiotic treatment 
(Spoering et al, 2006; Ma et al, 2010; Girgis et al, 2012; Leung & Lévesque, 2012). 
Obviously, detailed analysis of metabolism may even help to identify new drug 
targets.   
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3.4 Metabolism as part of the resistome – the intrinsic bacterial resistance  
The intrinsic resistome comprises natively encoded elements of the chromosome, 
which directly or indirectly provide an increased resistance to administered 
antimicrobial agents (Figure 6) (Olivares et al, 2013).  
 
Figure 6. The intrinsic resistome comprises elements of metabolism, regulation, and 
classical determinants that contribute to resistance against antimicrobial agents. Classical 
determinants, e.g., antibiotic inactivating enzymes can further be acquired by means of 
horizontal gene transfer or mutation. These elements do not belong to the intrinsic resistome. 
Phenotypic resistance like biofilm formation can be classified as a consequence of the 
bacterial intrinsic capabilities to counteract antibiotic agents. This figure is adapted from 
(Olivares et al, 2013). 
In addition to classical resistant determinants like multi drug efflux pumps, 
antibiotic-inactivating or target-modifying enzymes, respectively, the resistome 
encompasses all kinds of regulators and metabolic factors that contribute to bacterial 
resistance and have not been acquired as a consequence of antibiotic use in society 
(Olivares et al, 2013). A regulator of the intrinsic resistome is not necessarily involved 
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in control of classical resistance determinants or the general stress response. 
However, expression of the DNA repair machinery, as consequence of quinolone 
treatment, is a famous example of intrinsic resistance (Howard et al, 1993; Olivares 
et al, 2013). Further beneficial regulatory events may concern rather general aspects 
of bacterial metabolism (Olivares et al, 2013). In this context, activation of proton-
motif force in persister cells by administration of specific metabolites was shown to 
increase susceptibility to aminoglycosides (Allison et al, 2011). Thus, the metabolic 
state of an organism plays a crucial role for intrinsic resistance. Analysis of the 
complex conjunction of metabolism, regulation and resistance bear the chance to 
uncover new targets for antimicrobial agents that have not been considered so far. A 
detailed understanding of the underlying processes of the intrinsic resistome may 
further help to avoid actions that favor evolution of resistance (Olivares et al, 2013). 
3.5 Systems-level analysis of biological systems 
Although there is lot of available information about virulence and first insights into 
metabolic responses to administration of antimicrobial agents, it was not possible so 
far to elucidate the underlying processes to great detail. Based on recent advances in 
systems biology, powerful tools are now available that allow experimental and 
computational analyses of complex biological systems. Shortly, such systems biology 
approach investigates the cells’ state through global monitoring of component 
concentrations (Sauer, 2006). Although analysis of the transcriptome successfully 
unraveled Yersinia’s virulence regulation cascade (Heroven et al, 2012b), this 
technology fails to describe the cells actual status on its own. The relative abundance 
of mRNA does not per se correlate with protein activity and despite all efforts made to 
ensure significance, a serious chance for misinterpretation is left.  
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Figure 7. Interplay of transcriptome, proteome and metabolome as complex functions of 
each other with the fluxome as integrated output and, hence, metabolic phenotype of the cell. 
The genome functions as the source of information. This figure is adapted from (Kohlstedt et 
al, 2010) and (Nielsen & Oliver, 2005). 
Protein and metabolite concentrations are also subject to a non-consistent correlation 
between quantity and activity. To sum up some essential points, translation is 
dependent on transcript availability and the overall activity of the translational 
apparatus. The overall activity of derived protein is then controlled by, e.g., 
abundance, phosphorylation status, presence of degrading enzymes, and 
metabolites acting either as reactants, activators, or inhibitors. The concentration of 
each metabolite is in turn subject to the integration of all enzymatic reactions that 
consume or build this component (Nielsen & Oliver, 2005). The integrated output of 
all these interactions is the metabolic phenotype, represented by the metabolic flux 
distribution of the cell: the fluxome (Figure 7). Therefore, the fluxome is at the heart of 
analyzing complex systems. A combined approach of fluxomics and transcriptomics 
appears useful to integrate metabolic and regulatory networks (Krömer et al, 2004; 
Buschke et al, 2013). The latter will help to evaluate the underlying regulation 
principle and may link the metabolic response of central carbon metabolism to further 
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unknown properties of the cell. This appears particularly useful to unravel the 
obviously complex links between virulence and metabolism. Admittedly, there is only 
one study that analyzes Yersinia virulence mechanisms with a systems biology 
approach (Ansong et al, 2013). Metabolic flux analysis evolved mainly in 
biotechnology research as flux data proved useful to guide rational strain design 
(Kohlstedt et al, 2010). A large number of successful applications confirmed 13C 
metabolic flux analysis as a powerful tool to unveil specific pathways as crucial 
control elements towards formation of the target product. In lysine-producing 
Corynebacterium glutamicum, the NADPH delivering pentose phosphate (PP) 
pathway was identified as such a control element. This insight was deciphered by 
comparing different mutants on the metabolic flux level (Wittmann & Heinzle, 2002). 
Through subsequent genomic modifications, lysine production was increased by 
about 50% (Becker et al, 2007). In more recent years, 13C metabolic flux analysis has 
been extended to a broader field of applications. The investigation of the network-
wide balancing of reducing equivalents (Fuhrer & Sauer, 2009), the disclosure of flux 
distributions in the rarely analyzed clade of Roseobacter (Fürch et al, 2009), 
identification of unusual metabolic routes in Mycobacterium tuberculosis (Beste et al, 
2011), and niche specific metabolic adaption of different clinical isolates of 
Pseudomonas aeruginosa (Berger et al, 2014) are excellent examples for the 
advanced appropriability of this technology. 
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3.6 Concept of 13C metabolic flux analysis 
The typical work-flow to assess the intracellular flux distribution of an intact and living 
cell under a certain condition can be divided into an experimental (A) and a 
computer-assisted (B) part (Figure 8). The calculation of intracellular fluxes typically 
requires measurement of substrate uptake, by-product formation, biomass formation, 
biosynthetic requirements, and 13C labeling data from 13C tracer experiments. Input 
and output fluxes can be directly inferred from measurements in culture broth using, 
e.g., HPLC or enzymatic assays. The complex and intertwined pathways of central 
carbon metabolism, some of which include complex fine structures as parallel or 
cyclic reactions, can only be calculated with direct information from reaction 
participants (Kohlstedt et al, 2010). This information is accessible by use of 13C-
labeled substrates. Depending on the underlying metabolism, a characteristic mass 
isotopomer distribution is derived from different positional isotopomers (molecules 
with a specific number and position of 13C carbon atoms) (Wittmann, 2002). Labeling 
patterns can be obtained from intracellular metabolites and from amino acids that 
reflect the carbon backbone of these metabolites by mass spectrometry. Amino acids 
are much more abundant, stable and easier accessible through cell extracts and 
hydrolyzed biomass. They can be separated by gas chromatography within less than 
30 minutes and provide data with measurement errors below 0.5% (Wittmann, 2007).  
Second, the calculation of intracellular fluxes is performed by isotopomer and 
metabolite balancing (Wittmann & Heinzle, 2002; Krömer et al, 2004). The open 
source software OpenFlux, e.g., compiles the required isotopomer and metabolite 
balance models from user input (Quek et al, 2009). The user input comprises a linear 
system of equations that represents the stoichiometry of the reaction network and 
information about the carbon transition of each reaction. 
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Figure 8. Schematic overview of 13C metabolic flux analysis. Plane A illustrates the 
experimental part. Here, all information is generated by tracer experiments with subsequent 
analysis of substrate uptake, by-product formation, biomass formation, and labeling patterns. 
12C-atoms of intermediary metabolites are illustrated as empty circles, 13C-atoms as filled 
circles. The computational part (B) comprises the construction of the metabolic reaction 
network, the integration of experimental data, least-square parameter estimation and 
parameter sensitivity analysis with the modeling software OpenFlux (Quek et al, 2009). Plane 
C shows the visualized result of metabolic flux analysis. The relative carbon flux is indicated 
by the thickness of the arrows. Black arrows are intracellular carbon fluxes, blue arrows 
represent in- and output fluxes. Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 6-
phosphate; 6PG, 6-phosphogluconate; P5P, pentose 5-phosphates; T3P, triose 3-
phosphates; PEP, phosphoenolpyruvate; PYR, pyruvate; OAA, oxaloacetate; ICI, isocitrate; 
SUC, succinate; FUM, fumarate; MAL, malate; LAC, lactate; FORM, formate; ACE, acetate; 
EtOH, ethanol; AKG, α-ketoglutaric acid; AcCoA, acetyl-CoA. This figure is adapted from 
(Wittmann, 2007). 
At branch points free and independent fluxes need to be assigned. The calculation 
starts with an initial guess for free fluxes and the subsequent computation of 
dependent fluxes via stoichiometric mass balances. Gradient solvers can then be 
used to perform an iterative optimization of free fluxes towards minimal residual 
errors between computed and measured labeling data. The weighted sum of least-
squares is best used as error criterion, thus accuracy of label measurement can be 
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taken into account. The identification of a global minimum can be verified by variation 
of initial start values for the free fluxes and repetitive flux estimation (Wittmann & 
Heinzle, 2002). The best solution of the parameter estimation delivers almost 
identical 13C labeling data compared to experimental values and, therefore, 
represents the metabolic fluxes in the living cell (Quek et al, 2009). 
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4 MATERIALS AND METHODS 
4.1 Bacterial strains and mutant construction 
The strains, plasmids, and primers for genetic construction, used in this work, are 
listed in Table 1 and 2. The wild type strain Y. pseudotuberculosis (YPIII) and the 
mutants YP3 (∆rovA), YP53 (∆csrA), and YP89 (∆crp) were obtained from (Bölin et 
al, 1982), (Nagel et al, 2001), (Heroven et al, 2008), and (Heroven et al, 2012b), 
respectively. 
Additionally, a set of defined mutant strains was constructed for this work in the group 
of Petra Dersch (Department of Molecular Infection Biology, Helmholtz Centre for 
Infection Research, Braunschweig, Germany). Particularly, these were single gene 
deletion strains: YP49 (∆arcA), YP252 (∆ptsN), YP253 (∆pykF), and YP274 (∆pdhR). 
DNA manipulation and transformation were performed using standard genetic and 
molecular techniques, as previously described (Miller, 1992; Sambrook & Green, 
2001). For construction of the mutagenesis plasmids pAKH175, pAKH177, and 
pAKH187, respectively, a PCR fragment harboring a kanamycin resistance gene 
(kan) was generated for insertion into the ptsN, pykF, or pdhR gene (ptsN::KanR, 
pykF::KanR, or pdhR::KanR). The kanamycin gene was amplified using primer pair 
I661/I662 and plasmid pKD4 as template. Next, Yersinia YPIII genomic DNA was 
used as template to amplify 300-500 bp regions flanking the target genes. The 
upstream fragment was amplified with a primer pair of which the reverse primer 
contained additional 20 nt at the 5′-end which were homologous to the start of the 
kanamycin cassette (ptsNup: primer IV971/IV972; pykFup: primer IV977/IV978; 
pdhRup: primer V567/V548). The downstream fragment was amplified with a primer 
pair of which the forward primer contained additional 20 nt at the 3′-end which were 
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homologous to the end of the kanamycin cassette (ptsNdown: primer IV973/IV974; 
pykFdown: primer IV979/IV980; pdhRdown: primer V549/V550). In the next step, a PCR 
reaction was performed with the forward and the reverse primer using the upstream 
and downstream PCR products of the respective target gene and the kan gene 
fragment as templates. The resulting fragment was digested with SacI and ligated 
into the SacI site of pAKH3. Construction of the Y. pseudotuberculosis YPIII 
arcA::KanR mutant YP49 was performed by allelic exchange as described previously 
(Derbise et al, 2003; Heroven et al, 2008). The kanamycin gene was amplified from 
pACYC177 with the primer pair 360/361. The upstream and downstream fragment, 
flanking the arcA gene, was amplified with primer pair 655/656 and 657/658, 
respectively. Each fragment contained 20 nucleotides, homologous to the kan gene. 
In the next step, a PCR reaction was performed with the forward primer of the 
upstream fragment and the reverse primer of the downstream fragment, using the 
upstream and downstream PCR products of the target gene and the kan PCR 
fragment as template. The PCR fragment was transformed into Y. 
pseudotuberculosis YPIII pKOBEG-sacB. Chromosomal integration of the fragment 
was selected by plating on solid LB medium, supplemented with kanamycin. Mutants 
were subsequently grown on LB agar plates without NaCl plus 10% sucrose, and 
faster growing colonies without pKOBEG-sacB were selected and proven by PCR 
and DNA sequencing. The Yersinia mutants YP252 (YPIII ptsN::KanR), YP253 (YPIII 
pykF::KanR) and YP274 (YPIII pdhR::KanR) were constructed as described in 
(Heroven et al, 2012b), using the suicide plasmids pAKH175, pAKH177, and 
pAKH187.  
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Table 1. Bacterial strains and plasmids. 
Strains, plasmids Description Source and reference 
E. coli   
S17-λpir recA1 thi pro hsdR
-
 RP4-2Tc::Mu 
Km::Tn7 λpir (Herrero et al, 1990) 
Y. pseudotuberculosis   
YPIII   plB1, wild type (Bölin et al, 1982) 
YP3 plB1, rovA::Tn10(60)a, CmlR (Nagel et al, 2001) 
YP49 plB1, ∆arcA, KanR This study 
YP53 plB1, ∆csrA, KanR (Heroven et al, 2008) 
YP89 plB1, ∆crp (Heroven et al, 2012b) 
YP252 plB1, ∆ptsN, KanR This study 
YP253 plB1, ∆pykF, KanR This study 
YP274 plB1, ∆pdhR, KanR This study 
Plasmids 
  
pACYC177 Cloning vector, p15A, ApR, KanR (Chang & Cohen, 1978) 
pAKH3 pGP704, sacB+, ApR (Heroven et al, 2012b) 
pAKH175 pAKH3, ptsN::KanR This study 
pAKH177 pAKH3, pykF::KanR This study 
pAKH187 pAKH3, pdhR::KanR This study 
pKD4 kanamycin cassette template, KnR, ApR (Datsenko & Wanner, 2000) 
pKOBEG-sacB recombination vector, sacB+, CmR (Derbise et al, 2003) 
pkH70 
pFU76, ProvA::rovA-gfpLVA, AmpR, 
∆R6Kmob, ori29807; containing rovA 
promoter fragment from -622 to +170 
(Herbst, 2011) 
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Table 2. Oligonucleotides used as primers for genetic engineering of Y. pseudotuberculosis. 
Restriction sites for SacI are underlined. Nucleotides homologous to the kanamycin 
resistance cassette are given in bold.  
Number Sequence site 
I661 GTGTAGGCTGGAGCTGCTTC  
I662 CATATGAATATCCTCCTTAGTTCC  
IV971 GCGGCGGAGCTC CGAGAGTCGTTATCCATCCC SacI 
IV972 GAAGCAGCTCCAGCCTACACCTCATCTTTCACTTAAGCGC  
IV973 ACTAAGGAGGATATTCATATGCCTAGTTTGGGGCCAATACG  
IV974 GCGGCGGAGCTCCTATCGGCAAGTGTACTTGC SacI 
IV977 GCGGCGGAGCTCCGTCACTTACCGCTTATAATAC   SacI 
IV978 GAAGCAGCTCCAGCCTACACGACGGATTTTTTCTACAAGTTG    
IV979 ACTAAGGAGGATATTCATATGCTTCAGTACACGTGTTATAATTCC    
IV980 GCGGCGGAGCTCCGTCAGAAGACAGTTGATCG   SacI 
V567 GCGGCGGAGCTCGAGTCATGTGTGCTTTCTAGG SacI 
V548 GAAGCAGCTCCAGCCTACACGGTGTAAGCCGTATTGAGTG  
V549 ACTAAGGAGGATATTCATATGCGAAATGTTGGCCACTGTGAG    
V550 GCGGCGGAGCTCCCCAAGACCTGATCAATCAG SacI 
360 GGTGATTTTGAACTTTTGCTTTG  
361 CCAGTGTTACAACCAATTAACC  
655 CATCGCCATAATGCCAAGAG  
656 GCAAAGCAAAAGTTCAAAATCACCGCTACCTAAAATTGCCAACAAAATAGAAATAGGAAGTACAGAAGTCTTTG  
657 GGTTAATTGGTTGTAACACTGGCTTTCGCGAATAGAGACGGAAAGAGCCAGCACACAGATGCTGGCTTTTTTG  
658 GGTATTAAAGGCGGATTGGG  
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4.2 Cultivation 
4.2.1 Strain conservation  
Cells were stored in 1 mL of 10% glycerol solution with 50 mg L-1 lactose at -80°C in 
stock culture tubes. 
4.2.2 Batch cultivation for metabolic flux analysis 
Cells were cultivated at 25°C and 200 rpm under aeration on a rotary shaker (Lab 
Shaker, B. Braun Melsungen, Melsungen, DE) with a shaking diameter of 5.0 cm. 
First pre-cultures were inoculated with single colonies from 2 days old LB agar plates 
(per liter: 10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g agar) and grown in a 1:1 
mixture of HAM’s F-12 Nutrient Mixture (Invitrogen, Carlsbad, US) and liquid DMEM 
(Biochrom, Berlin, DE). Second pre-cultures and main cultures were grown in a 
Yersinia minimal medium (YMM) that was developed in the present work. YMM at pH 
6.8 contained the following per liter: 8 g glucose, 6.62 g KH2PO4, 13.26 g K2HPO4, 
0.31 g NaCl, 5 g (NH4)2SO4, 0.20 g MgSO4·7H2O, 30 mg 3,4-dihydroxybenzoic acid, 
0.5 mg FeSO4·7H2O, 1.3 mg ZnSO4·7H2O, 2 mg FeCl3·6H2O, 2 mg MnSO4·H2O, 0.2 
mg CuCl2·2H2O, 0.2 mg Na2B4O7·10H2O and 0.1 mg (NH4)6Mo7O24·4H2O. In tracer 
experiments for metabolic flux analysis, the natural glucose was replaced by 99% 
[1-13C] glucose (Euriso-top, Saint-Aubin Cedex, FR), and the inoculum level was 
below 1% of the sampled cell concentration (Wittmann, 2007). The dissolved oxygen 
concentration was quantified on-line by immobilised sensor spots (Wittmann et al, 
2003). 
4.2.3 Continuous cultivation for temperature shift experiments 
First, single colonies were taken from selective carbenicillin LB agar plates (per liter: 
10 g tryptone, 5 g  yeast extract, 5 g NaCl, 0.1 g carbenicillin, 15 g agar) and were 
used to inoculate pre-cultures performed in baffled shake-flasks. The complex 
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ingredients were obtained from Becton, Dickinson and Company (Franklin Lakes, 
US). After 16 h, cells were harvested by centrifugation for 5 min at 9,016 x g and 
25°C (Heraeus Multifuge X1R, Thermo Fisher Scientific, Waltham, US), washed with 
sterile 0.9% NaCl and used for inoculation. Main cultures were carried out in a lab 
scale bioreactor (Vario 500, Medorex, Nörten-Hardenberg, DE), which was 
specifically modified for precise temperature programming and control. The reactor 
contained 220 mL of selective LB broth. After inoculation, an initial batch phase was 
performed at 25°C. When cells reached a specific growth rate of µ = 0.32 h-1, as 
monitored via the optical density (OD600), the system was switched to continuous 
cultivation mode (D = 0.32 h-1). OD600, pH and oxygen saturation were used to check 
for steady-state. Once steady-state was confirmed, i.e., after at least five residence 
times, individual temperature programs were initiated. 
The reactor was equipped with a pH-probe (Mettler-Toledo, Gießen, DE) and an 
amperiometric electrode for measurement of dissolved oxygen (InPro, Mettler-
Toledo, Greifensee, CH). Process parameters were assembled by the system’s 
control unit (FCU 05, Medorex, Nörten-Hardenberg, DE). Dissolved oxygen was kept 
above 30% by mixing oxygen and air as aeration gasses (5850 TR, Brooks 
Instrument, Hatfield, US connected to a WMR-C4 control unit, Westphal Mess- und 
Regeltechnik, Ottobrunn, DE). The aeration rate was set to 0.77 vvm. The 
temperature was precisely controlled by a combination of the integrated heating rod 
of the reactor and of a self-constructed water jacket. The latter was manually 
controlled by an Ecoline RE 107 thermostat (Lauda, Lauda-Königshofen, DE). The 
liquid condenser in the exhaust gas duct was supplied with periodic air pulses, to 
transfer excess liquid from the condenser back into the reactor, which improved 
process stability. The pulse was automatically conducted every 30 seconds by a 
clock generator (KPT 31 KD, Schleicher, Berlin, DE) through a magnetic valve 
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(244DVF, M&M International, Mailand, IT). The imposed pressure was 0.4 bar in 
closed and 0.2 bar in open valve position, respectively. Mixing (400 rpm) was 
performed with a self-constructed two-blade-stirrer, each blade with 0.8 cm height 
and width, respectively, assembled at a stirrer shaft attachment with same 
dimensions. The stirrer was placed 1.5 cm above the reactor bottom for efficient 
mixing. Pumping of fresh medium into the reactor, of exhaust medium out of the 
reactor, and circulation of condenser cooling water, respectively, was maintained by 
a peristaltic pump (101 U/R, Watson Marlow, Cornwall, UK). 
4.3 Analytical Methods 
4.3.1 Glucose, organic acids, and amino acids 
Glucose concentration was measured by enzymatic analysis (YSI 2700 Select, YSI 
Incorporated, Yellow Springs, US). Organic acids and alcohols were quantified by 
HPLC (Becker et al, 2013). Amino acid quantification was conducted as previously 
described (Krömer et al, 2005).  
4.3.2 Cell concentration 
The cell concentration was measured as optical density at 600 nm (OD600) with a 
photometer (Libra S11, Biochrom, Cambridge, GB). In addition, the cell dry weight 
(CDW) was determined by gravimetric analysis. For this purpose, 15 mL samples of 
culture broth were taken at different time points during the exponential growth phase. 
Cells were harvested by centrifugation for 15 min at 6,800 x g and 4°C in 
pre-weighed tubes (Sigma 2K15C, Sigma GmbH, Osterode, DE) and washed with ice 
chilled 0.9% NaCl and water. The cells were then dried to constant weight at 80°C. 
From both measurements, conducted for the wild type, a correlation factor of 0.325 
(gCDW L-1) = 1 OD600 unit was obtained (Figure 9). This correlation was used to infer 
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cell dry weight from measurement of optical density, whereby the value for the wild 
type was also used for mutant strains. 
 
Figure 9. Correlation of gravimetrically determined cell dry weight (CDW) with optical density 
at 600 nm (OD600). From both measurements a correlation factor of 0.325 (gCDW L-1) = 1 
OD600 was obtained. 
4.3.3 GC-MS labeling analysis 
Mass isotopomer distributions of proteinogenic amino acids were quantified by gas 
chromatography-mass spectrometry (GC-MS) after derivatization with N-methyl-N-
tert-butyldimethylsilyl-trifluoroacetamide (Wittmann et al, 2002). GC-MS analysis was 
performed as previously described (Kiefer et al, 2004; Wittmann et al, 2004). To 
check for potential isobaric interference, all samples were first measured in scan 
mode. The labeling analysis was then conducted in duplicate by selective ion-
monitoring of representative ion clusters for each analyte. The chosen settings 
allowed complete separation of all analytes of interest (Figure 10). 
For metabolic flux estimation the following ion clusters were measured: alanine (m/z 
260, 261, 262, 263), glycine (m/z 246, 247, 248), valine (m/z 288, 289, 290, 291, 
292, 293), serine (m/z 390, 391, 392, 393), threonine (m/z 404, 405, 406, 407, 408), 
phenylalanine (m/z 336, 337, 338, 339, 340, 341, 342, 343, 344, 345), aspartate (m/z 
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418, 419, 420, 421, 422), glutamate (m/z 432, 433, 434, 435, 436, 437), tyrosine (m/z 
466, 467, 468, 469, 470, 471, 472, 473, 474, 475). 
 
Figure 10. GC-MS spectrum of t-butyl-dimethylsilyl-derivatized proteinogenic amino acids of 
Yersinia pseudotuberculosis in selective ion-monitoring mode. Blue signals represent amino 
acids used for calculation of metabolic flux distribution. Amino acids were identified by their 
retention time and compound-specific ions as described by (Wittmann et al, 2002). 
4.3.4 Quantification of RovA by Western blot analysis 
From cells, sampled by centrifugation from culture broth for 2 min at 16,060 x g and 
4°C (Biofuge fresco, Heraeus, Hanau, DE), whole cell extracts were prepared by 
addition of 100 µL SDS (sodium dodecyl sulfate) sample buffer per 0.65 mgCDW and 
repeated pipetting at 25°C for 10 seconds. Aqueous SDS sample buffer contained 
per 50 mL: 5 mL Tris-HCl solution (121.14 g L-1 Tris, pH 6.8), 20 mL glycerol, 5 mL 
β-mercaptoethanol, 8 mL SDS solution (200 g L-1) and 0.1 g bromophenol blue 
(Sambrook & Green, 2001). For DNA digestion, one percent by volume of benzonase 
(Merck, Darmstadt, DE) was added to whole cell extracts, and the mixture was 
incubated for 1 h at 37°C. Separation of cell extracts and Western blotting were 
performed as previously described (Heroven et al, 2004) and conducted by the group 
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of Petra Dersch (Department of Molecular Infection Biology, Helmholtz Centre for 
Infection Research, Braunschweig, Germany). 
4.3.5 Quantification of RovA by fluorescence-activated cell sorting  
A volume of 200 µL culture broth was centrifuged for 1 min at 16,100 x g and 25°C 
(Centrifuge 5415R, Eppendorf, Hamburg, DE). Harvested cells were fixed for 20 min 
with 1 mL paraformaldehyde (4%, pH 7.5) at 25°C. Fixed cells were washed twice 
with phosphate buffered saline (PBS, contained per liter: 8 g NaCl, 0.2 g KCl, 0.61 g 
Na2HPO4, 0.2 g KH2PO4, pH 7.3), re-suspended in 1 mL PBS and subsequently 
stored at 4°C. Following appropriate dilation, fixed cell samples were used for 
measurement of fluorescence in a BD LSR II flow cytometer (BD Biosciences, 
Franklin Lakes, US). The evaluation of 100.000 counted cells per run was performed 
with the software FlowJo (Version 9.3.1., Tree Star Inc., Ashland, US). The 
measurement was conducted by the group of Petra Dersch (Department of Molecular 
Infection Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany). 
4.4 Analysis of cellular composition of Y. pseudotuberculosis  
In this work, thorough analysis of cellular composition was conducted to provide 
precise and most representative data for anabolic fluxes in metabolic flux studies with 
Y. pseudotuberculosis.  
4.4.1 Protein content and amino acid composition 
Protein content was determined after enzymatic treatment of frozen cell pellets. For 
this purpose, the cell pellet was re-suspended in lysis buffer with 25 U mL-1 
benzonase and 10 KU mL-1 lysozyme (Bug Buster, Merck, Darmstadt, DE) and 
incubated for 1 h at 170 rpm and 25°C on a rotary shaker. To ensure efficient 
digestion, the cell concentration was adjusted to between 3 and  
15 mgCDW L-1. Subsequently, the sample was clarified from cell debris by 
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centrifugation for 20 min at 6,800 x g and 4°C (Sigma 2K15C, 137 Sigma GmbH, 
Osterode, DE). The protein amount was then quantified by UV absorption 
measurement at 280 and 260 nm (Nanodrop ND-1000, Thermo Fisher Scientific, 
Waltham, US) in the supernatant. The protein concentration was calculated as 
described previously (Walker, 2002). The amino acid composition of cell protein was 
quantified after acidic hydrolysis of cells in 50 µL 6 M HCl per mg of cell dry weight at 
105°C for 24 h. Amino acids in the hydrolyzates were then quantified by HPLC as 
described above. Values for cysteine, methionine, and tryptophan, respectively, were 
not accessible, because these were degraded during the hydrolysis procedure. 
Accordingly, these data were inferred from the closely related gut bacterium 
Escherichia coli (Neidhardt et al, 1990).  
4.4.2 RNA content and nucleotide composition 
For quantification of the RNA content cells were washed twice with ice cold killing 
buffer (20 mM Tris/HCl pH 7.5; 5 mM MgCl2; 20 mM NaN3) to prevent RNA 
degradation. RNA preparation was performed as described previously (Dauner & 
Sauer, 2001), followed by quantification using a Nanodrop ND-1000 at 260 nm. The 
nucleotide composition of RNA was calculated from the sequences of the 5S, 16S 
and 23S rRNA genes of Y. pseudotuberculosis (NCBI reference sequence of the 
genome: NC_010465), based on the assumption that the total RNA pool is mainly 
composed of rRNA (Brown, 2002).  
4.4.3 DNA content and nucleotide composition 
The DNA content was determined after phenol-chloroform-extraction. For this 
purpose, cells were harvested by centrifugation at 16,100 x g and 4°C for 5 min. An 
appropriate amount of cells (0.2 - 0.5 mg cell dry weight) was re-suspended in 
560 µL lysis buffer (pH 8.0) containing per liter 2.88 g Tris, 6.96 g EDTA 
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(ethylenediaminetetraacetic acid), 97.80 g sucrose, and 0.48 mg lysozyme and then 
disrupted by incubation at 800 rpm and 30°C for 30 min (Thermomixer comfort, 
Eppendorf, Hamburg, DE). A second disruption was performed with FastPrep-24 (MP 
Biomedicals, Santa Ana, US) involving two cycles of 40 s each at 6.0 m s-1 and 4°C. 
Subsequently, 140 µL RES buffer with RNaseA (NucleoBond Xtra, Macherey-Nagel, 
Düren, DE) was added to degrade RNA residues, otherwise interfering with the 
subsequent analysis. The aqueous DNA solution was extracted twice with 700 µL 
Roti-P/C/I (Carl-Roth, Karlsruhe, DE) and 700 µL chloroform. Precipitation of DNA 
was performed after addition of 65 µL sodium acetate (3 M) and 1.3 mL ethanol 
(100%). The DNA pellet was washed with 70% ethanol, dried and re-suspended in 
deionized water. All centrifugation steps were performed at 16,100 x g and 4°C for 10 
min. Quantification was carried out by measuring the absorbance at 260 nm using a 
Nanodrop ND-1000 (Thermo Fisher Scientific, Waltham, US). The nucleotide 
composition of DNA was calculated from the genomic GC content of 47.5% (NCBI 
reference sequence of the genome: NC_010465).  
4.4.4 Glycogen and Lipids  
Data for glycogen, lipids and minor shares of further biomass constituents were taken 
from E. coli (Neidhardt et al, 1990). 
4.5 Gene expression profiling 
Global gene expression was analyzed with DNA microarrays (Agilent, Waldbronn, 
DE, 8 × 15 K format). The analysis comprised three biological replicates for each 
strain and samples from three different time points during exponential growth phase 
to validate constant expression during cultivation. Array design, RNA extraction, and 
hybridization were performed as previously described  (Heroven et al, 2012b). 
Microarray data processing was conducted using the Limma package (Smyth, 2005) 
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from the R/Bioconductor framework (Gentleman et al, 2004). Unprocessed array 
intensity values were read-in using the function read.maimages, and the background 
was corrected with the improved saddle-point approximation to the maximum 
likelihood method (Silver et al, 2009) using an intensity offset of 50. The array 
intensities were normalized within each array using loess normalization (Yang et al, 
2002) and between arrays using quantile normalization (Bolstad et al, 2003; Yang & 
Thorne, 2003) to obtain similar distributions of expression intensities. To obtain 
reliable gene expression values, normalized intensities of at least three probes 
targeting the same gene were averaged. Differentially expressed genes were 
determined using the lmFit function for linear modeling and by computing moderated 
t-statistics and log-odds with the function eBayes (Smyth, 2004). P-values from the 
moderated t-tests were corrected for multiple testing using the Benjamini-Hochberg 
procedure for controlling the false discovery rate. Finally, the set of differentially 
expressed genes was filtered by the fold change (|log2FC| >=0.8). All array data 
generated in this study were deposited in the Gene Expression Omnibus (GEO) 
database and are available under accession number GSE54547. Hybridization and 
data processing was conducted by the group of Petra Dersch (Department of 
Molecular Infection Biology, Helmholtz Centre for Infection Research, Braunschweig, 
Germany). 
4.5.1 Hierarchical clustering analysis 
Hierarchical clustering of transcriptome data was conducted with the heatmap.2 
function of the R package gplots (Warnes et al, 2012).  
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4.6 Metabolic flux analysis 
4.6.1 Metabolic network and biomass requirements 
The metabolic network of Y. pseudotuberculosis was constructed from its genome-
encoded pathway repertoire (NCBI Reference Sequence: NC_010465.1). The 
network comprised all relevant central metabolic pathways, i.e., the Embden-
Meyerhof-Parnas (EMP) pathway, the pentose phosphate (PP) pathway, the Entner-
Doudoroff (ED) pathway, and the tricarboxylic acid (TCA) cycle, as well as the 
anaplerotic glyoxylate shunt, phosphoenolpyruvate (PEP) carboxylase, PEP 
carboxykinase, and malic enzyme. Furthermore, biosynthetic pathways for by-
product formation and anabolism were implemented. The requirement of Y. pseudo-
tuberculosis for anabolic precursors was estimated on the basis of its cellular 
composition, which was experimentally determined. The full set of reactions is given 
in the appendix (Table 11). 
4.6.2 Metabolic flux calculation and statistical evaluation 
For calculation of metabolic fluxes the reconstructed metabolic network, extracellular 
and anabolic fluxes, and labeling data were implemented into the open source 
software OpenFlux 2.1 (Quek et al, 2009). Extracellular fluxes were obtained by 
thorough analysis of all organic acids, amino acids, sugars, alcohols, and glucose as 
the sole carbon source. All anabolic fluxes were calculated from the determined 
cellular composition and the biomass yield on glucose. Mass isotopomer distribution 
data was obtained from GC-MS analysis of t-butyl-dimethylsilyl-derivatized 
proteinogenic amino acids. Matlab 7.11 (MathWorks Inc., Natick, US) was used as a 
numerical computing environment. The gradient solver FMINCON (Optimization 
Toolbox of Matlab) was used to perform an iterative optimization of free fluxes 
towards minimal residual errors between computed and measured labeling data. The 
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weighted sum of least-squares was used as error criterion, thus, accuracy of label 
measurement was taken into account. The identification of a global minimum was 
verified by variation of initial start values for the free fluxes and repetitive flux 
estimation (Wittmann & Heinzle, 2002). The best solution of the parameter estimation 
delivered almost identical 13C labeling data compared to experimental values and, 
therefore, represents the metabolic fluxes in the living cell (Quek et al, 2009). 
Subsequent statistical analysis by a Monte-Carlo approach was performed to 
calculate 95% confidence intervals (Wittmann & Heinzle, 2002).  
4.7 In vivo mouse studies 
4.7.1 Mouse infections 
The bacteria used for oral infection were grown overnight at 25°C in LB medium and 
re-suspended in PBS (contained per liter: 8 g NaCl, 0.2 g KCl, 0.61 g Na2HPO4, 
0.2 g KH2PO4, pH 7.3). To assess the effect of single gene deletions on 
Y. pseudotuberculosis virulence, groups (n=20) of 7-week-old female BALB/c mice 
(Janvier, Saint Berthevin, FR) were orally infected with an equal mixture of 
107 bacteria of the wild type strain (YPIII) and an isogenic mutant strain, i.e., YP49 
(∆arcA), YP252 (∆ptsN), YP253 (∆pykF), or YP274 (∆pdhR). At 5 days post-infection, 
the mice were euthanized by CO2 asphyxiation. Peyer’s patches (PPs), mesenteric 
lymph nodes (MLNs), and the liver and spleen were isolated. The ileum was rinsed 
with sterile PBS and incubated with 100 µg mL-1 gentamicin to kill the bacteria on the 
luminal surface. After 30 min, gentamicin was removed by extensive washing with 
PBS. Subsequently, all organs were weighed and homogenized in sterile PBS at 
30,000 rpm for 20 s using a Polytron PT 2100 homogenizer (Kinematica, Lucerne, 
CH). The bacterial organ burden was determined by plating three independent serial 
dilutions of the homogenates on LB plates with and without kanamycin. The colony-
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forming units (CFU) were counted and are given as CFU per gram of organ/tissue. 
The levels of statistical significance for differences in the organ burden between test 
groups were determined by the Mann-Whitney test. The competitive index relative to 
the wild type strain YPIII was calculated as previously described (Monk et al, 2008). 
Mouse in vivo studies were conducted in the group of Petra Dersch (Department of 
Molecular Infection Biology, Helmholtz Centre for Infection Research, Braunschweig, 
Germany). 
4.7.2 Ethics statement 
All animal work was performed in strict accordance with the German Recom-
mendations of the Society for Laboratory Animal Science (GV-SOLAS) and the 
European Health Recommendations of the Federation of Laboratory Animal Science 
Associations (FELASA). The animal protocol was approved by the Nieder-
sächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (animal 
licensing committee permission no. 33.9-42502-04-12/1010). Animals were handled 
with appropriate care and welfare, and all efforts were made to minimize suffering.
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5 RESULTS AND DISCUSSION 
5.1 Integration of virulence and metabolism - A systems biology approach 
5.1.1 Glucose-grown Y. pseudotuberculosis secretes high amounts of 
pyruvate under fully aerobic conditions 
When grown on minimal medium, Y. pseudotuberculosis completely consumed the 
carbon source glucose within 8.8 h, indicating high activity of the cultured bacteria 
(Figure 11).  
 
Figure 11. Cultivation profile of wild type Y. pseudotuberculosis in YMM with glucose as the 
sole source of carbon and energy. The data comprise the concentrations of glucose (gray 
circle), pyruvate (gray square), lactate (open circle), acetate (open triangle), and the optical 
density (open diamond) and represent the mean of three biological replicates with the 
corresponding deviations given as error bars. 
Indeed, the specific rates of growth (0.32 h-1) and substrate uptake (7.1 mmol g-1 h-1) 
were consistently maintained at high levels throughout the cultivation (Table 4). 
Glucose, however, was only partially converted into biomass, as indicated by a low 
biomass yield (45.2 g mol-1). A range of metabolites was secreted into the medium. 
Surprisingly, high amounts of pyruvate accumulated (22.6 mmol L-1). Lactate 
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(5.4 mmol L-1) and acetate (3.0 mmol L-1) were also observed (Figure 11). Additional 
by-products (formate, ethanol, α-ketoglutarate, succinate, and fumarate) were found 
at lower levels (Table 4). The level of dissolved oxygen, which was monitored on-line, 
remained above 30% of saturation throughout the entire cultivation period (Figure 
12). This finding indicates that the observed overflow metabolism was active in fully 
aerobic cells. The developed set-up enabled highly reproducible growth for the wild 
type (Figure 11, Figure 12) and for all investigated deletion mutants (Figure 13). 
 
Figure 12. Dissolved oxygen remained above 30% of saturation throughout the entire 
cultivation. Oxygen measurement was carried out on-line by non-invasive oxygen sensor 
spots in triplicate. Samples were taken at different time points to monitor the cell 
concentration by optical densities OD600 (open diamond). Data of dissolved oxygen are given 
in gray shades. 
Efficient expression of RovA is an indicator for virulence promoting conditions and 
was hence an important pre-requisite for the subsequent fluxome analysis. Thus far, 
efficient expression of RovA has only been achieved in complex media (Nagel et al, 
2001). However, fluxome profiling, as performed here, requires defined conditions 
(Wittmann, 2002), which excludes the use of a complex medium due to the 
unresolvable effects expected from the utilization of undefined nutrient mixtures. A 
thorough analysis of the expression of RovA revealed a significant influence of 
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monovalent and bivalent ions. Increased levels of bivalent iron and of the iron 
chelator 3,4-dihydroxybenzoic acid stimulated RovA expression, whereas calcium
 
and sodium ions reduced the level of the virulence regulator (Table 3).  
Table 3. Impact of monovalent and bivalent ions on the expression of the early stage 
virulence regulator RovA in Y. pseudotuberculosis. The tested conditions comprise growth in 
complex medium (DMEM/F12) as a positive control and in Yersinia minimal medium (YMM) 
with variations in the added amounts of Ca2+, Na+, Fe2+, and the chelating agent 3,4-
dihydroxybenzoic acid. The level of RovA was visualized by Western blotting using a 
polyclonal antibody as previously described (Heroven et al, 2004). 
 
5.1.2 Influence of the global regulators RovA, CsrA, and Crp on the growth 
behavior and overflow metabolism of Y. pseudotuberculosis 
Next, the manner in which RovA, CsrA, and Crp affect the overall growth behavior of 
Y. pseudotuberculosis was investigated. Deletion of each of the regulators affected 
the fitness and product formation. Y. pseudotuberculosis YP3 (∆rovA) showed a 21% 
enhanced secretion of pyruvate. The growth, substrate uptake, and spectrum of other 
by-products were approximately maintained at the values of the wild type (Table 4). 
The loss of CsrA resulted in a 56% reduction in the growth and substrate uptake. The 
pyruvate excretion increased by 13%, whereas the formation of all other by-products 
was much weaker or even diminished. 
Type of 
medium 
Ca2+ 
[mmol L-1] 
Na+ 
[mmol L-1] 
Fe2+  
[µmol L-1] 
3,4-DHB 
[mmol L-1] RovA 
DMEM/F12 2.1 304 3 - 
 
YMM 2.0 5 2 - 
YMM 1.0 5 2 - 
YMM - 93 2 - 
YMM - 5 2 - 
YMM - 5 2 0.2 
YMM - 5 20 0.2 
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Table 4. Growth characteristics of the Y. pseudotuberculosis wild type strain YPIII and the 
mutants YP3 (∆rovA), YP53 (∆csrA), YP89 (∆crp). The data comprise the specific growth 
rate (µ), the specific rate of glucose uptake (qGlc), and yields on glucose for biomass (YX/S), 
pyruvate (YPyr/S), lactate (YLac/S), acetate (YAce/S), formate (YForm/S), succinate (YSuc/S), fumarate 
(YFum/S), ethanol (YEtOH/S), and α-ketoglutarate (YAkg/S). The values represent the mean of 
three biological replicates and the corresponding standard deviations. 
Strain 
µ qGlc YX/S YPyr/S YLac/S YAce/S YForm/S YSuc/S YFum/S YEtOH/S YAkg/S 
[h-1] [mmol g-1 h-1] [g mol-1]  [molar percentage of the specific glucose uptake rate] 
YPIII  
(Wt) 
0.32 
±	0 
7.1 
± 0.3 
45.2 
±	2.0 
46.4 
±	1.4 
7.1 
± 0.6 
6.7 
±	0.3 
3.0 
±	0.4 
0.2 
±	0 
0.1 
±	0 
3.3 
±	0.7 
1.1 
±	0.1 
YP3 
(∆rovA) 
0.31 
± 0.01 
7.1 
± 0.2 
44.9 
± 2.8 
56.1 
± 4.6 
8.2 
± 0.8 
6.9 
± 0.5 
2.6 
± 0.1 
0.2 
± 0 
0.1 
±	0 
4.0 
± 0.7 
1.5 
± 0.1 
YP53 
(∆csrA) 
0.14 
± 0 
3.1 
± 0.3 
45.0 
± 0.9 
52.5 
± 2.4 
3.5 
± 0.2 
3.0 
± 1.0 
0.3 
± 0.4 < 0.1 <0.1 
0.2 
± 0.4 
0.9 
± 0.1 
YP89  
(∆crp) 
0.11 
± 0 
1.5 
± 0 
69.3 
± 3.3 <0.1 
1.0 
± 0.1 
0.2 
± 0.1 
0.8 
± 0.1 < 0.1 <0.1 
-2.0 
± 2.5 
0.9 
±	0 
Values below 0.1% for the by-product yields were below the detection limit. 
The crp mutant (YP89) exhibited a further reduction of fitness. This mutant secreted 
almost no by-products and showed enhanced anabolism (Table 4). In summary, 
various fluxes, ranging from glucose to biomass and to extracellular products, were 
affected in all three regulator mutants. The extent of the cellular response clearly 
matched the hierarchy of the control of proteins within the virulence cascade 
(Figure 3). 
5.1.3 Metabolic and isotopic steady state – two important prerequisites for 
metabolic flux analysis 
The applied flux analysis requires a metabolic and isotopic steady state to ensure flux 
calculation that is valid for the whole exponential growth phase. As previously shown, 
the set-up provides constant specific growth with sufficient supply of oxygen 
(Figure 11, Figure 12). Metabolic steady state was further proven by constant 
by-product yields on glucose (Figure 13). 
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Figure 13. Stoichiometry of by-product formation during cultivation of the 
Y. pseudotuberculosis wild type strain (YPIII) and of single gene deletion mutants: YP3 
(∆rovA), YP53 (∆csrA), and YP89 (∆crp). The linear correlation between formed pyruvate 
(gray square), acetate (open triangle), lactate (open circle) and consumed glucose indicates 
metabolic steady state. All cultivations were performed in triplicate.   
To ensure isotopic steady state, samples were taken from parallel tracer experiments 
with [1-13C] glucose at different cell dry mass concentrations, reflecting different 
cultivation time points. Subsequently, proteinogenic amino acids were analyzed in 
respect to their labeling patterns (Figure 14). The constant mass isotopomer 
distributions of nonlabeled (M0), single labeled (M1), and double labeled (M2) t-butyl-
dimethylsilyl derivates of proteinogenic alanine, serine, phenylalanine, glutamate, 
and aspartate, reflecting different parts of central carbon metabolism, verified isotopic 
steady state (Figure 14).  
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Figure 14. Verification of isotopic steady state during 13C tracer studies of 
Y. pseudotuberculosis wild type (WT) and of single gene deletion mutants YP3 (∆rovA), 
YP53 (∆csrA), and YP89 (∆crp) grown on 99% [1-13C] glucose by constant labeling patterns 
of t-butyl-dimethylsilyl derivates of proteinogenic amino acids at different cell dry mass 
(CDM) concentrations, reflecting different cultivation time points. The data comprise the 
relative fractions of nonlabeled (M0), single labeled (M1), and double labeled (M2) M-57 
fragments of alanine, serine, phenylalanine, glutamate, and aspartate. 
5.1.4 Cellular composition of Yersinia pseudotuberculosis  
The determination of the biomass composition is a crucial prerequisite for an 
accurate analysis of carbon flux distribution. All macromolecules for biomass 
formation derive from 12 precursor molecules that are part of central carbon 
metabolism. Hence, the demand for a certain precursor influences the flux 
distribution. Thereby, a thorough investigation of the cellular composition was 
performed (Table 5). The NADPH demand that arises from the underlying precursor 
demand was determined to 17,428 µmol gCDW-1. This amount of co-factor has to be 
supplied by NADPH forming reactions of PP pathway and TCA cycle and thus bears 
significant influence on the flux distribution. 
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Table 5. Anabolic precursor demand of Y. pseudotuberculosis for biomass synthesis derived 
from analysis of the cellular composition and the underlying pathway stoichiometry. The latter 
was deduced from the genomic inventory of biosynthetic pathways of Y. pseudotuberculosis 
(Kyoto Encyclopedia of Genes and Genomes). Abbreviations: G6P, glucose 6-phosphate; 
F6P, fructose 6-phosphate; R5P, ribose 5-phosphate; E4P, erythrose 4-phosphate; GAP, 
glyceraldehyde 3-phosphate; PGA, glycerate 3-phosphate; PEP, phosphoenolpyruvate; 
PYR, pyruvate; AcCoA, acetyl-CoA; OAA, oxaloacetate; AKG, alpha-ketoglutaric acid. 
Precursor 
Demand 
[µmol g-1] G6P F6P R5P E4P GAP PGA PEP PYR AcCoA OAA AKG NADPH 
Alanine 604 1 1 
Arginine 277 1 4 
Aspartate/Asparagine 572 1 1 
Cysteine 92 1 5 
Glutamate/Glutamine 557 1 1 
Gycine 483 1 1 
Histidine 98 1 1 
Isoleucine 236 1 1 5 
Leucine 463 2 1 2 
Lysine 340 1 1 4 
Methionine 155 1 8 
Phenylalanine  180 1 2 2 
Proline 297 1 3 
Serine 275 1 1 
Threonine 270 1 3 
Tryptophan 57 1 1 1 3 
Tyrosine 91 1 2 2 
Valine 333 2 2 
Protein 
  
    155 328   850 598 2,772 463 1,573 1,131 11,940 
ATP 117 1 1 1 
UTP 92 1 1 1 
GTP 140 1 1 
CTP 99 1 1 1 
RNA 
  
    448     257       191   307 
dATP 55 1 1 2 
dTTP 55 1 1 3 
dGTP 49 1 1 1 
dCTP 49 1 1 2 
DNA  
      
208     104       104   421 
Lipid 
      
    129 129     2,116     3,870 
LPS components 
  
51 16 24     24 24   329     470 
Peptidoglycan 
  
  55         28 83 55 28 28 193 
Glycogen 
  
154                       
C1-units 
      
      49           49 
Polyamines 
      
                59 178 
Total   205 71 834 328 129 1,412 649 2,855 2,963 1,895 1,218 17,428 
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5.1.5 Intracellular fluxes of glucose-grown Yersinia pseudotuberculosis 
strongly differ from those of its relative Escherichia coli 
The fluxes could be precisely determined throughout the entire central metabolism, 
as indicated by the narrow confidence intervals (Figure 15, Table 11). Moreover, the 
excellent agreement between the measured and simulated mass isotopomer 
distributions demonstrated high confidence in the obtained flux distributions 
(Table 6). The in vivo carbon flux distribution revealed that Y. pseudotuberculosis 
channelled 33% of the consumed glucose into the pentose phosphate (PP) pathway 
(Figure 15A). This flux exceeded the requirement for PP pathway-derived anabolic 
precursors. Carbon was channelled back from the PP pathway into the Embden-
Meyerhof-Parnas (EMP) pathway at the level of fructose 6-phosphate and 
glyceraldehyde 3-phosphate. The Entner-Doudoroff (ED) pathway was found to be 
inactive, and approximately 67% of the glucose uptake was catabolized by the EMP 
pathway. Although this part of the metabolism upstream of the phosphoenolpyruvate 
(PEP) node is similar to that of the related gut bacterium E. coli (Sauer et al, 2004; 
Haverkorn van Rijsewijk et al, 2011), the fluxes through the downstream pathways 
differ significantly between the two microorganisms for growth under aerobic 
conditions on glucose. Y. pseudotuberculosis showed a high flux through the TCA 
cycle. The flux through the entry step, which is catalyzed by citrate synthase, was 
63% in Y. pseudotuberculosis, whereas only 27% has been reported for E. coli 
(Haverkorn van Rijsewijk et al, 2011). In addition, the anaplerotic fluxes in 
Y. pseudotuberculosis were generally very low. The pathogen did not exhibit any 
activity in the glyoxylate shunt, whereas E. coli has shown a carbon flux of 
approximately 10% (Haverkorn van Rijsewijk et al, 2011). Similarly, the flux through 
PEP carboxylase was also substantially lower in Y. pseudotuberculosis (17%) 
compared with the value of 32% for E. coli (Haverkorn van Rijsewijk et al, 2011).  
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Table 6. Relative mass isotopomer fractions of t-butyl-dimethylsilyl derivates of proteinogenic 
amino acids used for 13C metabolic flux analysis of Y. pseudotuberculosis YPIII and of the 
single gene deletion mutants YP3 (∆rovA), YP53 (∆csrA), and YP89 (∆crp) cultivated on 
99% [1-13C] glucose. The data set comprises experimental values with deviations from 
replicate GC/MS measurement (Exp) and calculated values (Calc), predicted by the solution 
of the mathematical model that corresponded to the optimized set of fluxes.  
 
 Wild type YP3 (∆rovA) YP53 (∆csrA) YP89 (∆crp) 
    M0 M1 M2 M0 M1 M2 M0 M1 M2 M0 M1 M2 
Ala Exp 0.480 (±0.06%) 
0.384 
(±0.02%) 
0.105 
(±0.30%) 
0.469 
(±0.03%) 
0.392 
(±0.06%) 
0.106 
(±0.04%) 
0.474 
(±0.13%) 
0.387 
(±0.11%) 
0.106 
(±0.32%) 
0.510 
(±0.04%) 
0.358 
(±0.03%) 
0.102 
(±0.13%) 
(m/z) 
260 Calc 0.474 0.381 0.111 0.465 0.390 0.111 0.470 0.384 0.112 0.508 0.354 0.107 
Val Exp 0.301 (±0.12%) 
0.411 
(±0.13%) 
0.208 
(±0.63%) 
0.286 
(±0.13%) 
0.415 
(±0.11%) 
0.217 
(±0.03%) 
0.292 
(±0.09%) 
0.409 
(±0.02%) 
0.212 
(±0.10%) 
0.340 
(±0.25%) 
0.399 
(±0.18%) 
0.187 
(±0.30%) 
(m/z) 
288 Calc 0.299 0.409 0.209 0.286 0.413 0.216 0.296 0.410 0.211 0.346 0.398 0.185 
Thr Exp 0.287 (±0.35%) 
0.385 
(±0.34%) 
0.217 
(±0.07%) 
0.282 
(±0.02%) 
0.385 
(±0.07%) 
0.222 
(±0.07%) 
0.274 
(±0.14%) 
0.379 
(±0.23%) 
0.225 
(±0.00%) 
0.303 
(±0.03%) 
0.377 
(±0.02%) 
0.211 
(±0.29%) 
(m/z) 
404 Calc 0.288 0.380 0.219 0.282 0.382 0.221 0.274 0.378 0.227 0.303 0.374 0.213 
Asp Exp 0.291 (±0.35%) 
0.383 
(±0.24%) 
0.217 
(±0.54%) 
0.281 
(±0.11%) 
0.386 
(±0.09%) 
0.220 
(±0.18%) 
0.278 
(±0.07%) 
0.378 
(±0.12%) 
0.224 
(±0.07%) 
0.307 
(±0.29%) 
0.375 
(±0.12%) 
0.210 
(±0.10%) 
(m/z) 
418 Calc 0.287 0.379 0.219 0.281 0.381 0.221 0.274 0.377 0.227 0.303 0.374 0.213 
Glu Exp 0.210 (±0.38%) 
0.357 
(±0.01%) 
0.263 
(±0.03%) 
0.199 
(±0.08%) 
0.358 
(±0.05%) 
0.268 
(±0.01%) 
0.201 
(±1.19%) 
0.353 
(±0.16%) 
0.267 
(±0.73%) 
0.233 
(±0.38%) 
0.359 
(±0.01%) 
0.249 
(±0.17%) 
(m/z) 
432 Calc 0.207 0.357 0.263 0.198 0.356 0.268 0.199 0.353 0.266 0.235 0.359 0.247 
Ser Exp 0.417 (±0.04%) 
0.383 
(±0.19%) 
0.147 
(±0.18%) 
0.409 
(±0.12%) 
0.389 
(±0.09%) 
0.149 
(±0.10%) 
0.415 
(±0.07%) 
0.383 
(±0.22%) 
0.148 
(±0.70%) 
0.446 
(±0.19%) 
0.360 
(±0.20%) 
0.143 
(±0.27%) 
(m/z) 
390 Calc 0.420 0.379 0.148 0.410 0.386 0.150 0.415 0.381 0.150 0.447 0.359 0.144 
Phe Exp 0.231 (±0.41%) 
0.379 
(±0.57%) 
0.256 
(±0.17%) 
0.213 
(±0.62%) 
0.374 
(±0.19%) 
0.261 
(±0.29%) 
0.221 
(±0.29%) 
0.378 
(±0.30%) 
0.259 
(±1.88%) 
0.257 
(±0.15%) 
0.378 
(±0.78%) 
0.237 
(±0.77%) 
(m/z) 
336 Calc 0.229 0.381 0.255 0.213 0.377 0.265 0.223 0.378 0.259 0.259 0.379 0.237 
Gly Exp 0.754 (±0.01%) 
0.175 
(±0.02%)   
0.754 
(±0.02%) 
0.175 
(±0.03%)   
0.747 
(±0.09%) 
0.181 
(±0.26%)   
0.743 
(±0.08%) 
0.184 
(±0.01%) 
 
(m/z) 
246 Calc 0.755 0.174   0.755 0.174   0.749 0.179   0.745 0.182   
Tyr Exp 0.203 (±0.21%) 
0.351 
(±0.77%) 
0.266 
(±0.37%) 
0.191 
(±0.29%) 
0.346 
(±0.04%) 
0.267 
(±0.24%) 
0.196 
(±2.39%) 
0.344 
(±0.04%) 
0.267 
(±1.62%) 
0.225 
(±0.12%) 
0.351 
(±0.35%) 
0.249 
(±0.30%) 
(m/z) 
466 Calc 0.197 0.352 0.266 0.184 0.347 0.274 0.192 0.348 0.269 0.223 0.353 0.252 
 
Moreover, Y. pseudotuberculosis exhibited a high flux of almost 50% towards 
extracellular pyruvate, whereas E. coli typically does not secrete this metabolite 
under similar respiratory conditions. The formation and secretion of large amounts of 
pyruvate is surprising because this metabolic route does not provide additional ATP, 
in contrast to the acetate pathway preferred by E. coli (Valgepea et al, 2010). 
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5.1.6 The lack of RovA, CsrA, and Crp perturbs the intracellular carbon fluxes 
in Y. pseudotuberculosis 
Deletion of the virulence-promoting metabolic regulator genes rovA, csrA, and crp 
resulted in a significant perturbation of the Y. pseudotuberculosis carbon flux (Figure 
15B-D, Figure 16). The lack of the most specific virulence regulator RovA decreased 
the flux through the PP pathway and the TCA cycle. Both pathways deliver NADPH, 
and the TCA cycle also provides NADH and FADH. Overall, this change resulted in a 
decreased amount of reducing power. The reduced TCA cycle flux originated from 
the increased pyruvate secretion, which withdrew carbon from the core metabolism. 
In addition, Y. pseudotuberculosis YP53 (∆csrA) and YP89 (∆crp) showed a substan-
tial difference in the metabolic flux distribution compared with that of the wild type. In 
YP53 (∆csrA) and YP89 (∆crp), the TCA cycle flux was significantly upregulated by 
approximately 10% and 45%, respectively, coinciding with a reduced formation of 
pyruvate-derived by-products (Figure 15C-D, Figure 16). Overall, the deletion of the 
global regulator Crp led to the most extensive change in flux. This deletion also 
affected additional pathways, including the PP and EMP pathways, and several 
anabolic reactions, and most strikingly, it resulted in the disappearance of all overflow 
fluxes (Figure 15D, Figure 16). 
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Figure 15. In vivo carbon flux distribution of glucose-grown Y. pseudotuberculosis (YPIII) (A) 
and the single gene deletion mutants Y. pseudotuberculosis YP3 (∆rovA) (B), YP53 (∆csrA) 
(C), and YP89 (∆crp) (D) estimated from the best fit to the experimental results using a 
comprehensive approach of combined metabolite balancing and 13C tracer experiments with 
labeling measurements of proteinogenic amino acids. For flux analysis, cells were grown on 
[1-13C] glucose as a tracer substrate, which has been shown to resolve the major catabolic 
routes in Y. pseudotuberculosis, i.e., the PP, EMP, ED pathways, and TCA cycle (Wittmann, 
2007). All fluxes are expressed as a molar percentage of the corresponding specific glucose 
uptake rate (7.1 mmol g-1 h-1, 7.1 mmol g-1 h-1, 3.1 mmol g-1 h-1 and 1.5 mmol g-1 h-1), which 
was set as 100%. Significantly altered fluxes (p<0.01) are marked (*) and color indicates the 
relative change in metabolic fluxes compared with wild type. The errors represent 95% 
confidence intervals and were calculated by Monte-Carlo analysis. 
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Figure 16. Control of the metabolic fluxes of Y. pseudotuberculosis YPIII by the catabolite 
repressor protein (Crp), the carbon storage regulator (CsrA), and the regulator of virulence 
(RovA). The data indicate the relative flux changes in the defined virulence mutants YP3 
(∆rovA), YP53 (∆csrA), and YP89 (∆crp), normalized to the wild type flux. The data refer to 
the intracellular flux distributions (Figure 15).  
5.1.7 Mutants deficient in RovA, CsrA, and Crp reveal an altered expression 
pattern of virulence-associated, stress adaptation, and metabolic genes 
To gain a more comprehensive understanding of how the virulence regulators 
interact with metabolism and mediate flux adaptations, changes in the fluxome were 
correlated with alterations in the gene expression pattern. For this purpose, 
microarray analyses were performed using total RNA isolated from the 
Y. pseudotuberculosis YPIII (wild type), YP3 (∆rovA), YP53 (∆csrA), and YP89 (∆crp) 
cultures, which were also used for the fluxome analyses. The most representative 
changes in virulence and metabolic genes are given in Figure 17 and Figure 18, 
respectively. Additional transcriptional changes are provided in the appendix (Table 
13). Of all of the protein-encoding chromosomal (4172) and virulence plasmid genes 
(92), the following changes (>1.7-fold, p<0.01) were observed compared with the wild 
type: 316 genes were affected in the rovA mutant (128 upregulated/188 down-
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regulated), 913 genes were affected in the csrA mutant (475 upregulated/438 
downregulated), and 729 genes were affected in the crp mutant (336 upregu-
lated/393 downregulated) (Table 13). Classification according to the genome anno-
tation of Y. pseudotuberculosis YPIII showed that the altered genes belonged to the 
following categories: virulence, motility and chemotaxis, stress adaptation, informa-
tion storage and processing, and metabolism. The lack of each regulator caused a 
rather specific change in expression, i.e., only a subset of genes responded similarly 
in the different mutants (Figure 17, Figure 18, Table 13). 
In all of the regulator deletion strains, multiple virulence-associated genes were 
affected (Figure 17, Table 13). Y. pseudotuberculosis YP3 (∆rovA) exhibited specific 
changes in the expression of genes linked to host-pathogen interactions and serum 
resistance, including the previously identified RovA-dependent virulence genes of 
Y. pestis and Y. enterocolitica (Cathelyn et al, 2006; Cathelyn et al, 2007). 
Y. pseudotuberculosis YP53 (∆csrA) and YP89 (∆crp) showed a broader set of 
affected genes, e.g., regulators involved in initial colonization of the intestine and 
other host tissues (e.g., rovA, invA, psaAB, multiple adhesins and fimbrial factors), 
pathogenicity genes responsible for dissemination and immune defense during an 
ongoing infection (yadA, ailA, ysc and yop genes), and type VI secretion systems that 
support survival in the host (Figure 17, Table 13) (Heesemann et al, 2006; Cascales, 
2008). 
In addition to the classical pathogenicity factors, several virulence-associated 
physiological processes showed changes in expression. The flhDC operon and 
several FlhDC-induced genes (motAB, cheAWD, fli, flg and flh genes) controlling the 
synthesis of flagella and motility were downregulated in the crp and csrA mutants. 
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Figure 17. Impact of the virulence regulators RovA, CsrA, and Crp on expression of 
virulence genes of Y. pseudotuberculosis. The data are given as the fold change in 
expression in the single gene deletion mutants YP3 (∆rovA), YP53 (∆csrA), and YP89 (∆crp) 
compared with the wild type YPIII expression and are arranged according to the hierarchical 
clustering analysis by the complete linkage clustering algorithm. The clusters of orthologous 
groups (cog) of proteins were used to classify the genes. “X” denotes non-existing 
classification. The data were obtained from three biological replicates, each with three 
samples.  
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Motility was previously shown to be activated by CsrA and was found to promote the 
host cell invasion and virulence of Yersinia (Young et al, 2000; Heroven et al, 2008; 
Heroven et al, 2012a). Several autoinducer systems were differently expressed in the 
crp mutant (yspIR, ypsI, and luxS) known to affect the biofilm formation, autoinducer 
AI-2 production, and pathogenicity of Yersinia species (Atkinson et al, 2008; Atkinson 
et al, 2011; Yu et al, 2013). In addition, many of the identified Crp- and CsrA-
dependent genes are involved in the adaptation to environmental changes, such as 
heat shock (e.g., ibpAB, groEL, and groES), cold shock (cspA-D genes), carbon 
starvation (cstA), and other stress resistance genes (katA, katY, sodA, sodC, clpA, 
and htrA), which altogether seem to adapt and maximize biological fitness during the 
infection process (Table 13).  
Inspection of the metabolic genes controlled by the different virulence-promoting 
regulators revealed the pyruvate-TCA cycle node as the focal point of transcriptional 
control (Figure 18). The TCA cycle was affected in all three mutant strains. The 
transcriptional response was most pronounced in Y. pseudotuberculosis ∆csrA. This 
mutant exhibited upregulation of multiple TCA cycle genes, i.e., gltA, acnA, acnB, 
icdA, and fumA, as well as the sdhBADC and sucABCD operons, whereas the rovA 
and crp mutants exhibited a partly downregulated and upregulated TCA cycle. In 
addition, a large set of genes encoding metabolic enzymes that are active at the 
junction between pyruvate and the TCA cycle node were induced in the absence of 
Crp and/or CsrA. This induction included a mild upregulation of the glyoxylate shunt 
(aceA and aceB) and of gluconeogenesis (pckA, sfcA, maeB, and ppsA). This 
change was complemented by upregulation of poxB, which encodes pyruvate 
oxidase as a ubiquinone-reducing alternative pathway for acetate formation.  
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Figure 18. Impact of the virulence regulators RovA, CsrA, and Crp on the expression of 
genes related to the core metabolism of Y. pseudotuberculosis and of known transcriptional 
regulators (GlpR, IhfA/B, Fur, PdhR, ArcA, and HdfR) (Haverkorn van Rijsewijk et al, 2011). 
The data are given as the fold change in expression in the single gene deletion mutants YP3 
(∆rovA), YP53 (∆csrA), and YP89 (∆crp) compared with the wild type YPIII expression and 
are arranged according to the hierarchical clustering analysis by the complete linkage 
clustering algorithm. The clusters of orthologous groups (cog) of proteins were used to 
classify the genes. The data were obtained from three biological replicates, each with three 
samples. 
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In contrast, NADH-consuming alcohol dehydrogenase (adhE) was significantly 
downregulated in the ∆csrA and ∆crp mutants. Furthermore, the expression levels of 
catabolic enzymes, which are responsible for the uptake and utilization of carbo-
hydrates and amino acids, and glycogen synthesis (glgXAP) were affected in the 
different mutant strains. Multiple phosphotransferase systems, permeases, and ABC 
transporters were differentially expressed in the crp and the csrA mutant. In particular 
the ptsG gene encoding the EIIBC subunit of the glucose phosphotransferase system 
(PTS), the ulaABC/sgaTBA operon encoding a putative ascorbate PTS system, and 
glnQPH for polar amino acid transport were strongly altered in the crp mutant and to 
a smaller extent in the csrA deficient strain. In agreement with previous results 
(Heroven et al, 2012b), also expression of ptsIH, fruKB, manXZ, glpFK, mglBAC for 
the uptake of glucose, fructose, mannose/sorbose, glycerol, and galactose were 
affected in the absence of the virulence-promoting metabolic regulator Crp, and 
several amino acid peptide transporter-encoding operons (opp, ddp, tau) were affec-
ted by the loss of Crp and/or CsrA. In addition, several genes involved in the 
nucleotide and fatty acid uptake and metabolism were regulated by Crp, CsrA, and/or 
RovA (e.g., nupC1, ndk, pyrD, cdd, gpt, udp, xanP, uhpC, accA, fadBA, fadLIJ) 
(Table 13).  
5.1.8 The pyruvate-TCA cycle node as metabolic switch point of virulence 
Taken together, the data strongly support a central role of the virulence-promoting 
regulator cascade in host-adapted re-adjustment of the carbon core metabolism in 
Y. pseudotuberculosis. In particular, Crp and CsrA seem to tightly coordinate the ex-
pression of virulence-associated traits with the operation of the central metabolic 
switch point: the pyruvate-TCA cycle node. To test this hypothesis and investigate 
the effect of this metabolic control point for virulence, targeted perturbations were 
focused. Different master regulators and enzymes are known to control the flux 
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through this central metabolic switch point in related bacteria (Haverkorn van 
Rijsewijk et al, 2011). Interestingly, several of these candidates were affected in the 
crp and csrA mutants. For example, the gene encoding the pyruvate dehydrogenase 
regulator protein (pdhR) was specifically downregulated in the Y. pseudotuberculosis 
crp mutant. PdhR acts as a transcriptional regulator in a pyruvate-dependent manner 
to control central metabolic fluxes, e.g., during the transition from anaerobic to 
microaerobic conditions (Göhler et al, 2011; Trotter et al, 2011). The expression of 
another key regulator of the TCA cycle, i.e., ArcA, was repressed in the ∆csrA strain. 
This global regulator is involved in the reprogramming of metabolism according to O2 
concentration (Spiro & Guest, 1991). The impact of this transcription factor is further 
supported by the fact that several genes (cydAB, ptsG, sucBCD, poxB, cmk, and 
fadBA) known to be under the control of ArcA in E. coli or Salmonella (Iuchi & Lin, 
1988; Liu & De Wulf, 2004; Evans et al, 2011) were also controlled by CsrA and/or 
Crp in Y. pseudotuberculosis (Table 13). 
In addition to ArcA and PdhR, which were among the Crp- and CsrA-dependent 
genes, PtsN and PykF appeared to be promising candidates to modulate the 
pyruvate-TCA cycle node in Y. pseudotuberculosis based on their impact in E. coli. A 
recent study showed that the second phosphotransferase system of E. coli, denoted 
as nitrogen-PTS (PTSNtr), controls fluxes in the central metabolism, especially at the 
pyruvate-TCA cycle node (Commichau et al, 2006; Jahn et al, 2013). The identified 
PTSNtr-dependent genes include multiple TCA cycle genes, which are differentially 
expressed in the Y. pseudotuberculosis csrA and/or crp mutant strains (gltAB, sucB, 
sdhD, and aceA) (Figure 18), indicating a close link between these global regulatory 
systems. In support of this assumption, expression of the kdpFABC operon, a well-
known target of PTSNtr in E. coli (Lüttmann et al, 2009), was found to be upregulated 
in the Crp-deficient mutant (Table 13). The phosphorylation state of EIIANtr (PtsN) is 
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influenced by the activity of the sugar PTS through crosstalk (e.g., by competition for 
PEP); thus, alterations in the PTSGlc components in the Crp- and CsrA-deficient 
strains (e.g., repression of ptsG and ptsIH in a crp mutant) might also affect the flux 
through the pyruvate-acetyl-CoA node and the TCA cycle via alteration of the PTSNtr 
activity. Utilization as well as strong upregulation of the sugar PTS (e.g., ptsG 
induction in the presence of Crp) might drain the phosphoryl groups of PEP towards 
the EIIAGlc, leading to preferentially dephosphorylated EIIANtr.  
During growth on glucose, pyruvate is generated from PEP as a product of PTSGlc 
and by the pyruvate kinase isoenzymes (PykA and PykF). To specifically target the 
pyruvate–TCA cycle node, it seemed appropriate to also directly perturb a particular 
enzyme of this metabolic control point. The deletion of pyruvate kinase in E. coli 
results in rerouting of a local flux through the combined reactions of PEP carboxylase 
and malic enzyme (Emmerling et al, 2002; Al Zaid Siddiquee et al, 2004). Of the two 
pyruvate kinase enzymes (PykA and PykF), PykF was selected because it is highly 
active during growth on glucose in E. coli, whereas PykA has a much lower activity 
(Al Zaid Siddiquee et al, 2004; Meza et al, 2012).  
In this regard, single mutants of arcA, pykF, ptsN, and pdhR were constructed to 
study their impact on virulence. The first characterization of their growth physiology 
under laboratory conditions revealed that the glucose uptake was comparable to that 
of the wild type, suggesting the absence of any major effect on the biological fitness 
of the pathogen. In contrast, the pyruvate-derived by-products differed significantly, 
indicating that the fluxes around the pyruvate-TCA cycle node were affected. Each 
mutant showed a unique metabolic phenotype (Table 7).  
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Table 7. Growth characteristics of the Y. pseudotuberculosis wild type strain (YPIII) and the 
mutants YP49 (∆arcA), YP252 (∆ptsN), YP253 (∆pykF), and YP274 (∆pdhR). The data 
comprise the specific growth rate (µ), the specific rate of glucose uptake (qGlc), and yields on 
glucose for biomass (YX/S), pyruvate (YPyr/S), lactate (YLac/S), acetate (YAce/S), formate (YForm/S), 
succinate (YSuc/S), fumarate (YFum/S), ethanol (YEtOH/S), and α-ketoglutarate (YAkg/S). The values 
represent the mean of three biological replicates and the corresponding standard deviations. 
Strain 
µ qGlc YX/S YPyr/S YLac/S YAce/S YForm/S YSuc/S YFum/S YEtOH/S YAkg/S 
[h-1] [mmol g-1 h-1] [g mol-1] [molar percentage of the specific glucose uptake rate] 
YPIII  
(Wt) 
0.32 
±	0 
7.1 
± 0.3 
45.2 
±	2.0 
46.4 
±	1.4 
7.1 
± 0.6 
6.7 
±	0.3 
3.0 
±	0.4 
0.2 
±	0 
0.1 
±	0 
3.3 
±	0.7 
1.1 
±	0.1 
YP253 
(∆pykF) 
0.26 
±0 
5.5 
±0 
46.4 
±1.4 
36.5 
±2.8 
16.2 
±1.3 
3.5 
±0.4 
0.4 
± 0.1 
0.8 
± 0.1 
0.6 
± 0 
3.8 
±0.8 
1.4 
±0.1 
YP252 
(∆ptsN) 
0.23 
±0 
6.4 
±0.4 
35.9 
±2.9 
64.5 
±4.1 
3.4 
±0.5 
5.4 
±0.3 
0.5 
± 0 
0.3 
± 0.1 
0.2 
± 0 
5.8 
±0.3 
1.7 
±0.1 
YP274 
(∆pdhR) 
0.19 
±0 
6.3 
±0.3 
32.3 
±1.5 
70.7 
±5.4 
2.6 
±0.5 
16.4 
±1.1 <0.1 <0.1 
0.2 
±0 
3.4 
±0.4 
1.3 
±0.1 
YP49 
(∆arcA) 
0.31 
±0.01 
6.4 
±0.3 
48.2 
±1.6 
41.5 
±2.1 
4.0 
±0.3 
13.5 
±0.3 
0.5 
±0.1 <0.1 <0.1 
4.5 
±0.9 
1.1 
±0.1 
Values below 0.1% for the by-product yields were below the detection limit. 
5.1.9 Perturbations of the metabolic core machinery at the pyruvate-TCA cycle 
node reduce Yersinia virulence 
To examine whether the pyruvate-TCA cycle node represents a focal point of 
virulence control, co-infection experiments with the wild type and the mutant strains 
YP49 (∆arcA), YP252 (∆ptsN), YP253 (∆pykF), and YP274 (∆pdhR) were performed. 
Groups of BALB/c mice were orally infected with approximately 107 bacteria in an 
inoculum comprised of an equal mixture of the wild type and the isogenic mutant 
strains. The number of bacteria present in the Peyer’s patches (PPs), the mesenteric 
lymph nodes (MLN), the liver, and the spleen were quantified five days post-infection 
(Figure 19). The loss of pykF, ptsN, and arcA resulted in a strong reduction of 
Y. pseudotuberculosis virulence, and a mild effect was observed for the pdhR 
mutant. The absence of PdhR and ArcA significantly reduced the initial colonization 
of the PPs early in the infection. The subsequent dissemination of the pathogen into 
the MLNs was significantly decreased or totally abolished in the arcA, pykF, and ptsN 
mutants (Figure 19). 
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Our experiments further revealed that PykF and PtsN functioning was crucial for 
colonization and/or persistence in deeper tissues, such as the liver and spleen. 
These results clearly indicate that the presence of the pyruvate-TCA cycle node-
modulating factors ArcA, PtsN, and PykF is particularly important for the 
pathogenesis of Y. pseudotuberculosis, whereby the individual modulators seem to 
participate at different stages during the course of the infection. The observed effects 
are not based on a general growth defect of the investigated mutants because each 
mutant had an overall glucose uptake rate comparable to that of the wild type 
(Table 7) and a similar colonization rate in at least one of the tested tissues 
(Figure 19).  
 
 
 
 
 
 
 
 
Figure 19►. Influence of a perturbation of the pyruvate-TCA cycle node on the virulence of 
Y. pseudotuberculosis. BALB/c mice were orally infected with an equal mixture of 107 CFU of 
wild type Y. pseudotuberculosis (YPIII) and one isogenic mutant strain, i.e., YP49 (∆arcA), 
YP252 (∆ptsN), YP253 (∆pykF), or YP274 (∆pdhR). After 5 days of infection, the mice were 
sacrificed, and the number of bacteria in homogenized host tissues and organs (Peyer’s 
patches (PPs), mesenteric lymph nodes (MLNs), spleen, and liver) was determined by 
plating. Data from two independent experiments (10 mice/group) are represented in scatter 
plots of the CFU per gram as determined by the counts of viable bacteria on the plates 
(upper panel). Each spot represents the CFU count in the indicated tissue samples from one 
mouse. The log (CFU/gr.) of 102 bacteria marks the limit of detection. The statistical 
significances between the wild type and the mutants were determined by a Mann-Whitney 
test. P-values: n.s.: not significant; *: <0.05; **: <0.01; ***: <0.001. Lower panel: Data are 
graphed as competitive index values for tissue samples from one mouse. The bars represent 
the medians of the competitive index values. A competitive index score of 1 denotes no 
difference in virulence compared to that of YPIII. 
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5.1.10 Post-transcriptional control of flux as a crucial strategy for virulence 
The present work, using a systems biology approach that integrates transcriptional 
control (transcriptome) with functional network operation (fluxome) in the human 
pathogen Y. pseudotuberculosis, elucidated a close link between the metabolic core 
machinery and pathogenic traits. It was shown that the virulence-promoting 
regulators RovA, CsrA, and Crp strongly affect the intracellular carbon fluxes (Figure 
15, Figure 16) and the expression of multiple metabolic and virulence genes of 
Y. pseudotuberculosis (Figure 17, Figure 18). In particular, pyruvate metabolism and 
the TCA cycle emerged as focal points of control (Figure 21). Among the large set of 
metabolic flux changes, only a subset can be explained by transcriptional control 
(Figure 20). 
 
Figure 20. Quantitative correlation of the fluxome and transcriptome in the central carbon 
metabolism of Y. pseudotuberculosis. The integrated data are given as the relative change in 
the virulence mutants YP3 (∆rovA), YP53 (∆csrA), and YP89 (∆crp) compared with the wild 
type YPIII. Abbreviations: actP, acetate permease; adhE, alcohol dehydrogenase; pflB, 
formate acetyl-transferase; ldh, lactate dehydrogenase; acnB, aconitase; icdA, isocitrate 
dehydrogenase; pykF, pyruvate kinase; A/D, Embden-Meyerhof-Parnas pathway and 
pentose phosphate pathway; B, tricarboxylic acid cycle; C, fumarase and malate 
dehydrogenase; E, pentose phosphate pathway; F, tricarboxylic acid cycle, pyruvate 
dehydrogenase and phosphoenolpyruvate carboxylase. 
Obviously, the carbon fluxome of Y. pseudotuberculosis is largely under post-trans-
criptional control. Similarly, the primary metabolism of other bacteria is mainly 
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controlled by post-transcriptional mechanisms (Schilling et al, 2007; Haverkorn van 
Rijsewijk et al, 2011; Chubukov et al, 2013), which typically involve direct regulation 
of flux at the enzyme level by allosteric control (Link et al, 2013). Such a strategy 
seems crucial for the ability of pathogenic bacteria, such as Y. pseudotuberculosis, to 
cope with the rapidly changing environments that they face during their infection 
cycle. 
 
Figure 21. The pyruvate-TCA cycle node as the central control switch in the host-adapted 
control of metabolism and virulence in Y. pseudotuberculosis. The reaction arrows point in 
the physiological direction. The transcriptional control of genes by CsrA and Crp, which were 
identified by gene expression analysis (Table 13), is indicated. Bluish squares denote 
inhibition, yellowish arrows denote activation. Abbreviations: pykF/pykA, pyruvate kinases; 
ppsA, phosphoenolpyruvate synthase; poxB, pyruvate oxidase; acs, acetyl-CoA synthetase; 
ackA, acetate kinase; adhE, alcohol dehydrogenase; pta, phosphate acetyltransferase; gltA, 
citrate synthase; acnBA, aconitase; icdA, isocitrate dehydrogenase; sucAB, alpha-
ketoglutarate dehydrogenase; sucCD, succinyl-CoA synthetase; sdhABCD, succinate 
dehydrogenase; fumA, fumarate hydratase; mdh, malate dehydrogenase; aceA, isocitrate 
lyase; aceB, malate synthase; ppc, PEP carboxylase; pckA, PEP carboxykinase; 
aceEF/lpdA, pyruvate dehydrogenase; maeB, sfcA, malic enzymes. 
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5.1.11 The secretion of high amounts of pyruvate by Y. pseudotuberculosis is 
unique among pathogens 
The present study showed that Y. pseudotuberculosis released large amounts of 
pyruvate into the medium during growth on glucose. Excretion of pyruvate to this 
extent (46% of the glucose uptake) under these conditions is uncommon among 
related bacteria and primarily seems to be a transient phenomenon triggered during 
specific metabolic shifts, e.g., from aerobic to anaerobic growth (Trotter et al, 2011). 
Metabolically, the pyruvate secretion is somewhat intriguing at a first glance because 
its synthesis does not yield additional ATP or contribute to redox balancing, as in the 
case of pyruvate-derived acetate or lactate formation. The observed high fluxes for 
glucose uptake and glycolysis could induce pyruvate secretion due to a metabolic 
bottleneck downstream of this node. However, a limitation of the respiratory capacity 
can be excluded as a trigger for the pronounced pyruvate overflow due to the fully 
aerobic conditions during growth. Alternatively, the excretion of pyruvate could be 
important for the bacteria to avoid glucose-phosphate stress. High rates of nutrient 
uptake, in particular readily metabolizable PTS sugars, provide an advantage in the 
gut environment because these high rates reduce the availability of carbon nutrients 
for competing strains and organisms. However, an intracellular accumulation of 
phosphorylated sugar intermediates is growth inhibitory or bactericidal and induces a 
specific stress response (Vanderpool, 2007). Under this type of phosphate-sugar 
stress, E. coli induces the expression of the small regulatory RNA SgrS, which 
negatively controls the translation of ptsG mRNA, the mRNA that encodes the major 
glucose transporter EIICBGlc, to reduce the substrate influx (Vanderpool & 
Gottesman, 2007). In fact, the ptsG transcript was found to be much less abundant in 
the Y. pseudotuberculosis crp mutant (Table 13), in which significantly lower amounts 
of pyruvate are secreted and glucose uptake is reduced (Figure 15 D, Table 4). 
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Additionally, pyruvate is a key signal in bacteria to program core metabolism (Trotter 
et al, 2011; Link et al, 2013); thus, the secretion might contribute to the fine 
adjustment of the intracellular level of this metabolite. Taken together, these findings 
indicate that pyruvate metabolism and export are likely used to control the biological 
fitness and virulence of Yersinia. 
5.1.12 The pyruvate node and the TCA cycle are focal points of virulence 
control 
The present study showed that the virulence-promoting metabolic regulators CsrA 
and Crp regulate the expression of multiple enzymes implicated in the control of the 
pyruvate-TCA cycle node (Table 13, Figure 21). Furthermore, it was demonstrated 
that modulators of this control point and, particularly, one of its enzymes (PykF) are 
crucial for Y. pseudotuberculosis virulence.     
With regard to CsrA and Crp, both deletion mutants secreted much less or even no 
by-products; instead, these mutants channeled the carbon into the TCA cycle. This 
finding can be explained by the fact that CsrA and Crp act as repressors of multiple 
TCA cycle enzymes and associated pathway genes, and their deletion results in a 
moderate and strong derepression of the flux through the TCA cycle and the fuelling 
pathways (Figure 16, Figure 21, Table 13). Obviously, the control of the central 
carbon flow through the TCA cycle towards complete substrate oxidation seems to be 
important for optimizing overall fitness, reinforcing competitiveness, and adjusting the 
virulence functions of the pathogen. Recent work on the metabolic flux response in 
the commensal E. coli Nissle 1917 also revealed that CsrA has a strong influence on 
the central metabolism of glucose. However, in this case, strikingly lower fluxes via 
the TCA cycle were observed, which were accompanied by a 34% increase in 
acetate production (Revelles et al, 2013). This finding indicates significant differences 
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in the operation of central carbon metabolism between the commensal E. coli strain 
and the invasive enteropathogenic Yersinia, which most likely reflect different 
adaptation techniques of the colonized niches.  
Pioneering systems biology studies of pathogenic Yersinia species, including 
Y. pestis, have reported that the metabolic core machinery is tightly regulated by 
virulence-associated environmental parameters in concert with virulence genes 
(Motin et al, 2004; Ansong et al, 2013). The first observations revealed the following: 
(i) an adjustment of many catabolic pathways for the metabolites available in 
mammals in response to a temperature shift from 26°C to 37°C (Motin et al, 2004); 
(ii) conserved post-transcriptional control of metabolism and (iii) the translational 
machinery, including the modulation of glutamate levels in Yersinia spp. (Ansong et 
al, 2013). Here, it was discovered that the pyruvate-TCA cycle node is a focal point of 
virulence control. It was demonstrated that regulators and enzymes modulating the 
fine adjustment of the pathway fluxes at this node affect important cellular 
components linked to metabolism and virulence in Y. pseudotuberculosis. The mouse 
infection data indicate that the discovered metabolic control point is of an utmost but 
previously unrecognized importance for the pathogenicity of this microorganism.  
There are other interesting precedents tempt to speculate that the co-adjustment of 
metabolism and virulence through the pyruvate-TCA cycle node is not only crucial for 
the genus Yersinia but also constitutes a more general strategy in pathogenic 
bacteria. For instance, deletions in the pyruvate pathway have been shown to alter 
the SPI1-mediated gene expression and infectivity of the Salmonella enterica serovar 
Typhimurium (Abernathy et al, 2013). Furthermore, it has been reported that 
Salmonella mutants that are unable to convert malate to pyruvate and oxaloacetate 
are avirulent and immunogenic in BALB/c mice (Mercado-Lubo et al, 2009) and that 
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an incomplete TCA cycle increases the survival of Salmonella during infection 
(Bowden et al, 2010). Moreover, in Pseudomonas aeruginosa, mutations in TCA 
cycle enzymes have been shown to affect the type III secretion system of the 
pathogen (Dacheux et al, 2002), and regulators of Staphylococcus 
aureus responding to TCA cycle-associated metabolic changes have also been 
implicated in virulence control (Somerville & Proctor, 2009).  
A more detailed investigation of the interplay between the pyruvate-TCA cycle node 
and the regulation of virulence factors in enteric and other pathogens promises a 
better understanding of the complex networks of host-adapted metabolism and may 
aid in the discovery of novel drug targets and in the design of more effective 
therapies against bacterial infections.  
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5.2 Antibiotic treatment 
5.2.1 Response of core metabolism to antibiotic treatment  
As shown, the virulence program of Y. pseudotuberculosis involves flux 
rearrangement at the pyruvate-TCA cycle node, probably to face the changing 
environments during its life cycle. Obviously, survival in the host is, at least, partly 
controlled and supported by metabolism. Therefore, it was tempting to see, to which 
extent metabolism is affected by standard antibiotic therapies and how 
Y. pseudotuberculosis responds to antibiotic stress. For this purpose, the carbon flux 
distribution of Y. pseudotuberculosis was analyzed at sub-inhibitory concentrations of 
erythromycin and tetracycline, two standard antibiotics of clinical therapies applied 
against infections. Shortly, the macrolide antibiotic erythromycin acts through 
reversible binding of the 50S ribosome subunit and subsequent inhibition of 
translocation (Mutschler et al, 2005). Erythromycin is a narrow-spectrum antibiotic, 
preferentially used for treatment against Gram-positive bacteria. The low 
susceptibility by Gram-negative bacteria to erythromycin is due to its high 
hydrophobicity (Köhler et al, 2001). The minimal inhibitory concentration (MIC) of 
erythromycin ranges from 16 to 128 mg L-1 for different Y. pseudotuberculosis strains 
(Stock & Wiedemann, 1999). Here, an intermediate concentration of 50 mg L-1 was 
used for metabolic flux analysis. In contrast, tetracycline is a broad-spectrum 
antibiotic with high efficiency against a set of Gram-negative bacteria. Furthermore, 
tetracycline is used against multiple infections of the gastro intestinal tract (Burger & 
Wachter, 1998). It acts through prohibition of the binding of aminoacyl-tRNA to the 
acceptor site of bacterial ribosomes (Mutschler et al, 2005). Here, reported inhibitory 
concentrations of tetracycline (0.5 – 2 mg L-1) (Stock & Wiedemann, 1999) did not 
permit growth under tested conditions. Hence, a concentration of 0.1 mg L-1 was 
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used to enable growth. Taken together, the two chosen antimicrobial agents affect a 
similar target, but show distinct susceptibilities among bacterial genera. 
 
Figure 22. In vivo carbon flux distribution of glucose-grown Y. pseudotuberculosis wild type 
(YPIII) under administration of 50 mg L-1 erythromycin (A) and under administration of 
0.1 mg L-1 tetracycline (B) estimated from the best fit to the experimental results using a 
comprehensive approach of combined metabolite balancing and 13C tracer experiments with 
labeling measurements of proteinogenic amino acids. For flux analysis, cells were grown on 
[1-13C] glucose as the tracer substrate. The cultures showed metabolic (Figure 23) and 
isotopic steady states (Figure 24). All fluxes are expressed as the molar percentage of the 
corresponding specific glucose uptake rate (6.0 mmol g-1 h-1 and 5.6 mmol g-1 h-1), which was 
set as 100%. Significantly altered fluxes (p<0.01) are marked (*). Color indicates the relative 
change in metabolic fluxes compared with wild type under standard growth conditions. The 
errors represent 95% confidence intervals and were calculated by Monte-Carlo analysis. 
When grown under antibiotics stress, Y. pseudotuberculosis showed a decreased 
specific growth rate and an altered flux distribution at the pyruvate-TCA cycle node. 
Administration of erythromycin lowered the growth rate by 9%, whereas the pyruvate 
efflux was increased by 53% (Table 8). The carbon to form the additional amount of 
pyruvate was mainly withdrawn from the TCA cycle (Figure 22A). The pyruvate efflux 
was increased even at the level of absolute fluxes (Figure 25B). Metabolic steady 
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state was verified by the constant stoichiometry of by-product formation (Figure 23) 
and isotopic steady state by the constant mass isotopomer distributions of 
nonlabeled (M0), single labeled (M1), and double labeled (M2) t-butyl-dimethylsilyl 
derivates of proteinogenic amino acids (Figure 24). The excellent agreement 
between measured and simulated mass isotopomer distributions demonstrated high 
confidence in the obtained flux distribution (Table 9). 
Table 8. Growth characteristics of Y. pseudotuberculosis wild type (YPIII) in Yersinia minimal 
medium (YMM) and under administration of the antimicrobial agent erythromycin (YMM+Ery) 
or tetracycline (YMM+Tet). The data comprise the specific growth rate (µ), the specific rate of 
glucose uptake (qGlc), and yields on glucose for biomass (YX/S), pyruvate (YPyr/S), lactate 
(YLac/S), acetate (YAce/S), formate (YForm/S), succinate (YSuc/S), fumarate (YFum/S), ethanol 
(YEtOH/S), and α-ketoglutarate (YAkg/S), respectively. Values represent the mean of three 
biological replicates with corresponding standard deviations. 
Condition 
µ qGlc YX/S YPyr/S YLac/S YAce/S YForm/S YSuc/S YFum/S YEtOH/S YAkg/S 
[h-1] [mmol g-1 h-1] [g mol-1] [molar percentage of the specific glucose uptake rate] 
YMM 0.32 
±	0 
7.1 
± 0.3 
45.2 
±	2.0 
46.4 
±	1.4 
7.1 
± 0.6 
6.7 
±	0.3 
3.0 
±	0.4 
0.2 
±	0 
0.1 
±	0 
3.3 
±	0.7 
1.1 
± 0.1 
YMM+Ery 0.29 
± 0 
6.0 
± 0.2 
49.2 
± 2.3 
70.9 
± 2.2 
7.5 
± 0.3 
6.7 
± 0.6 
1.6 
± 0.4 
0.2 
± 0 <0.1 
5.1 
± 0.1 
1.4 
± 0.1 
YMM+Tet 0.26 
± 0.01 
5.6 
± 0.4 
46.5 
± 5.0 
57.6 
± 5.1 
3.2 
± 0.3 
3.3 
± 0.6 
0.8 
± 0.3 < 0.1 <0.1 
1.6 
± 0.3 
1.1 
± 0.1 
Values below 0.1% for the by-product yields were below the detection limit. 
The administration of tetracycline lowered the specific growth rate and the glucose 
uptake rate by approximately 20%, similar to what was observed for erythromycin 
(Table 8). In contrast, the relative carbon flux through glycolysis, PP pathway, and 
TCA cycle remained approximately at the values of the wild type under standard 
growth conditions. However, pyruvate efflux was increased by 24% at the expense of 
other by-products (Figure 22B). With regard to absolute flux, fluxes through central 
carbon metabolism were generally decreased (Figure 25B), whereas the pyruvate 
secretion rate was maintained at 3 mmol g-1 h-1, as found for the wild type under 
standard growth conditions (Table 8, Figure 25B). 
RESULTS AND DISCUSSION   
66 
 
Figure 23. Stoichiometry of by-product formation during cultivation of the wild type of 
Y. pseudotuberculosis (YPIII) under administration of 50 mg L-1 erythromycin and 0.1 mg L-1 
tetracycline. The linear correlation between formed pyruvate (gray square), acetate (open 
triangle), lactate (open circle), biomass (open diamond) and consumed glucose indicates 
metabolic steady state. All cultivations were performed in triplicate. 
 
Figure 24. Verification of isotopic steady state during 13C tracer studies of 
Y. pseudotuberculosis grown on 99% [1-13C] glucose and under administration of either 
50 mg L-1 erythromycin or 0.1 mg L-1 tetracycline by constant labeling patterns of 
proteinogenic amino acids at different cell dry mass concentrations, reflecting different 
cultivation time points. The data comprise the relative fractions of nonlabeled (M0), single 
labeled (M1), and double labeled (M2) M-57 fragments of alanine (black square), serine (black 
circle), phenylalanine (open triangle), glutamate (black triangle), and aspartate (open circle). 
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5.2.2 Inherent erythromycin resistance of Yersinia pseudotuberculosis is 
accompanied by maintaining a highly active glycolysis 
A recent study has demonstrated that erythromycin susceptibility by 
methicillin-resistant Staphylococcus was restored by inhibition of ATP delivering 
pyruvate kinase. Hereby, the tested Staphylococcus strains harbored multiple copies 
of a plasmid coding for the efflux pump MsrA that provides resistance against 
different macrolide antibiotics and obtains necessary energy by two ATP-binding 
motifs (Chan et al, 2013). According to this, the increased pyruvate secretion could 
be a viable strategy to maintain a high glycolytic flux under antibiotic stress to provide 
high amounts of ATP (Figure 22A). The ATP could then be used for inherent drug 
efflux pumps. ATP is further known as a crucial co-factor for enzymatic inactivation of 
antimicrobial macrolides (O'Hara et al, 1998). Concerning this, sufficient supply of 
ATP is at least crucial for two main strategies to overcome antimicrobial stress. 
Hence, simultaneous manipulation of glycolytic activity and administration of 
erythromycin implies the possibility to recover drug efficiency. 
5.2.3 The high susceptibility for tetracycline is accompanied by the absence of 
major flux rerouting in Yersinia pseudotuberculosis 
The administration of tetracycline led to an increased pyruvate efflux at the expense 
of other by-products (Figure 22B; Figure 25). However, a major decrease in TCA 
cycle flux, as observed for erythromycin, did not occur. This tempts to speculate that, 
a high TCA cycle flux is a crucial characteristic for maintenance of bacterial fitness 
under tetracycline induced stress. In general, efflux determinants are the most wide 
spread resistant factors in Gram-negative bacteria. At present, 38 tetracycline 
resistant determinants are described of which 23 act by efflux, 11 act by ribosomal 
protection, 3 act by enzymatic protection, and 1 acts by an unknown mode of 
mechanism (Roberts, 2005). Interestingly, tetracycline efflux is generally maintained 
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by a metal-tetracycline/H+ antiporter with NADH as driving force (Yamaguchi et al, 
1990; Chopra & Roberts, 2001). Assuming that the efflux of tetracycline by 
Y. pseudotuberculosis requires NADH, it seems reasonable that Yersinia maintains a 
high TCA cycle flux and concomitantly decreases the flux through NADH-consuming 
reactions, such as lactate dehydrogenase and alcohol dehydrogenase (Figure 22B, 
Figure 25).  
 
 
Figure 25. Relative (A) and absolute (B) flux changes in Y. pseudotuberculosis YPIII under 
administration of 50 mg L-1 erythromycin or 0.1 mg L-1 tetracycline, normalized to the flux 
distribution of the wild type without addition of antimicrobial agents.  
Taken together, the chosen sub-inhibitory levels of antibiotics resulted in a similar 
slight reduction of bacterial fitness, at concentrations of 0.2 µmol L-1 and 68 µmol L-1 
A 
B 
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for tetracycline and erythromycin, respectively (Table 8). However, 
Y. pseudotuberculosis responded differently on the level of intracellular fluxes. 
Whereas maintenance of a high glycolytic flux and ATP supply were the major 
benefits of the altered fluxes under treatment with erythromycin, tetracycline seemed 
to reduce NADH consuming pathways and to maintain a high TCA cycle flux. Both 
flux adaptations might be explained by the needs to specifically support efflux of the 
antibiotic, thus pointing at a possible role of metabolism to defend against antibiotic 
stress.  
Table 9. Relative mass isotopomer fractions of t-butyl-dimethylsilyl derivates of proteinogenic 
amino acids used for 13C metabolic flux analysis of Y. pseudotuberculosis YPIII cultivated on 
99% [1-13C] glucose and under administration of 50 mg L-1 erythromycin or 0.1 mg L-1 
tetracycline. The data set comprises experimental values with deviations from replicate 
GC/MS measurement (Exp) and calculated values (Calc), predicted by the solution of the 
mathematical model that corresponded to the optimized set of fluxes.  
  Erythromycin Tetracycline 
 M0 M1 M2 M0 M1 M2 
Ala 
(m/z) 260 
Exp 0.467 (±0.01%) 
0.394 
(±0.03%) 
0.106 
(±0.04%) 
0.479 
(±0.04%) 
0.384 
(±0.05%) 
0.105 
(±0.05%) 
Calc 0.462 0.391 0.113 0.474 0.383 0.110 
Val 
(m/z) 288 
Exp 0.284 (±0.11%) 
0.416 
(±0.04%) 
0.217 
(±0.16%) 
0.298 
(±0.45%) 
0.412 
(±0.30%) 
0.209 
(±0.03%) 
Calc 0.282 0.412 0.219 0.297 0.411 0.210 
Thr 
(m/z) 404 
Exp 0.281 (±0.05%) 
0.388 
(±0.13%) 
0.221 
(±0.25%) 
0.285 
(±0.14%) 
0.384 
(±0.09%) 
0.219 
(±0.16%) 
Calc 0.282 0.382 0.221 0.286 0.380 0.220 
Asp 
(m/z) 418 
Exp 0.281 (±0.47%) 
0.387 
(±0.29%) 
0.221 
(±0.36%) 
0.287 
(±0.53%) 
0.383 
(±0.12%) 
0.219 
(±0.28%) 
Calc 0.282 0.381 0.221 0.285 0.379 0.220 
Glu 
(m/z) 432 
Exp 0.197 (±0.38%) 
0.358 
(±0.34%) 
0.269 
(±0.10%) 
0.205 
(±0.30%) 
0.358 
(±0.01%) 
0.264 
(±0.18%) 
Calc 0.197 0.355 0.268 0.204 0.356 0.264 
Ser 
(m/z) 390 
Exp 0.404 (±0.03%) 
0.392 
(±0.14%) 
0.150 
(±0.31%) 
0.415 
(±0.07%) 
0.384 
(±0.04%) 
0.148 
(±0.18%) 
Calc 0.408 0.387 0.150 0.418 0.381 0.148 
Phe 
(m/z) 336 
Exp 0.211 (±0.23%) 
0.375 
(±0.26%) 
0.263 
(±0.04%) 
0.223 
(±0.35%) 
0.378 
(±0.05%) 
0.255 
(±0.04%) 
Calc 0.209 0.375 0.267 0.224 0.380 0.259 
Gly 
(m/z) 246 
Exp 0.757 (±0.08%) 
0.172 
(±0.20%)  
0.756 
(±0.00%) 
0.173 
(±0.03%)  
Calc 0.753 0.175  0.756 0.173  
Tyr 
(m/z) 466 
Exp 0.185 (±1.21%) 
0.344 
(±0.08%) 
0.270 
(±0.06%) 
0.198 
(±0.09%) 
0.348 
(±0.49%) 
0.263 
(±0.31%) 
Calc 0.180 0.344 0.275 0.193 0.350 0.269 
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5.3 Control of virulence by temperature  
5.3.1 Impact of temperature on virulence of Y. pseudotuberculosis  
As shown, the abundance of the global virulence regulator RovA in 
Y. pseudotuberculosis is mediated by the nutrient environment (Table 3), which 
reflects a fine-tuned adaptation of the pathogen to respond to the different 
environment inside and outside of its host. Similarly, also temperature strongly affects 
the level of RovA. The regulator of virulence shows decreased stability and only little 
autoactivation at 37°C (Herbst et al, 2009). So far, the temperature dependence of 
RovA expression is only known as qualitative phenomenon. Towards a better 
understanding and model-based description, it appeared straightforward to study this 
on a quantitative basis, which, however, required precise and defined experimental 
handling. For this purpose, Y. pseudotuberculosis, expressing green fluorescent 
protein (GFP) under control of the rovA promoter, should be cultivated in a small 
scale continuously operated reactor. Coupled to fluorescence-activated cell sorting 
and Western blot analysis, this provided the possibility to precisely analyze the gene 
expression of RovA as function of temperature and time.  
5.3.2 Development of a reactor setup for precise temperature profiles 
The analysis of temperature dependence of RovA expression is limited, when 
performed in shake flasks. Particularly, accurate and fast step changes of 
temperature are not feasible in standard incubators, so that it is impossible to 
uncover common phenomena such as bistability and hysteresis, as intended here. 
Accordingly, a continuous reactor set-up was used for temperature shift experiments. 
First tests with the conventional reactor system revealed that the commercial heating 
system, based on a heating element, did not allow fast changes of broth temperature, 
but that it took up to 15 minutes until a desired temperature was reached. This was 
  RESULTS AND DISCUSSION 
71 
not suitable for the planned experiments. To this end, the built-in heating rod was 
combined with temperature control by a water-filled jacket around the reactor to 
control temperature. For fast and precise temperature up-shifts, the temperature of 
water in the jacket was set to a value slightly below the target temperature. Using this 
procedure, temperature overshooting, otherwise observed, was avoided. Almost 
intermediate temperature down-shifts were realized by adding ice chilled water to the 
water cycle, so that the temperature of the cooling jacket was temporally far below 
the desired one. The interplay of cooling water and heating rod then provided exact 
temperature control. 
5.3.3 Determination of an appropriate dilution rate for RovA synthesis 
In batch culture of Y. pseudotuberculosis, rovA transcription starts at mid-log phase 
and reaches a peak during stationary phase (Nagel et al, 2001). Obviously, RovA 
expression is promoted under reduced rates of growth. Hence, a relatively low 
dilution rate representing this growth phase seemed favorable for the planned 
continuous culture. Initial growth experiments were conducted at 25°C and 37°C, 
respectively, to determine the process window with regard to suitable specific growth 
rates. These were carried out in 100 mL baffled shake flasks with a working volume 
of 10 mL of LB broth. Specific growth rates, obtained from differentiation of data on 
cell concentration, varied between 0.6 h-1 and 0.2 h-1 at both temperatures 
(Figure 26). From this, a dilution rate of about 0.3 h-1 seemed appropriate for 
continuous cultivation, because it is significantly below the maximum specific growth 
rate (µmax). Moreover, the resulting hydrodynamic residence time of 3.3 hours is 
relatively short and, thus, reduces the time necessary for achieving steady state.  
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Figure 26. Initial growth experiments of Yersinia pseudotuberculosis (YPIII) harboring 
plasmid pkH70 at 25°C and 37°C, respectively, to determine the process window with regard 
to suitable specific growth rates for subsequent continuous cultivations. Experiments were 
taken out in 10 mL selective LB broth in 100 mL baffled shake flasks in triplicate. The first 
derivation (1st Deriv) equals the specific growth rate [h-1] and was calculated for discrete 
points by the average of the slopes between the point and its two closest neighbors as 
performed by the data analysis software OriginPro 9 (OriginLab, Northampton, US). 
 
5.3.4 Temperature up-shift mimicking the entrance of Y. pseudotuberculosis 
into the host 
An initial batch phase of approximately five hours was performed at 25°C, and then 
the reactor was switched to continuous operation (D = 0.32 h-1). For an ideal stirred 
tank reactor, volume exchange is 95% and more than 99% after three and five 
residence times, respectively (Dunn et al, 2003). After 15.2 hours, equal to 3.2 
hydrodynamic residence times, the culture reached constant states regarding cell 
concentration and pH-value (Figure 27). At this point, however, the dissolved oxygen 
level had reached a minimum (29%) and started to increase to a constant level of 
53% within the next six hours. Hence, steady state was accomplished after 5.1 
residence times. Then, defined step changes of the temperature were realized: the 
temperature was increased from the initial value of 25°C, to 28°C, 30°C, 32°C, 34°C, 
and 37°C, linked to periodic sampling of cells from the reactor outlet for monitoring of 
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cell concentration and subsequent fluorescence-activated cell sorting and Western 
blotting. 
 
Figure 27. Cultivation profile of Yersinia pseudotuberculosis YPIII harboring plasmid pkH70. 
The given temperature up-shift mimics the entrance into the host. Optical density (OD) at 600 
nm is given as filled circles (●), oxygen saturation as filled squares (■), pH as empty triangles 
(△), actual and target temperature as blue and gray lines, respectively.  
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5.3.5 Temperature down-shift mimicking release from the host 
An initial batch phase at 25°C was performed. After five hours, the reactor was 
switched to continuous mode. A constant optical density and pH value was achieved 
within 15 hours post inoculation. The oxygen saturation reached a constant value 
after 21 hours. Thus, the process showed high consistence with the previous 
cultivation (Figure 27 and Figure 29). In contrast to the up-shift experiment, a drastic 
down-shift without any interim steps was performed. This was due to the fact that a 
preliminary study revealed that the restart of RovA synthesis only occurs at ambient 
temperatures. The fraction of fluorescing cells, representing an active RovA 
transcription, was far below 1% until the temperature was set to 25°C (Figure 28). 
 
Figure 28. Preliminary study on reactivation of rovA transcription as function of time and 
temperature. The decreasing temperature mimics the release of Yersinia pseudotuberculosis 
from the host. Data represent the relative fractions of fluorescing Yersinia 
pseudotuberculosis YPIII harboring plasmid pkH70 (expressing the green fluorescent protein 
under control of the rovA promoter), estimated by FACS analysis. Samples were taken at 
different temperatures and after certain time intervals from the outlet of a continuous 
cultivation at a dilution rate of 0.32 h-1. 
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Figure 29. Cultivation profile of Yersinia pseudotuberculosis YPIII harboring plasmid pkH70. 
The temperature down-shift mimics the release from the host. Optical density (OD) at 600 
nm is given as filled circles (●), oxygen saturation as filled squares (■), pH as empty triangles 
(△), actual and target temperature as blue and gray lines, respectively.  
 
5.3.6 Fluorescence-activated cell sorting correlates with Western blot analysis 
The fraction of green fluorescent positive (GFP+) Yersinia cells possess an active 
rovA transcription (Figure 30A). Simultaneously processed Western blot analysis 
illustrates the correlation of transcription and actual protein availability (Figure 30B).  
5.3.7 Silencing and activation of rovA transcription follow different kinetics  
The entire data set from fluorescence-activated cell sorting of the continuous reactor 
cultures is given in Figure 30 and Table 10. Within the first hours (25°C - 28°C, 5h), 
the amount of GFP+ cells, i.e., cells that expressed RovA, did not alter significantly. 
The increase of temperature to 30°C and to 32°C, respectively, induced a slow but 
steady decrease of the traceable rovA transcription to 88% (after five hours at 32°C). 
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The switch from 32°C to 34°C then induced a strong decrease of the RovA level 
(63% GFP+ cells, after five hours at 34°C). The decrease of RovA was even more 
pronounced at 37°C, the temperature reflecting the host of the pathogen. After 
growth of Y. pseudotuberculosis for one hour at this temperature, the amount of 
GFP+ cells was reduced to 32%, and it further decreased within the next two hours to 
only 2% (Figure 30). The direct comparison of transcriptional activity (GFP 
expression) and traceable RovA levels (Western blot) at 37°C showed that, although 
32% of Yersinia cells remained in the GFP+ state and obviously still expressed rovA, 
no RovA was detected in the prepared cell lysates. During the temperature up-shift, 
Yersinia showed similar changes of rovA expression and RovA level. This is 
consistent with post-transcriptional control of RovA by temperature induced 
conformational change that makes the protein more susceptible to degradation by 
proteases (Herbst et al, 2009). From the fact that the number of GFP+ cells 
decreased significantly slower than the actual amount of RovA, it is tempting to 
speculate that delayed inactivation of rovA transcription is favorable for survival of the 
population during the infection.  
After transcription of rovA was completely halted at 37°C, the re-activation of 
transcription after cooling down of the population to 25°C was markedly prolonged. 
Temperatures above 25°C did not favor re-activation (Figure 28). At 25°C, it took 
more than six hours to reach significant amounts of GFP+ cells (4.1% ± 3.4%). Even 
after 17 hours at 25°C, only half of the population (46% ± 12%) showed active rovA 
transcription (Figure 30, Table 10). Additionally, the standard deviation of FACS 
analyses increased significantly compared to the up-shift experiments, which might 
indicate a certain degree of culture heterogeneity due to statistical probability of the 
process of reactivation. 
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5.3.8 Bistability can explain the observed RovA expression pattern 
Taken together, the progression of RovA expression indicates bistability: a 
genetically homogenous population that diverges into two phenotypically different 
subpopulations without genetic changes (Smits et al, 2005; Dubnau & Losick, 2006; 
Casadesus & Low, 2013). Since the environmental conditions were equal for every 
cell within the bioreactor, the stochastically driven re-activation of rovA transcription 
(Figure 30) seems an indicator of such a behavior. Additionally, evidence for 
bistability was the observed hysteresis (Figure 30), an inevitable property of bistability 
(Ferrell, 2002). Hysteresis describes the fact that the time profile of the switch 
between two states differs depending on whether the system is switched forward or 
backward (Smits et al, 2006). It is known that population heterogeneity, mediated by 
bistability, provides an efficient way to prepare for different circumstances and 
maximize the chance for survival (Dubnau & Losick, 2006).  
5.3.9 Does RovA expression fit with known models of bistability? 
Two mechanisms are known to mediate bistability, i.e., bifurcation of an isogenic 
population. The first mechanism is based on positive, non-linear auto-regulation and 
the second mechanism is based on two mutually repressing regulators (Gardner et 
al, 2000; Dubnau & Losick, 2006). Previously, the activity of the rovA promoter was 
found to correlate with the amount of the RovA protein (Heroven et al, 2004; Nagel et 
al, 2001) and, hence, to be subjected to auto-regulation. Moreover, the experimental 
data in this work show striking parallels to an auto-regulated bistable system in 
B. subtilis. The progression of RovA during the down-shift from 37°C to 25°C (Figure 
30) matches the bistable response of Bacillus subtilis during developing competence 
(Smits et al, 2005). Auto-regulation and stochastic fluctuation of an activator protein 
were found as crucial elements to mediate bistability in Bacillus subtilis. Additionally 
identified regulatory elements were found to influence the properties of bistability in 
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controlling the basal level of the activating transcription factor and the threshold at 
which auto-regulation is initiated (Smits et al, 2005). In B. subtilis the auto-regulator 
ComK (transcription regulator of competence) is proteolyzed during exponential 
growth, whereas at stationary phase, a signal cascade inhibits the involved proteases 
and prevents degradation of ComK. As a consequence, individual cells have a 
certain probability to reach the threshold concentration of ComK, at which the auto-
regulation starts. In Yersinia, RovA is constitutively expressed, but undergoes a 
conformational change at 37°C, which makes it inactive and susceptible to 
proteolysis. At decreasing temperature, RovA switches back to the stable form and 
starts to compete with the RovA repressor H-NS (Herbst et al, 2009).  
In summary, the quantitative analysis of RovA by defined temperature variations in 
continuous culture revealed a bistable behavior of this global virulence regulator. 
Hence, heterogeneity in RovA expression will lead to at least two fundamentally 
different subpopulations. As RovA affects a wide range of metabolic, stress, and 
virulence genes (Herbst et al, 2009), this probably has fundamental effects on cellular 
physiology of Y. pseudotuberculosis. Bistability seems an important phenomenon in 
the lifestyle of the pathogen. The experimental data, together with additional studies 
will provide the basis for a further investigation of the underlying mechanisms and 
kinetics of virulence control. 
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Table 10. Fractions of fluorescing Yersinia pseudotuberculosis YPIII with plasmid pkH70 
(expressing the green fluorescent protein under control of the rovA promoter). Samples were 
taken at different temperatures and after certain time intervals from the outlet of a continuous 
cultivation at a dilution rate of 0.32 h-1 performed in triplicate. The evaluation of 100,000 
counted cells per run was performed to ensure statistical certainty. 
Program step Replicate 1 GFP+ [%] 
Replicate 2 
GFP+ [%] 
Replicate 3 
GFP+ [%] 
Mean 
GFP+ [%] 
Standard 
deviation [%] 
25°C 99.6 99.1 97.8 98.8 0.9 
28°C 1h 99.5 99.2 97.8 98.8 0.9 
28°C 2h 99.4 99.0 97.9 98.8 0.8 
28°C 3h 99.2 98.9 97.7 98.6 0.8 
28°C 4h 98.8 97.7 97.6 98.0 0.7 
28°C 5h 99.3 97.8 97.3 98.1 1.0 
30°C 1h 98.7 96.9 96.5 97.4 1.2 
30°C 2h 98.3 96.4 96.0 96.9 1.2 
30°C 3h 97.6 96.1 94.6 96.1 1.5 
30°C 4h 97.1 95.4 94.4 95.6 1.4 
30°C 5h 96.2 94.5 93.5 94.7 1.4 
32°C 1h 94.3 93.0 92.4 93.2 1.0 
32°C 2h 94.1 91.1 91.3 92.2 1.7 
32°C 3h 93.0 90.7 89.7 91.1 1.7 
32°C 4h 91.9 88.4 87.2 89.2 2.4 
32°C 5h 90.4 86.3 86.3 87.7 2.4 
34°C 1h 87.7 84.3 84.2 85.4 2.0 
34°C 2h 83.4 80.2 82.0 81.9 1.6 
34°C 3h 77.6 75.9 77.6 77.0 1.0 
34°C 4h 69.4 66.4 72.7 69.5 3.2 
34°C 5h 61.3 60.1 67.0 62.8 3.7 
37°C 1h 30.4 30.2 34.9 31.8 2.7 
37°C 2h 11.1 8.0 8.9 9.4 1.6 
37°C 3h 2.8 1.7 2.1 2.2 0.5 
37°C 4h 0.7 0.9 1.1 0.9 0.2 
37°C 5h 0.2 0.6 0.7 0.5 0.3 
25°C 1h 0.1 0.2 0.2 0.2 0.1 
25°C 2h 0.1 0.1 0.2 0.2 0.1 
25°C 3h 0.2 0.2 0.2 0.2 0.0 
25°C 4h 0.7 0.2 0.2 0.4 0.3 
25°C 5h 3.2 0.8 0.5 1.5 1.5 
25°C 6h 8.1 2.5 1.9 4.1 3.4 
25°C 7h 13.5 5.4 4.0 7.6 5.1 
25°C 8h 18.7 8.9 7.1 11.6 6.3 
25°C 9h 25.3 13.2 10.9 16.5 7.7 
25°C 10h 31.5 18.7 15.0 21.7 8.7 
25°C 11h 36.5 23.3 18.5 26.1 9.3 
25°C 12h 43.6 26.6 22.1 30.8 11.3 
25°C 13h 47.2 31.4 25.3 34.6 11.3 
25°C 14h 51.3 33.7 28.6 37.9 11.9 
25°C 15h 54.5 37.4 33.5 41.8 11.2 
25°C 16h 56.5 39.0 35.3 43.6 11.3 
25°C 17h 59.1 41.7 36.9 45.9 11.7 
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6 CONCLUSION AND OUTLOOK 
The interaction of pathogens with the human host has been studied for more than 
200 years (Brown et al, 2008) and, since then, a lot of information about virulence 
has been obtained. Although the human host is even considered as a chemostat that 
provides specific nutritional conditions for different infection sites (Brown et al, 2008), 
the complex interplay between nutritional status, metabolism, and virulence is still not 
understood, and the metabolic requirements of Yersinia for adapting to and surviving 
in different host niches are largely unknown. In this work, a systems biology approach 
was utilized to address this question with a focus on central carbon metabolism. In 
particular, the link between virulence and metabolism was investigated in the wild 
type and in specific mutants lacking the key virulence regulators CsrA, Crp, and 
RovA that coordinate virulence and metabolism. To this end, transcriptome and 13C 
based fluxome analyses were integrated. The latter involved 13C tracer studies, mass 
spectrometric labeling analysis, and comprehensive computer models to assess the 
pathway flux (Sauer, 2006; Kohlstedt et al, 2010). This work provided quantitative 
insight into the molecular fluxes of Y. pseudotuberculosis. Derived data sets were 
integrated into a carefully curated concept, which identified the pyruvate-TCA cycle 
node as a focal point of virulence control. Second generation mutants with 
knock-outs in regulatory genes of this metabolic branch point, i.e., ∆arcA, ∆ptsN, and 
∆pdhR and of its central enzyme, i.e., pyruvate kinase, were constructed and tested 
in an oral mouse infection model. The loss of each factor resulted in significant 
reduction of Yersinia virulence. Since the glucose uptake rate of all new mutants was 
comparable to that of the wild type, and a similar colonization rate in at least one of 
the tested mouse tissues was observed, a reduction of virulence based on a growth 
defect could be excluded. In summary, this work proved integrated transcriptome and 
13C fluxome studies as a powerful tool to provide new insights into the life style of 
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pathogens and point at the pyruvate-TCA cycle node as a focal point of virulence 
control in Yersinia pseudotuberculosis.  
Different directions of research appear particularly promising to further explore the life 
style of the pathogen. A closer view to the real infection process might be obtained by 
applying 13C metabolic flux analysis, i.e., investigation of the actual phenotype of the 
cell at the level of pathway flux, to a host model using a prepared mouse intestine as 
culture vessel. This would allow to directly correlate tissue integrity and data from the 
in-depth profiling of virulence mutants. In addition, in vitro experiments mimicking 
organ-specific growth environments will further help to decipher the control 
mechanisms of the identified pyruvate-TCA cycle node. One way to approach this 
task is to determine the metabolic phenotype in the presence of alternative carbon 
sources (e.g., pyruvate, glucose, acetate, or glutamine) as the access to these 
metabolites differs throughout the host (Sugimoto et al, 2012). 
As shown, the effect of erythromycin and tetracycline on the metabolic phenotype 
was analyzed. The observed effect on carbon flux distribution was different even 
though both antibiotics inhibit translocation. Administration of erythromycin, e.g., 
increased the pyruvate efflux by 53% at the expense of TCA cycle flux. An increased 
pyruvate efflux could be a viable strategy to provide high amounts of ATP and thus 
favors ATP driven macrolide efflux (Chan et al, 2013). In contrast, active tetracycline 
secretion is a NADH driven process (Yamaguchi et al, 1990; Chopra & Roberts, 
2001) and in accordance therewith, Yersinia maintains a high TCA flux under 
tetracycline therapy. Thereby, both flux adaptions might be explained by the needs to 
specifically support efflux of the antibiotic. Hence, analysis of a Yersinia mutant with 
an altered pyruvate kinase activity, e.g., the single gene deletion mutant YP253 
(∆pykF), seems interesting to further investigate the role of metabolism under 
administration of the tested antibiotics. 
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Finally, the abundance of the global regulator RovA is an indicator for virulence 
promoting conditions and was shown to be mediated by the nutrient environment. 
The fine-tuned adaption of the pathogen to respond to different conditions inside and 
outside the host is further mediated by temperature (Herbst et al, 2009). Thus far, 
RovA abundance as a function of temperature was mainly analyzed qualitatively. In 
this work, RovA abundance was determined quantitatively using fluorescence-
activated cell sorting and Western blot analysis. A continuous culture with defined 
temperature variations was used to mimic the infection process. In summary, the 
measured progression of RovA expression showed stochastically driven re-activation 
and hysteresis as a characteristic property of bistability (Ferrell, 2002). As a wide 
range of metabolic, stress, and virulence genes (Herbst et al, 2009) is controlled by 
RovA, bistability probably leads to fundamentally different subpopulations. The 
resulting heterogeneity prepares the population best for different challenges and thus 
maximizes survival (Dubnau & Losick, 2006). The experimental data is an excellent 
basis for further analyses and will help to investigate the underlying mechanisms and 
kinetics of virulence control towards dynamic models. 
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7 APPENDIX 
7.1 Abbreviations 
3,4-DHB 3,4-Dihydroxybenzoic acid 
B and BT (suffix) Metabolite serves as biomass precursor 
EX (suffix) Secreted metabolite 
∆ Indicates a gene deletion 
1st Deriv First derivation 
3PG 3-Phosphoglycerate 
6PG 6-Phosphogluconate 
accA Gene encoding acetyl-CoA carboxylase, carboxyl transferase, alpha subunit 
AcCoA/ACCOA/Acetyl-CoA Acetyl coenzyme A 
Ace or ACE Acetate 
aceA Gene encoding isocitrate lyase 
aceB Gene encoding malate synthase A 
aceEF, lpdA Genes encoding pyruvate dehydrogenase 
ackA Gene encoding acetate kinase 
acnA, acnB Genes encoding aconitate hydratase 1 and 2 
acs Gene encoding acetyl-CoA synthetase 
actP Gene encoding acetate permease 
adhE Gene encoding acetaldehyde/alcohol dehydrogenase 
ailA Gene encoding virulence-related outer membrane protein 
Akg or AKG α-Ketoglutaric acid 
Ala/ALA Alanine 
Asp/APSX Aspartate 
ArcA Transcriptional regulator of aerobic respiratory control 
arcA Gene encoding transcriptional regulator of aerobic respiratory control 
ATP Adenosine triphosphate 
B. subtilis Bacillus subtilis 
BALB/c mice Bagg albino c inbred mice strain 
BP Bisphosphate 
bp Base pairs 
Calc Calculated values 
cdd Gene encoding cytidine deaminase 
CDM Cell dry mass 
CDW Cell dry weight 
CFU Colony-forming units 
cheA Gene encoding CheA signal transduction histidine kinase 
cheD Gene encoding methyl-accepting chemotaxis sensory transducer 
cheW Gene encoding CheW protein 
CHRM Chorismate 
CI Confidence interval 
CIT Citrate 
clpA Gene encoding ATP-dependent Clp protease, ATP-binding subunit clpA 
cmk Gene encoding cytidylate kinase 
CO2 Carbon dioxide 
CoA Coenzyme A 
cog Clusters of orthologous groups of proteins 
ComK Transcriptional regulator of competence 
Crp Catabolite repression protein 
crp Gene encoding catabolite repression protein 
cspA-D Genes encoding cold-shock DNA-binding domain proteins 
CsrA Carbon storage regulator A  
csrA Gene encoding carbon storage regulator A 
CsrB and CsrC Regulatory RNAs of the Carbon storage regulator system 
cstA Gene encoding carbon starvation protein CstA 
cTrans Carbon transitions 
cydA Gene encoding cytochrome bd ubiquinol oxidase subunit I 
cydB Gene encoding cytochrome d ubiquinol oxidase, subunit II 
ddp genes Genes encoding peptide transport factors 
DHAP Dihydroxyacetone phosphate 
DMEM Dulbecco’s Modified Eagle Medium (Commercial nutrient mixture) 
DNA Deoxyribonucleic acid 
E. coli  Escherichia coli 
E4P Erythrose 4-phosphate 
ED pathway Entner-Doudoroff pathway 
EDTA Ethylenediaminetetraacetic acid 
EMP pathway/EMPP Embden-Meyerhof-Parnas pathway 
Ery Erythromycin 
EtOH Ethanol 
Exp Experimental values 
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F16BP Fructose 1,6-bisphosphate 
F6P Fructose 6-phosphate 
FACS Fluorescence-activated cell sorting 
fadA Gene encoding acetyl-CoA C-acyltransferase FadA 
fadB Gene encoding fatty oxidation complex, alpha subunit FadB 
fadI Gene encoding acetyl-CoA C-acyltransferase FadI  
fadJ Gene encoding fatty acid oxidation complex, alpha subunit FadJ 
fadL Gene encoding membrane protein involved in aromatic hydrocarbon degradation 
FELASA Federation of Laboratory Animal Science Associations 
flhDC Operon encoding flagellar transcriptional activators 
fli, flg, flh genes Genes encoding the flagella apparatus 
Form or FORM Formate 
fruB Gene encoding phosphocarrier, HPr family (fructose uptake) 
fruK Gene encoding 1-phosphofructokinase (fructose uptake) 
Fum or FUM Fumarate 
fumA Gene encoding hydrolyase, Fe-S type, tartrate/fumarate subfamily, beta subunit 
Fur Ferric uptake regulator 
G3P Glyceraldehyde 3-phosphate 
G6P Glucose 6-phosphate 
GAP Glyceraldehyde 3-phosphate 
gapA Gene encoding glyceraldehyde 3-phosphate dehydrogenase 
GC content Guanine-cytosine content 
GC-MS Gas chromatography-mass spectrometry 
Gene::KanR Disrupted gene by insertion of kanamycin resistance gene 
GEO Gene Expression Omnibus database 
GFP Green fluorescent protein 
GFP+/- Green fluorescent positive/negative 
Glc Glucose 
GLC6P Glucose 6-phosphate 
glgXAP Genes encoding glycogen debranching enzyme GlgX, glycogen/starch synthase and 
glycogen/starch/alpha-glucan phosphorylase 
glnH Gene encoding cationic amino acid ABC transporter, periplasmic binding protein 
glnP Gene encoding polar amino acid ABC transporter, inner membrane subunit 
glnQ Gene encoding ABC transporter  
glpFK Genes encoding MIP family channel protein and glycerol kinase (glycerol uptake) 
GlpR DNA-binding transcriptional repressor GlpR, glycerol metabolism 
gltA Gene encoding citrate synthase I 
gltB Gene encoding glutamate synthase (ferredoxin) 
Glu/GLUX Glutamate 
Gly/GLY Glycine 
GLYO/GLYOX Glyoxylate 
gnd Gene encoding 6-phosphogluconate dehydrogenase 
gpt Gene encoding xanthine phosphoribosyltransferase 
gr. Gram 
groEL, groES Genes encoding chaperonin GroEL and Cpn10 
GV-SOLAS Gesellschaft für Versuchstierkunde / Society for Laboratory Animals Science 
H Proton 
HAM’s F-12 Commercial nutrient mixture 
HdfR Transcriptional Regulator (flagella formation) 
H-NS Nucleoid-associated protein 
HPLC High performance liquid chromatography 
htrA Gene encoding protease Do 
ibpAB Genes encoding for heat shock protein Hsp20 
icdA Gene encoding isocitrate dehydrogenase 
ICI or ICIT Isocitrate 
IhfA/B Integration host factor 
invA Gene encoding invasin region 3 
kan Gene encoding kanamycin resistance 
katA Gene encoding catalase 
katY Gene encoding catalase/peroxidase HPI 
kdpFABC  Genes encoding potassium transport factors 
Lac/LAC Lactate 
LB Lysogeny broth (microbial growth medium) 
ldh Gene encoding lactate dehydrogenase 
luxS Gene encoding quorum-sensing autoinducer 2 (AI-2), LuxS 
M cells Microfold cells 
M0 Relative mass isotopomer fraction of nonlabeled t-butyl-dimethylsilyl-derivatized amino acids 
M1 Relative mass isotopomer fraction of single labeled t-butyl-dimethylsilyl-derivatized amino acids 
M2 Relative mass isotopomer fraction of double labeled t-butyl-dimethylsilyl-derivatized amino 
acids 
maeB Gene encoding malic enzyme 
MAL Malate 
manXZ Genes encoding PTS system for mannose/fructose/sorbose 
mdh Genes encoding malate dehydrogenase 
MDV Mass isotopomer distribution vector 
mglBAC Genes encoding periplasmic binding protein/LacI transcriptional regulator, ABC transporter 
related and ABC transporter related (galactose uptake) 
APPENDIX   
86 
MIC Minimal inhibitory concentration 
mid-log phase In the middle of the logarithmic growth phase 
MLNs mesenteric lymph nodes 
motA Gene encoding chemotaxis protein MotA 
motB Gene encoding chemotaxis protein MotA 
mRNA Messenger ribonucleic acid 
MsrA Macrolide efflux pump 
MTHF 5,10-Methylenetetrahydrofolate 
n.s. not significant 
NAD(H) Nicotinamide adenine dinucleotide 
NADP(H) Nicotinamide adenine dinucleotide phosphate 
NCBI National Center for Biotechnology Information 
ndk Gene encoding nucleoside-diphosphate kinase 
nt Nucleotides 
nupC1 Nucleoside transporter 
OAA Oxaloacetate 
oppAB Gene encoding for extracellular solute-binding protein family 5 and alkaline phosphatase 
(amino acid peptide transport) 
P Phosphate 
p p-value 
P5P Ribulose 5-phosphate / Ribose 5-phosphate 
PBS Phosphate buffered saline 
pckA Gene encoding phosphoenolpyruvate carboxykinase 
PCR Polymerase chain reaction 
PDHR Pyruvate dehydrogenase regulator 
pdhR Gene encoding pyruvate dehydrogenase regulator 
PEP Phosphoenolpyruvate 
pflB Gene encoding formate acetyl-transferase 
PGA Glycerate 3-phosphate 
pgk Gene encoding phosphoglyceratekinase 
Phe/PHEX Phenylalanine 
PM Pyruvate metabolism 
poxB Gene encoding quinone-reducing pyruvate dehydrogenase 
PP pathway Pentose phosphate pathway 
ppc Gene encoding phosphoenolpyruvate carboxylase 
PPs Peyer’s patches 
ppsA Gene encoding phosphoenolpyruvate synthase 
psaA Gene encoding pH 6 antigen precursor (antigen 4, adhesin) 
psaB Gene encoding pili assembly chaperone 
pta Gene encoding phosphate acetyltransferase 
PTS Phosphotransferase systems 
ptsG Gene encoding EIIBC subunit of the glucose phosphotransferase system 
PTSGlc Glucose-phosphotransferase system 
ptsH Gene encoding phosphotransferase system, phosphocarrier protein HPr 
ptsI Gene encoding phosphoenolpyruvate-protein phosphotransferase 
ptsN Gene encoding for EIIANtr (part of the phosphotransferase system) 
PtsN EIIANtr (part of the phosphotransferase system) 
PTSNtr Nitrogen-phosphotransferase system 
PykA Pyruvate kinase A 
pykAF Genes encoding pyruvate kinases 
PykF Pyruvate kinase F 
Pyr/PYR Pyruvate 
pyrD Gene encoding dihydroorotate oxidase 
R Software environment for statistical computing and graphics 
R5P Ribose 5-phosphate 
RES Resuspension buffer of the NucleoBond Xtra kit 
RNA Ribonucleic acid 
RovA Regulator of virulence A 
rovA Gene encoding the regulator of virulence A 
RovM Regulator of virulence M 
rpm Revolutions per minute 
rRNA Ribosomal ribonucleic acid 
rxnEQ Reaction equations 
S7P Sedoheptulose 7-phosphate 
SacI Restriction enzyme from Streptomyces achromogenes 
sdhABCD Genes encoding succinate dehydrogenase 
SDS Sodium dodecyl sulfate 
Ser/SER Serine 
sfcA Gene encoding malate dehydrogenase (oxaloacetate-decarboxylating) 
SgrS Regulatory RNA that negatively controls the translation of ptsG mRNA 
SHKM Shikimate 
soda, sodC Genes encoding superoxide dismutases 
SPI1 Salmonella pathogenicity island 1 
spp. Species 
Suc or SUC Succinate 
sucAB Genes encoding α-ketoglutarate dehydrogenase 
sucCD Genes encoding succinyl-CoA synthetase 
  APPENDIX 
 
87 
T3P Triose 3-phosphates 
tau Genes encoding taurine transport proteins  
TCA cycle Tricarboxylic acid cycle 
Tet Tetracycline 
Thr/THR Threonine 
Tris Tris(hydroxymethyl)aminomethane 
tRNA Transfer ribonucleic acid 
Tyr/TYRX Tyrosine 
udp Gene encoding uridine phosphorylase 
uhpC Gene encoding phosphoglycerate transporter 
ulaABC/sgaTBA Genes encoding putative ascorbate PTS system 
UV Ultraviolet (light) 
UvrY Response regulator of the two-component signal transduction system BarA/UvrY 
Val/VAL Valine 
Wt Wild type 
X Denotes genes without classification according to the clusters of orthologous groups of proteins 
xanP Gene encoding uracil-xanthine permease 
Y. pestis Yersinia pestis 
Y. pseudotuberculosis Yersinia pseudotuberculosis 
yadA Gene encoding adhesin YadA 
YMM Yersinia minimal medium 
yop genes Genes encoding for Yersinia outer proteins 
ysc genes Genes encoding type III secretion protein 
yspI, ypsI Genes encoding autoinducer synthesis proteins 
yspR, ypsR Genes encoding transcriptional regulators, LuxR family 
zwf Gene encoding glucose 6-phosphate dehydrogenase  
 
7.2 Symbols 
µ Specific growth rate [h-1] 
OD600 Optical density at 600 nm [-] 
vvm Volume of gas per volume of liquid and minute [L L-1 min-1] 
m/z Mass-to-charge ratio [-] 
qGlc Specific rate of glucose uptake [mmol gCDW-1 h-1] 
YX/S Yield on glucose for biomass [g mol-1] 
YP/S Yields on glucose for by-products given as the molar 
percentage of the specific glucose uptake rate 
[%] 
D Dilution rate [h-1] 
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Table 12. Additional inputs required to perform 13C metabolic flux analysis with OpenFlux. 
The list Excluded Metabolites contains metabolites that are not used for metabolite balances. 
The list Simulated MDVs contains metabolites that are used for isotopomer modeling. The 
binary code defines the availability of carbon atoms within the backbone of the metabolite 
according to the rules of OpenFlux (Quek et al, 2009). 
Excluded Metabolites Simulated MDVs Input substrates 
MTHF ALA#111 GLC_EX 
FUM_EX VAL#11111 CO2_EX 
PYR_EX THR#1111  
ACE_EX ASPX#1111  
ETOH_EX GLUX#11111  
SUC_EX SER#111  
FORM_EX PHEX#111111111  
GLC_EX GLY#11  
AKG_EX TYRX#111111111  
AKG_B   
LAC_EX   
GLC6P_B   
F6P_B   
P5P_BT   
E4P_BT   
G3P_B   
3PG_BT   
PYR_BT   
OAA_BT   
ACCOA_BT   
CO2_EX   
BIOMASS   
PEP_BT   
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7.4 Data from gene expression analysis 
Table 13. Transcriptional profile of glucose-grown single gene deletion mutants 
Y. pseudotuberculosis YP3 (∆rovA), YP53 (∆csrA), and YP89 (∆crp). Data are given as the 
fold change in expression compared with Y. pseudotuberculosis wild type (YPIII). The data 
were obtained from three biological replicates, each with three samples. The set of 
differentially expressed genes was filtered by the fold change (|log2FC| >=0.8). All array data 
generated in this study were deposited in the Gene Expression Omnibus (GEO) database 
and are available under accession number GSE54547. 
Locus Gene 
name 
Product, desciption Fold Change 
 
  
∆crp ∆csrA ∆rovA 
VIRULENCE GENES 
pYV0013 yadA adhesin YadA 1.60 -2.06 2.72 
pYV0020 sycH YopH targeting protein -1.33 -2.17 -1.56 
pYV0024 sycE, yerA YopE chaperone -1.96 -2.00 -1.58 
pYV0025 yopE outer membrane virulence protein -1.29 -1.89 -1.13 
pYV0040 yopK/yopQ 
Yop targeting protein 
YopK, YopQ -2.67 -3.43 -1.69 
pYV0055 yopB Yop targeting protein 2.01 1.15 1.79 
pYV0057 lcrV V antigen, antihost protein/regulator -1.24 -2.66 -1.15 
pYV0058 lcrG Yop regulator -1.29 -2.77 -1.31 
pYV0062 yscX type III secretion protein 1.75 1.55 1.64 
pYV0063 sycN type III secretion protein 2.20 1.78 1.61 
pYV0064 tyeA Yop secretion and targeting protein 2.36 1.75 1.64 
pYV0065 yopN, lcrE 
membrane-bound Yop 
targeting protein 2.16 1.85 1.69 
pYV0067 sctN Yops secretion ATP 
synthase 1.01 -1.97 -1.32 
pYV0073 yscT  type III secretion protein -1.30 -2.28 -1.46 
pYV0074 yscU  type III secretion protein -1.33 -2.58 -1.48 
pYV0075 virG Yop targeting lipoprotein -1.73 -2.01 -1.80 
pYV0076 lcrF, virF thermoregulatory protein -1.35 -1.96 -1.58 
pYV0087 yscK  type III secretion protein -1.38 -1.96 -1.13 
pYV0089 yscM, lcrQ 
type III secretion 
regulatory -1.47 -2.05 -1.72 
pYV0094 yopH  protein-tyrosine phosphatase Yop effector 3.39 1.60 1.61 
YPK_0051 fimA-1 fimbrial protein 9.57 -1.43 -1.06 
YPK_0053 fimC-1 pili assembly chaperone 2.72 1.13 -1.17 
YPK_0054 
  fimbrial protein 2.00 -1.17 -1.22 
YPK_0220 hofM pilus assembly protein 1.11 2.08 1.16 
YPK_0251 yhhZ-1 type VI secretion system 
effector, Hcp1 family -2.16 1.84 -1.47 
YPK_0280 bfd bacterioferritin-associated ferredoxin -1.98 -5.76 -1.64 
YPK_0281 bfr bacterioferritin 3.07 -1.18 -1.58 
YPK_0385 hcp1-1 type VI secretion system 
effector, Hcp1 family 1.92 -1.41 -1.31 
YPK_0386 impB type VI secretion protein, VC_A0107 family 2.55 -1.11 -1.01 
YPK_0387 impC-1 type VI secretion protein, EvpB/VC_A0108 family 3.51 1.60 1.65 
YPK_0388 
  
type VI secretion system 
lysozyme-related protein 3.14 1.46 1.33 
YPK_0389 impG-1, 
vasA-1 
type VI secretion protein, 
VC_A0110 family 2.40 1.20 1.22 
YPK_0390 impH-1, 
vasB-1 
type VI secretion protein, 
VC_A0111 family 2.39 1.16 1.46 
YPK_0391 impI, 
vasC 
type VI secretion cluster, 
FHA domain containing 
protein 
1.77 1.27 -1.17 
YPK_0392 vasD, lip type VI secretion cluster, putative lipoprotein 2.12 1.18 1.25 
YPK_0393 impJ, 
vasE 
type VI secretion protein, 
VC_A0114 family 2.53 1.52 1.41 
YPK_0394 
  
type VI secretion cluster, 
conserved protein 2.00 1.39 1.28 
YPK_0395 clpB2 type VI secretion ATPase, ClpV1 family 1.95 1.32 1.39 
YPK_0398 vasJ 
type VI secretion-
associated protein, 
VC_A0119 family 
1.78 1.23 1.18 
YPK_0399 impL, 
vasK 
type VI secretion protein 
IcmF 1.82 1.27 1.20 
YPK_0400 vasL type VI secretion cluster, ImpA domain protein 1.77 1.28 1.37 
YPK_0694 smfA-1 fimbrial protein -2.35 -1.86 -1.47 
YPK_0696 papD pili assembly chaperone 1.75 1.02 1.31 
YPK_0791 yspR transcriptional regulator, LuxR family -1.87 1.01 -1.41 
YPK_0792 yspI autoinducer synthesis protein -3.15 -1.35 -1.94 
YPK_0798 
  
type VI secretion protein, 
VC_A0107 family 1.25 1.75 1.26 
YPK_0871 yadF YadA domain protein 2.25 -1.02 1.05 
YPK_1268 ailA virulence-related outer 
membrane protein 3.27 1.56 1.96 
YPK_1304 
  
type VI secretion system 
effector, Hcp1 family -2.53 -2.91 -1.72 
YPK_1475 fimA-2 fimbrial protein -1.89 1.71 -1.62 
YPK_1479 
  
type VI secretion protein, 
VC_A0107 family 1.46 1.76 1.49 
YPK_1481 
  
type VI secretion system 
effector, Hcp1 family -1.67 2.40 -1.54 
YPK_1522 smfA-2 fimbrial protein -2.35 -1.84 -1.48 
YPK_1559 rovM transcriptional regulator, LysR family 1.40 -7.63 -1.66 
YPK_1606 ompX/ailD 
virulence-related outer 
membrane protein -1.20 3.16 -2.09 
YPK_1655 ypsR transcriptional regulator, LuxR family -1.58 -2.20 -1.64 
YPK_1656 ypsI autoinducer synthesis protein -5.06 -3.82 -2.00 
YPK_1705 ycfJ 17 kDa surface antigen 3.74 9.70 1.15 
YPK_1761 yadE YadA domain protein 5.76 -1.54 1.16 
YPK_1775 fimC-2 chaperone protein 1.82 1.09 1.12 
YPK_1786 fimA-3 fimbrial protein -1.75 -3.06 -1.40 
YPK_1876 rovA transcriptional regulator, MarR family -1.67 1.84 -2.66 
YPK_1953 srfB putative virulence factor SrfB -5.02 -5.58 1.16 
YPK_2156 hlyA 
filamentous 
haemagglutinin domain 
protein 
-1.25 -1.58 -1.84 
YPK_2429 invA invasin region 3 -1.06 2.54 -1.15 
YPK_2758 psaB pili assembly chaperone -1.68 1.94 -1.70 
YPK_2759 psaA pH 6 antigen precursor (antigen 4) (adhesin) -1.18 12.53 -1.43 
YPK_2760 psaF conserved hypothetical protein -2.87 -1.44 -3.05 
YPK_2761 psaE transcriptional regulator, CadC -3.48 -1.28 -3.18 
YPK_2900 ybhG, yhiI secretion protein HlyD family protein 1.68 1.93 1.37 
YPK_3060 yhhZ-2 type VI secretion system 
effector, Hcp1 family -1.43 2.67 -1.43 
YPK_3214 ymoA haemolysin expression 
modulating family protein -1.34 -1.21 -1.76 
YPK_3289 crl transcriptional regulator Crl -2.41 -1.20 -1.78 
YPK_3550 icmF type VI secretion protein IcmF 5.40 2.01 1.23 
YPK_3551 
  
type IV / VI secretion 
system protein, DotU 
family 
7.82 2.48 1.48 
YPK_3552 
  
type VI secretion protein, 
VC_A0114 family 9.03 3.31 2.14 
YPK_3553 
  
type VI secretion cluster, 
putative lipoprotein 11.73 3.65 2.17 
YPK_3556 
  
pentapeptide repeat 
protein 9.28 3.54 1.74 
YPK_3557 
  
pentapeptide repeat 
protein 6.26 2.86 1.74 
YPK_3558 vgrG type VI secretion system Vgr family protein 8.29 2.52 1.52 
YPK_3559 clpB type VI secretion ATPase, ClpV1 family 4.25 1.77 1.20 
YPK_3560 impH-2, 
vasB-2 
type VI secretion protein, 
VC_A0111 family 7.04 2.63 1.20 
YPK_3561 impG-2, 
vasA-2 
type VI secretion protein, 
VC_A0110 family 5.48 2.81 1.56 
YPK_3562 impH-3 type VI secretion system lysozyme-related protein 11.86 3.88 1.70 
YPK_3563 impC-2 type VI secretion cluster, 
unknown protein DUF796 15.52 8.71 1.73 
YPK_3564 impC-3 type VI secretion protein, EvpB/VC_A0108 family 11.93 2.94 2.14 
YPK_3565 
  
type VI secretion protein, 
VC_A0107 family 9.65 2.79 2.16 
YPK_3566 
  ImpA domain protein 5.90 1.92 1.06 
YPK_4042 fimA-5 fimbrial protein -2.24 -1.95 -1.29 
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YPK_4085 HasA heme-binding A family protein -3.46 -3.00 -1.99 
YPK_4109 raxA secretion protein HlyD family protein -1.01 -1.77 -1.09 
CELL MOTILITY AND CHEMOTAXIS 
 
YPK_1745 flhD flagellar transcriptional 
activator -17.65 -14.68 -1.56 
YPK_1746 flhC flagellar transcriptional 
activator FlhC -9.69 -10.49 -1.14 
YPK_1747 motA chemotaxis protein MotA -4.78 -5.14 -1.21 
YPK_1748 motB OmpA/MotB domain protein -2.42 -2.65 -1.11 
YPK_1749 cheA CheA signal transduction histidine kinase -2.59 -3.10 1.29 
YPK_1750 cheW CheW protein -3.85 -4.97 -1.11 
YPK_1753 cheD 
methyl-accepting 
chemotaxis sensory 
transducer 
-2.14 -2.41 -1.01 
YPK_1759 cheZ chemotaxis phosphatase, CheZ -1.66 -2.05 -1.16 
YPK_2378 fliZ flagella biosynthesis protein FliZ -15.14 -19.04 -1.41 
YPK_2380 fliA RNA polymerase, sigma 28 subunit, FliA/WhiG -20.62 -22.06 1.07 
YPK_2381 fliC flagellin domain protein -27.81 -39.53 -1.69 
YPK_2382 fliD flagellar hook-associated 2 domain protein -6.01 -6.23 1.03 
YPK_2383 fliS flagellar protein FliS -3.32 -3.69 -1.22 
YPK_2384 fliT flagellar export chaperone -4.58 -5.57 -1.50 
YPK_2390 fliE flagellar hook-basal body 
complex subunit FliE -6.28 -8.33 1.24 
YPK_2391 fliF flagellar M-ring protein FliF -4.72 -4.84 1.18 
YPK_2392 fliG flagellar motor switch protein FliG -6.57 -7.65 1.29 
YPK_2393 fliH flagellar assembly protein FliH -4.29 -3.95 1.21 
YPK_2394 fliI ATPase, FliI/YscN family -4.81 -5.49 -1.24 
YPK_2395 fliJ flagellar export protein FliJ -4.71 -5.16 1.08 
YPK_2396 fliK-1 flagellar hook-length 
control protein -2.98 -3.61 1.22 
YPK_2398 fliL flagellar basal body-
associated protein FliL -8.36 -8.56 -1.28 
YPK_2399 fliM flagellar motor switch protein FliM -3.12 -2.83 -1.05 
YPK_2400 fliN flagellar motor switch protein FliN -3.83 -3.97 1.19 
YPK_2401 fliO flagellar biosynthesis protein FliO -3.30 -3.77 1.15 
YPK_2402 fliP flagellar biosynthetic protein FliP -3.45 -4.22 -1.11 
YPK_2403 fliQ flagellar biosynthetic protein FliQ -2.40 -2.48 1.12 
YPK_2415 flgL flagellar hook-associated protein 3 -2.08 -2.04 1.23 
YPK_2416 flgK flagellar hook-associated protein FlgK -2.39 -2.63 1.54 
YPK_2417 flgJ flagellar rod assembly protein/muramidase FlgJ -3.64 -3.63 -1.06 
YPK_2418 flgI flagellar P-ring protein -2.70 -3.06 1.28 
YPK_2419 flgH flagellar L-ring protein -2.67 -3.07 1.43 
YPK_2420 flgG flagellar basal-body rod protein FlgG -5.49 -5.15 1.22 
YPK_2421 flgF flagellar basal-body rod protein FlgF -3.28 -4.07 1.66 
YPK_2422 flgE flagellar basal body FlaE domain protein -4.10 -4.42 1.58 
YPK_2423 flgD flagellar hook capping protein -7.69 -7.87 1.54 
YPK_2424 flgC flagellar basal-body rod protein FlgC -11.36 -10.73 1.43 
YPK_2425 flgB flagellar basal-body rod protein FlgB -16.49 -18.73 1.04 
YPK_2426 flgA flagella basal body P-ring formation protein FlgA -3.25 -4.74 -1.10 
YPK_2427 flgM anti-sigma-28 factor, FlgM -2.11 -2.47 1.07 
YPK_2428 flgN FlgN family protein -3.31 -4.17 -1.33 
YPK_2430 flhE flagellar FlhE family protein -1.73 -1.78 1.18 
YPK_2431 flhA flagellar biosynthesis protein FlhA -5.32 -6.59 -1.33 
YPK_2432 flhB flagellar biosynthetic protein FlhB -2.69 -3.48 1.14 
STRESS ADAPTATION 
 YPK_0011 ibpA heat shock protein Hsp20 -2.58 -1.26 -2.04 
YPK_0012 ibpB heat shock protein Hsp20 -2.15 1.23 -1.72 
YPK_0035 sodA superoxide dismutase -2.23 -3.45 -1.93 
YPK_0120 uspA UspA domain protein -2.38 -1.40 -2.02 
YPK_0121 uspB universal stress protein B 2.65 1.03 -1.24 
YPK_0442 cspA-1 cold-shock DNA-binding domain protein -4.30 -1.56 -1.60 
YPK_0443 cspA-2 cold-shock DNA-binding domain protein -4.06 -1.53 -1.76 
YPK_0444 cspA-3 cold-shock DNA-binding domain protein -2.57 -1.05 -1.77 
YPK_1124 cspB-1 cold-shock DNA-binding domain protein -6.04 -4.23 -2.10 
YPK_1740 cspC-1 cold-shock DNA-binding domain protein -8.23 -4.13 -2.03 
YPK_1894 pspA phage shock protein A, PspA 1.81 1.46 1.25 
YPK_1896 pspC phage shock protein C, PspC 1.78 1.22 1.05 
YPK_1943 uspE UspA domain protein 2.93 2.52 1.12 
YPK_2017 cstA-1 carbon starvation protein CstA -1.43 1.75 1.03 
YPK_2355 uvrC exonuclease ABC, C 
subunit 2.25 1.66 1.27 
YPK_2474 cspC-2 cold-shock DNA-binding domain protein -2.81 -3.53 -2.02 
YPK_2662 cspB-2 cold-shock DNA-binding domain protein -4.26 1.56 -1.56 
YPK_2694 cspD-2 cold-shock DNA-binding domain protein -1.09 2.40 -2.10 
YPK_2855 katA catalase 2.66 2.20 1.58 
YPK_3031 cspE cold-shock DNA-binding domain protein 1.23 -1.46 -1.84 
YPK_3032 cspC-3 cold-shock DNA-binding domain protein -2.02 -1.90 -1.89 
YPK_3161 ybbN thioredoxin domain 1.13 1.83 1.14 
YPK_3269 ggt gamma-glutamyltransferase 2.45 1.49 1.25 
YPK_3388 katY catalase/peroxidase HPI 2.69 -1.68 1.20 
YPK_3445 sodC superoxide dismutase -1.35 4.74 -1.37 
YPK_3876 terA stress protein 1.18 1.82 1.73 
YPK_3877 terZ stress protein -1.05 1.83 1.60 
YPK_3948 cstA-2 carbon starvation protein CstA -3.83 -1.74 -1.02 
YPK_4035 trxA thioredoxin -1.97 -3.84 -1.83 
YPK_4131 cpxP protein of unknown function Spy-related -1.98 6.21 -1.58 
INFORMATION STORAGE AND PROCESSING 
REPLICATION, CELL DEVISION 
 YPK_0004 gyrB DNA gyrase, B subunit  1.67 1.70 1.80 
YPK_0228 dam DNA adenine methylase -2.11 -2.37 -1.53 
YPK_0317 smf, dprA DNA protecting protein DprA 1.25 2.07 1.02 
YPK_0888 dam DNA adenine methylase -1.31 2.41 1.04 
YPK_1032 mutH DNA mismatch repair 
endonuclease mutH -1.10 2.04 -1.04 
YPK_1043 RecB exodeoxyribonuclease V, beta subunit 1.87 1.68 1.35 
YPK_1142 ccrB-1 camphor resistance CrcB protein 1.85 2.47 -1.13 
YPK_1143 ccrB-2 CrcB protein 2.12 2.75 -1.13 
YPK_1301 xseA exodeoxyribonuclease VII, large subunit -2.03 -1.12 -1.38 
YPK_1431 zipA cell division protein ZipA -1.82 -2.27 -1.96 
YPK_1680 maf Maf protein -2.28 -2.30 -1.79 
YPK_1854 lpp LPP repeat-containing protein -2.64 -4.93 -2.93 
YPK_2121 minC septum site-determining protein MinC 1.32 1.84 1.51 
YPK_2122 minD septum site-determining protein MinD 1.51 2.14 1.61 
YPK_2625 helD UvrD/REP helicase 1.44 1.92 1.25 
YPK_2641 rlmL RNA methylase 1.29 2.30 1.54 
YPK_2655 mukB 
chromosome segregation 
and condensation protein 
MukB  
1.11 3.18 1.37 
YPK_2656 mukE 
chromosome segregation 
and condensation protein 
MukE 
-1.07 2.69 1.31 
YPK_2657 mukF 
chromosome segregation 
and condensation protein 
MukF 
1.02 2.58 1.09 
YPK_2685 ftsK cell division FtsK/SpoIIIE 1.52 3.32 1.36 
YPK_2756 nfo apurinic endonuclease Apn1 1.60 2.94 1.58 
YPK_2765 
  NUDIX hydrolase 2.01 1.42 1.06 
YPK_2815 
  
DNA circulation family 
protein 1.04 2.88 1.16 
YPK_2846 gyrA DNA gyrase, A subunit 1.05 1.92 1.19 
YPK_3144 ybjD 
SMC (structural 
maintenance of 
chromosomes) family 
protein 
1.55 1.98 1.54 
YPK_3229 comEA 
competence protein 
ComEA helix-hairpin-helix 
repeat protein 
1.03 4.03 -1.04 
YPK_3508 mutT mutator MutT protein -1.69 -1.77 -1.33 
YPK_3513 ftsZ cell division protein FtsZ 2.69 2.31 1.74 
YPK_3629 yjjV TatD-related deoxyribonuclease 1.46 1.75 1.08 
YPK_3783 priB primosomal replication protein N -1.16 1.61 1.76 
YPK_3850 ssb single-strand binding protein -1.44 -1.90 -1.15 
YPK_4111 zapB septal ring assembly protein ZapB -1.12 -1.47 -1.86 
GENERAL TRANSCRIPTION, TRANSCRIPTION FACTORS, SIGNAL 
TRANSDUCTION 
pYV0007 repB, 
copB 
repB, repA2, copB; 
putative replication 
transcriptional regulator 
-2.77 -2.44 -1.64 
YPK_0160 malT 
ATP-dependent 
transcriptional regulator, 
MalT-like, LuxR family 
-2.44 -1.15 1.03 
YPK_0172 ompR 
two component 
transcriptional regulator, 
winged helix family 
1.38 1.83 1.20 
YPK_0173 envZ 
integral membrane sensor 
signal transduction 
histidine kinase 
1.30 1.80 1.37 
YPK_0248 crp transcriptional regulator, Crp/Fnr family -24.13 -1.43 -1.29 
YPK_0308 rpoA DNA-directed RNA 1.85 2.41 2.19 
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polymerase, alpha subunit 
YPK_0341 rpoC DNA-directed RNA polymerase, beta' subunit 1.81 1.93 1.59 
YPK_0348 rsd regulator of RpoD, Rsd/AlgQ -1.11 -1.83 -1.48 
YPK_0452 fis transcriptional regulator, Fis family -2.75 -3.07 -1.40 
YPK_0493 rnk GreA/GreB family 
elongation factor -6.24 -3.16 -1.67 
YPK_0516 mlaB putative anti-sigma B factor antagonist 2.13 1.11 -1.09 
YPK_0565 
  putative kinase protein 1.79 1.24 1.40 
YPK_0642 ygiM SH3 domain protein 1.62 3.17 1.05 
YPK_0725 
  
putative transcriptional 
regulator, CadC 1.76 -1.06 -1.01 
YPK_0995 agaR transcriptional regulator, DeoR family -1.78 -1.84 -1.47 
YPK_1156 kdpD 
osmosensitive K+ channel 
signal transduction 
histidine kinase 
1.98 1.53 1.23 
YPK_1183 rseA anti sigma-E protein, RseA 1.81 1.07 -1.30 
YPK_1184 rseB sigma E regulatory protein, MucB/RseB 1.91 1.32 1.18 
YPK_1185 rseC positive regulator of sigma E, RseC/MucC 2.35 1.62 1.22 
YPK_1262 glnB nitrogen regulatory protein P-II 2.00 1.50 1.55 
YPK_1349 speG GCN5-related N-
acetyltransferase -2.04 -1.87 -1.41 
YPK_1671 csgD transcriptional regulator, LuxR family -1.89 2.72 -1.53 
YPK_1724 cscR transcriptional regulator, LacI family 1.78 1.11 1.21 
YPK_1793 kdgR transcriptional regulator, IclR family -1.85 -1.78 -1.69 
YPK_1927 
  
transcriptional regulator, 
XRE family 1.40 2.50 1.11 
YPK_1982 ynfL transcriptional regulator, LysR family 1.73 2.08 -1.25 
YPK_2009 
  
transcriptional regulator, 
AraC family -1.25 -1.85 -1.39 
YPK_2078 rssB response regulator 
receiver protein 2.65 1.26 1.17 
YPK_2083 rssB transcriptional regulator, LysR family -1.04 -1.01 1.02 
YPK_2100 prkA putative serine protein kinase, PrkA 3.37 2.48 1.53 
YPK_2109 fadR 
fatty acid metabolism 
transcriptional regulator 
FadR 
-1.32 -2.56 -1.71 
YPK_2235 phoH PhoH family protein 3.57 1.82 1.16 
YPK_2269 fimZ 
two component 
transcriptional regulator, 
LuxR family 
1.08 -4.23 -1.49 
YPK_2356 uvrY 
two component 
transcriptional regulator, 
LuxR family 
1.78 1.50 1.05 
YPK_2385 
  
transcriptional regulator, 
AraC family -2.29 -2.43 -1.74 
YPK_2470 atoS1 diguanylate cyclase with PAS/PAC sensor 3.43 1.30 1.13 
YPK_2484 
  
transcriptional regulator, 
AraC family -1.54 -2.59 -1.72 
YPK_2491 thuR transcriptional regulator, LacI family 1.38 1.88 1.28 
YPK_2499 uhpA 
two component 
transcriptional regulator, 
LuxR family 
-2.45 -2.50 -1.76 
YPK_2628 tfoX regulator of competence-
specific genes -1.24 6.15 -1.68 
YPK_2667 ihfB integration host factor, beta subunit 1.90 1.82 -1.05 
YPK_2686 lrp transcriptional regulator, AsnC family 1.37 2.44 1.54 
YPK_2780 uxuR GntR domain protein -1.23 5.89 1.01 
YPK_2843 rcsB 
two component 
transcriptional regulator, 
LuxR family 
-1.55 -1.24 -1.95 
YPK_3206 acrR transcriptional regulator, TetR family -1.83 -1.48 -1.68 
YPK_3231 hupB histone family protein DNA-binding protein -1.78 -2.48 -1.71 
YPK_3337 emrR transcriptional regulator, MarR family 2.05 4.59 1.41 
YPK_3368 luxS quorum-sensing 
autoinducer 2 (AI-2), LuxS 2.23 -1.50 -1.45 
YPK_3372 csrA carbon storage regulator, CsrA -1.41 
-
132.92 -1.68 
YPK_3425 rpoS RNA polymerase, sigma 70 subunit, RpoD family 3.64 1.34 -1.01 
YPK_3468 dksA transcriptional regulator, TraR/DksA family -4.31 -1.55 -1.55 
YPK_3492 pdhR GntR domain protein -2.45 -1.38 -1.03 
YPK_3606 arcA 
two component 
transcriptional regulator, 
winged helix family 
-1.30 -2.36 -1.45 
YPK_3612 trpR Trp operon repressor -1.51 -2.12 -1.65 
YPK_3638 hmsT diguanylate cyclase 1.24 -2.69 -1.61 
YPK_3649 ydeW transcriptional regulator, DeoR family 5.62 1.82 1.28 
YPK_3682 yjgM GCN5-related N-
acetyltransferase -1.21 -1.95 -1.46 
YPK_3731 nusA NusA antitermination 1.07 1.78 1.57 
factor 
YPK_3739 greA transcription elongation factor GreA -2.66 -1.70 -1.62 
YPK_3762 argR arginine repressor, ArgR -2.69 -2.63 -1.28 
YPK_3792 nsrR transcriptional regulator, BadM/Rrf2 family -1.51 -1.79 -1.38 
YPK_3832 
  
transcriptional regulator, 
TetR family 1.75 1.06 1.00 
YPK_3841 rhaR transcriptional regulator, AraC family -2.12 -1.07 -1.07 
YPK_3975 
  
GCN5-related N-
acetyltransferase -1.80 -1.58 -1.52 
YPK_3976 rpoH RNA polymerase, sigma 32 subunit, RpoH 2.43 1.16 1.24 
YPK_4064 hdfR transcriptional regulator, LysR family -1.37 -1.88 -1.53 
YPK_4101 cytR transcriptional regulator, LacI family -1.75 -1.14 1.72 
TRANSLATION 
YPK_0023 glyS glycyl-tRNA, B subunit 1.12 1.20 1.82 
YPK_0277 fusA translation elongation factor G 1.41 1.82 1.64 
YPK_0282 rpsJ ribosomal protein S10 1.13 1.81 1.57 
YPK_0283 rplC ribosomal protein L3 1.63 3.01 2.68 
YPK_0284 rplD ribosomal protein L4/L1e 1.59 3.14 2.76 
YPK_0285 rplW ribosomal protein L25/L23 1.59 3.05 2.50 
YPK_0286 rplB ribosomal protein L2 1.56 2.72 2.29 
YPK_0287 rpsS ribosomal protein S19 1.44 2.34 2.04 
YPK_0288 rplV ribosomal protein L22 1.26 2.13 1.92 
YPK_0289 rpsC ribosomal protein S3 1.11 1.78 1.73 
YPK_0296 rpsN ribosomal protein S14 1.49 2.05 1.72 
YPK_0297 rpsH ribosomal protein S8 1.96 2.56 2.44 
YPK_0298 rplF ribosomal protein L6 1.49 2.20 2.01 
YPK_0299 rplR ribosomal protein L18 1.86 2.44 2.27 
YPK_0300 rpsE ribosomal protein S5 1.60 2.25 1.99 
YPK_0301 rpmD ribosomal protein L30 2.21 2.63 2.28 
YPK_0302 rplO ribosomal protein L15 2.20 2.27 2.08 
YPK_0305 rpsM ribosomal protein S13 1.84 2.28 1.92 
YPK_0306 rpsK ribosomal protein S11 1.73 2.38 1.92 
YPK_0307 rpsD ribosomal protein S4 2.25 2.75 2.48 
YPK_0316 def peptide deformylase -1.72 -2.76 -1.77 
YPK_0335 rplK ribosomal protein L11 -2.40 -1.57 -1.11 
YPK_0336 rplA ribosomal protein L1 -2.54 -1.68 -1.24 
YPK_0337 rplJ ribosomal protein L10 -2.22 -1.80 -1.02 
YPK_0338 rplL ribosomal protein L7/L12 -2.29 -1.80 -1.00 
YPK_0453 dusB TIM-barrel protein, nifR3 family -2.42 -2.19 -1.21 
YPK_0504 yhbH 
sigma 54 modulation 
protein/ribosomal protein 
S30EA 
2.30 -1.04 -1.52 
YPK_0524 rplM ribosomal protein L13 -2.37 -1.78 -1.31 
YPK_0525 rpsI ribosomal protein S9 -2.54 -1.69 -1.13 
YPK_0636 rpsU ribosomal protein S21 -3.69 -3.30 -1.74 
YPK_0641 cca 
multifunctional tRNA 
nucleotidyl 
transferase/2'3'-cyclic 
phosphodiesterase/2'nucle
otidase/phosphatase 
1.78 3.41 1.09 
YPK_0924 lysS lysyl-tRNA synthetase 1.52 1.73 2.05 
YPK_1067 tsf translation elongation factor Ts 1.03 1.79 1.71 
YPK_1076 lpxD 
UDP-3-O-(3-
hydroxymyristoyl) 
glucosamine N-
acyltransferase 
2.08 1.91 1.49 
YPK_1274 trmJ RNA methyltransferase, TrmH family, group 1 -2.10 -1.96 -1.42 
YPK_1678 rluC pseudouridine synthase, RluA family -2.09 -2.30 -1.40 
YPK_1682 rpmF ribosomal protein L32 -2.32 -3.23 -1.79 
YPK_1824 pheS phenylalanyl-tRNA 
synthetase, alpha subunit 1.14 1.71 1.76 
YPK_2129 
  endoribonuclease L-PSP -1.98 -2.38 -1.81 
YPK_2161 rimJ GCN5-related N-
acetyltransferase 2.25 -1.40 1.09 
YPK_2179 prfA peptide chain release factor 1 -1.56 -1.84 -1.22 
YPK_2554 metG methionyl-tRNA 
synthetase 2.01 2.66 1.96 
YPK_2648 asnC asparaginyl-tRNA 
synthetase 1.02 1.79 1.49 
YPK_2668 rpsA ribosomal protein S1 2.14 1.66 1.43 
YPK_2681 serS seryl-tRNA synthetase 1.29 2.62 1.32 
YPK_2691 infA translation initiation factor IF-1 -1.84 1.31 -1.07 
YPK_2795 rplY ribosomal protein L25 -1.80 -1.34 -1.50 
YPK_2887 dusC dihydrouridine synthase DuS -1.22 1.88 1.36 
YPK_3015 leuS leucyl-tRNA synthetase 1.77 2.14 1.79 
YPK_3069 rluF pseudouridine synthase -2.28 -1.44 -1.38 
YPK_3590 rpsT ribosomal protein S20 -3.70 -5.04 -2.10 
YPK_3724 deaD DEAD/DEAH box helicase domain protein 3.71 1.48 2.09 
YPK_3727 rpsO ribosomal protein S15 -1.65 -2.45 -1.96 
YPK_3730 infB translation initiation factor IF-2 1.48 1.90 1.74 
YPK_3738 yhbY protein of unknown function UPF0044 -2.87 -3.97 -2.00 
YPK_3756 rpmA ribosomal protein L27 -2.38 -2.27 -1.48 
YPK_3757 rplU ribosomal protein L21 -2.52 -2.33 -1.52 
YPK_3818 efp-2 translation elongation factor P -2.40 -2.65 -1.61 
YPK_4074 trmA tRNA (uracil-5-)- -2.41 -2.73 -1.54 
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methyltransferase 
YPK_4098 rpmE ribosomal protein L31 -4.90 -5.37 -1.95 
YPK_4135 trmL, 
cspR 
RNA methyltransferase, 
TrmH family, group 2 -2.13 -1.87 -1.08 
YPK_4153 rpmG ribosomal protein L33 -2.83 -2.97 -1.84 
YPK_4154 rpmB ribosomal protein L28 -2.74 -2.47 -1.67 
YPK_4160 rph ribonuclease PH -1.67 -1.90 -1.01 
YPK_4249 rpmH ribosomal protein L34 -1.35 -2.09 -1.70 
POSTTRANSLATIONAL MODIFICATION, PROTEIN TURNOVER 
YPK_0242 ppiA peptidyl-prolyl cis-trans isomerase cyclophilin type -2.64 1.46 -1.45 
YPK_0268 slyD peptidylprolyl isomerase FKBP-type -2.12 -2.50 -1.25 
YPK_0437 yghU glutathione S-transferase domain 1.83 1.20 1.15 
YPK_0520 degQ protease Do 1.25 2.15 1.36 
YPK_0849 ycaL, loiP peptidase M48 Ste24p -1.68 -1.88 -1.34 
YPK_1019 
 
putative protein-disulfide 
isomerase 2.49 1.68 1.36 
YPK_1042 ptrA peptidase M16 domain protein 2.08 2.07 1.06 
YPK_1119 nrdH glutaredoxin-like protein NrdH 2.03 1.57 1.21 
YPK_1134 ureE urease accessory protein UreE  1.92 5.21 1.64 
YPK_1135 ureF urease accessory protein UreF 1.10 2.50 1.23 
YPK_1137 ureD urease accessory protein UreD 1.25 2.02 1.23 
YPK_1325 
ydcP-1, 
yegQ-1, 
yhbU-1 
peptidase U32 1.81 1.34 1.65 
YPK_1340 yegD putative chaperone protein -2.05 -1.38 -1.00 
YPK_1360 bcp peroxiredoxin 1.09 -1.81 -1.06 
YPK_1848 sufB FeS assembly protein SufB 1.77 1.20 1.68 
YPK_1866 grxD glutaredoxin-like protein -1.22 -2.63 -1.74 
YPK_1878 anmK anhydro-N-acetylmuramic 
acid kinase 1.69 3.88 1.12 
YPK_1883 gst glutathione S-transferase domain 2.96 1.51 1.29 
YPK_1903 tpx redoxin domain protein 2.37 1.34 1.04 
YPK_1917 hslJ heat-inducible protein 2.75 1.02 -1.04 
YPK_2683 ycaJ AAA ATPase central domain protein 1.07 1.88 -1.00 
YPK_2690 aat leucyltransferase 1.11 1.79 1.19 
YPK_2692 clpA 
ATP-dependent Clp 
protease, ATP-binding 
subunit clpA 
1.97 4.10 1.66 
YPK_2733 grxA glutaredoxin, GrxA family -1.86 -1.54 -1.94 
YPK_2747 yliJ, gst glutathione S-transferase domain 2.71 2.17 1.19 
YPK_2974 GrpE GrpE protein -2.21 -1.43 -1.51 
YPK_3153 ppiB peptidyl-prolyl cis-trans isomerase cyclophilin type -2.10 -1.96 -1.68 
YPK_3232 lon ATP-dependent protease La 1.62 2.22 2.28 
YPK_3234 clpP 
ATP-dependent Clp 
protease, proteolytic 
subunit ClpP 
1.64 1.83 1.68 
YPK_3235 tig trigger factor -1.97 -1.22 1.07 
YPK_3267 ahpC 
alkyl hydroperoxide 
reductase/thiol specific 
antioxidant/ Mal allergen 
-1.10 -1.79 -1.47 
YPK_3366 ypjD cytochrome c assembly protein -1.46 -2.52 -1.91 
YPK_3444 ygcF radical SAM domain protein 1.11 2.16 1.05 
YPK_3452 htrA protease Do 2.65 6.41 1.75 
YPK_3593 dnaJ chaperone protein DnaJ 1.06 1.75 1.78 
YPK_3778 fklB peptidylprolyl isomerase FKBP-type -4.06 -2.50 -1.42 
YPK_3796 hflK HflK protein 2.01 2.14 1.77 
YPK_3822 groEL chaperonin GroEL 2.14 2.74 2.32 
YPK_3823 groES chaperonin Cpn10 1.59 1.85 1.65 
YPK_3986 tusA, sirA SirA family protein -1.94 -1.80 -1.49 
YPK_4040 ppiC PpiC-type peptidyl-prolyl 
cis-trans isomerase -2.48 -2.58 -1.42 
YPK_4196 dsbA DSBA oxidoreductase 1.79 1.91 1.23 
METABOLISM 
ENERGY PRODUCTION AND CONVERSION 
YPK_0152 glpD FAD dependent 
oxidoreductase -4.09 1.35 1.01 
YPK_0174 pckA phosphoenolpyruvate 
carboxykinase (ATP) 3.47 2.36 1.35 
YPK_0235 nirB nitrite reductase (NAD(P)H), large subunit -1.36 -2.63 -1.17 
YPK_0364 aceB malate synthase A 1.82 2.96 1.47 
YPK_0365 aceA isocitrate lyase 1.73 1.83 1.36 
YPK_0486 gabD-1 succinic semialdehyde dehydrogenase 2.97 1.54 1.09 
YPK_0492 cybC-1 cytochrome b562 -1.08 -1.84 -1.52 
YPK_0819 yggX probable Fe(2+)-trafficking protein 1.62 2.10 1.16 
YPK_1031 tas aldo/keto reductase 1.75 1.66 1.43 
YPK_1174 grcA 
formate C-
acetyltransferase glycine 
radical 
-2.91 -3.61 -2.12 
YPK_1194 fdx iron-sulfur cluster-binding protein -1.84 -1.94 -1.78 
YPK_1385 napF ferredoxin-type protein NapF 1.08 -2.90 -1.21 
YPK_1389 napC periplasmic nitrate (or 1.11 -1.95 -1.16 
nitrite) reductase c-type 
cytochrome, NapC/NirT 
family 
YPK_1391 maeB 
malate dehydrogenase 
(oxaloacetate-
decarboxylating) 
(NADP(+)), Phosphate 
acetyltransferase 
1.20 1.82 1.68 
YPK_1550 pta phosphate 
acetyltransferase 1.03 1.88 1.64 
YPK_1562 nuoD NADH dehydrogenase I, D 
subunit 1.57 1.73 1.80 
YPK_1563 nuoE NADH-quinone 
oxidoreductase, E subunit 2.09 1.68 1.75 
YPK_1564 nuoF NADH-quinone 
oxidoreductase, F subunit 1.85 1.62 1.76 
YPK_1723 icdA isocitrate dehydrogenase, NADP-dependent 2.67 2.57 1.90 
YPK_1974 aldA aldehyde dehydrogenase 1.10 2.23 1.21 
YPK_2030 acnA aconitate hydratase 1 3.05 3.75 1.82 
YPK_2072 adhE iron-containing alcohol dehydrogenase -11.06 -3.31 -1.18 
YPK_2090 ydjA putative nitroreductase -2.32 -1.85 -1.17 
YPK_2227 astD 
succinylglutamic 
semialdehyde 
dehydrogenase 
1.90 1.93 1.10 
YPK_2363 wrbA flavoprotein WrbA 2.73 -1.35 1.07 
YPK_2506 lldD 
FMN-dependent alpha-
hydroxy acid 
dehydrogenase 
2.39 1.81 1.33 
YPK_2562 sfcA 
malate dehydrogenase 
(oxaloacetate-
decarboxylating) 
1.05 2.53 1.42 
YPK_2614 
  
FAD linked oxidase 
domain protein 1.69 1.84 -1.30 
YPK_2677 pflB formate acetyltransferase 1.29 1.86 1.10 
YPK_2771 gabD-2 aldehyde dehydrogenase 1.71 2.75 1.12 
YPK_2884 dld D-lactate dehydrogenase 1.64 1.97 1.40 
YPK_2906 morB 
NADH:flavin 
oxidoreductase/NADH 
oxidase 
1.45 1.94 1.11 
YPK_2963 cydB cytochrome d ubiquinol 
oxidase, subunit II -1.25 1.75 1.42 
YPK_2964 cydA cytochrome bd ubiquinol 
oxidase subunit I -2.48 1.12 1.01 
YPK_2965 sucD succinyl-CoA synthetase, 
alpha subunit -1.11 2.90 1.86 
YPK_2966 sucC succinyl-CoA synthetase, beta subunit 1.09 3.67 2.13 
YPK_2967 sucB 
2-oxoglutarate 
dehydrogenase, E2 
subunit, dihydrolipoamide 
succinyltransferase 
-1.04 3.43 1.91 
YPK_2968 sucA 
2-oxoglutarate 
dehydrogenase, E1 
subunit 
-1.46 2.63 1.49 
YPK_2969 sdhB 
succinate dehydrogenase 
and fumarate reductase 
iron-sulfur protein 
-1.21 3.50 1.74 
YPK_2970 sdhA succinate dehydrogenase, flavoprotein subunit -1.56 3.33 1.62 
YPK_2971 sdhD 
succinate dehydrogenase, 
hydrophobic membrane 
anchor protein 
-1.70 2.58 1.35 
YPK_2972 sdhC succinate dehydrogenase, 
cytochrome b556 subunit -2.69 2.11 1.19 
YPK_2973 gltA citrate synthase I 1.43 3.01 1.91 
YPK_2990 fldA flavodoxin -3.59 -3.28 -1.88 
YPK_3005 miaB 
tRNA-i(6)A37 
thiotransferase enzyme 
MiaB 
2.87 2.41 1.31 
YPK_3253 dxs deoxyxylulose-5-phosphate synthase 1.88 1.32 1.49 
YPK_3297 
  
glycerophosphoryl diester 
phosphodiesterase -1.23 3.36 -1.15 
YPK_3302 nqrD NADH:ubiquinone 
oxidoreductase, subunit D 1.03 1.98 1.04 
YPK_3389 cybC-2 cytochrome B562 1.47 -2.53 -1.37 
YPK_3390 cybB cytochrome B561 1.57 -1.94 -1.03 
YPK_3404 fumA 
hydrolyase, Fe-S type, 
tartrate/fumarate 
subfamily, beta subunit 
1.20 1.77 1.67 
YPK_3487 acnB aconitate hydratase 2 2.68 1.80 2.01 
YPK_3490 aceF 
pyruvate dehydrogenase 
complex dihydrolipoamide 
acetyltransferase 
1.43 1.57 2.19 
YPK_3536 leuB 3-isopropylmalate dehydrogenase 1.11 1.53 1.82 
YPK_3648 ydeV carbohydrate kinase FGGY 3.86 1.55 1.06 
YPK_3767 ppa inorganic diphosphatase -2.83 -4.26 -1.90 
YPK_3992 glpQ glycerophosphoryl diester phosphodiesterase 1.10 1.82 1.11 
YPK_4113 glpK glycerol kinase -2.47 4.10 1.78 
YPK_4115 fpr 
oxidoreductase 
FAD/NAD(P)-binding 
domain protein 
1.88 1.35 1.46 
YPK_4216 mioC flavodoxin/nitric oxide 
synthase -1.30 -2.33 -1.62 
YPK_4219 atpI ATP synthase I chain -7.82 -1.49 -1.30 
YPK_4220 atpB ATP synthase F0, A 
subunit -6.33 -1.23 -1.11 
YPK_4221 atpE ATP synthase F0, C -4.22 1.17 1.03 
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subunit 
YPK_4222 atpF ATP synthase F0, B 
subunit -3.89 1.28 1.23 
YPK_4223 atpH ATP synthase F1, delta 
subunit -3.90 1.37 1.33 
YPK_4224 atpA ATP synthase F1, alpha 
subunit -3.13 1.57 1.55 
YPK_4225 atpG ATP synthase F1, gamma 
subunit -2.43 1.88 1.90 
YPK_4226 atpD ATP synthase F1, beta 
subunit -2.45 1.68 1.55 
YPK_4227 atpC ATP synthase F1, epsilon 
subunit -3.47 1.12 1.23 
CARBOHYDRATE METABOLISM 
YPK_0016 malS alpha amylase catalytic 
region 1.96 1.78 1.20 
YPK_0147 glgB 1,4-alpha-glucan branching enzyme 1.13 1.85 1.11 
YPK_0148 glgX glycogen debranching 
enzyme GlgX 1.46 2.13 1.37 
YPK_0150 glgA glycogen/starch synthase, ADP-glucose type 1.48 2.59 1.11 
YPK_0151 glgP-1 glycogen/starch/alpha-glucan phosphorylase 6.79 5.10 1.78 
YPK_0161 glgP-2 glycogen/starch/alpha-glucan phosphorylase 1.45 2.28 1.88 
YPK_0162 malQ 4-alpha-glucanotransferase 1.59 2.54 1.49 
YPK_0379 
  glycosidase -2.12 1.39 -1.06 
YPK_0435 
  
FGGY-family pentulose 
kinase -1.07 1.23 1.83 
YPK_0494 treC alpha,alpha-phosphotrehalase 3.65 1.64 1.44 
YPK_0850 tktA transketolase 1.84 1.55 1.98 
YPK_0973 bgaB beta-galactosidase -1.83 -1.39 1.13 
YPK_1111 hpxB urate catabolism protein 2.65 4.13 1.34 
YPK_1273 suhB inositol-phosphate phosphatase -1.78 -1.37 1.10 
YPK_1427 ptsI 
phosphoenolpyruvate-
protein 
phosphotransferase 
-1.82 1.33 1.83 
YPK_1444 glk glucokinase -2.98 -1.25 -1.11 
YPK_1727 
  NmrA family protein 1.89 2.02 1.13 
YPK_1811 yniA fructosamine kinase 2.18 -1.68 -1.31 
YPK_1834 pmrJ polysaccharide deacetylase 1.76 1.30 -1.06 
YPK_1843 ppsA phosphoenolpyruvate 
synthase 2.10 2.19 1.30 
YPK_2014 
  
NAD-dependent 
epimerase/dehydratase 2.06 1.35 1.41 
YPK_2019 mipB transaldolase 1.24 -1.83 -1.07 
YPK_2204 rpiB-2 ribose/galactose isomerase -3.31 -2.68 -1.81 
YPK_2502 
  
polysaccharide 
deacetylase 1.29 2.14 1.14 
YPK_2536 galF UTP-glucose-1-phosphate 
uridylyltransferase 2.56 6.72 1.31 
YPK_2537 galU UTP-glucose-1-phosphate 
uridylyltransferase 2.35 7.26 1.35 
YPK_2624 mgsA methylglyoxal synthase -2.00 -1.13 -1.38 
YPK_2706 
  
NAD-dependent 
epimerase/dehydratase 1.29 1.93 1.38 
YPK_2763 fruK 1-phosphofructokinase -2.13 1.40 1.41 
YPK_2769 rpiA ribose 5-phosphate isomerase 1.51 2.14 1.03 
YPK_2805 bglA glycoside hydrolase family 1 1.49 2.71 1.24 
YPK_2879 
  
transglycosylase-
associated protein 3.35 4.64 -1.32 
YPK_3072 bglB glycoside hydrolase family 3 domain protein 1.68 2.86 1.40 
YPK_3176 gsk Inosine kinase -1.24 -1.92 -1.51 
YPK_3191 ddhA glucose-1-phosphate 
cytidylyltransferase 1.27 1.84 1.27 
YPK_3308 gmhA phosphoheptose isomerase -1.42 -2.03 -1.20 
YPK_3395 araD-2 L-ribulose-5-phosphate 4-
epimerase 1.12 2.37 -1.06 
YPK_3491 aceE 
2-oxo-acid dehydrogenase 
E1 subunit, homodimeric 
type 
1.37 1.48 2.35 
YPK_3625 deoB phosphopentomutase 1.95 1.22 2.20 
YPK_3775 cysQ 3'(2'),5'-bisphosphate 
nucleotidase -1.25 -2.32 -1.51 
YPK_3804 
  
carbohydrate kinase, YjeF 
related protein -1.15 -1.77 -1.36 
YPK_3882 
  
putative ATP/GTP-binding 
protein 1.75 1.31 1.51 
YPK_4228 glmU UDP-N-acetylglucosamine pyrophosphorylase 1.89 -1.24 1.28 
AMINO ACID METABOLISM 
YPK_0008 ilvA, tdcB threonine dehydratase 1.20 1.96 1.50 
YPK_0077 hutH histidine ammonia-lyase 1.88 1.57 1.16 
YPK_0088 dppA 4-phytase 1.34 1.77 1.48 
YPK_0141 asd aspartate-semialdehyde dehydrogenase -1.16 -2.33 1.03 
YPK_0225 aroK shikimate kinase -2.08 -1.81 -1.31 
YPK_0245 argD succinylornithine transaminase family -1.98 -1.95 -1.28 
YPK_0363 metA homoserine O-
succinyltransferase -1.80 1.17 1.06 
YPK_0372 lysC aspartate kinase -3.63 -4.54 -1.04 
YPK_0518 murA UDP-N-acetylglucosamine 1.37 1.80 1.16 
1-carboxyvinyltransferase 
YPK_0529 gltD glutamate synthase, small 
subunit 1.78 -1.75 1.15 
YPK_0530 gltB glutamate synthase (ferredoxin) 1.85 -1.18 1.57 
YPK_0671 metC cystathionine beta-lyase -1.29 -2.38 -1.23 
YPK_0749 pepT-1 peptidase T -1.55 -4.54 1.15 
YPK_0845 speA arginine decarboxylase 1.67 2.08 1.57 
YPK_0859 serA-1 
D-isomer specific 2-
hydroxyacid 
dehydrogenase NAD-
binding 
1.47 -2.08 1.22 
YPK_0868 gcsH glycine cleavage system H protein -2.17 -2.70 -1.44 
YPK_0891 
  
phosphoadenosine 
phosphosulfate reductase -1.02 2.18 -1.02 
YPK_1063 dapD 
2,3,4,5-tetrahydropyridine-
2,6-dicarboxylate N-
succinyltransferase 
-2.98 -2.49 -1.70 
YPK_1096 metN-1 
D-methionine ABC 
transporter, ATPase 
subunit 
-2.16 1.08 -1.00 
YPK_1097 gmhB D,D-heptose 1,7-bisphosphate phosphatase -1.02 -1.77 -1.39 
YPK_1131 ureA urease, gamma subunit 1.07 3.66 1.13 
YPK_1132 ureB urease, beta subunit 1.10 3.76 1.18 
YPK_1133 ureC urease, alpha subunit 1.55 5.22 1.66 
YPK_1136 ureG urease accessory protein UreG 1.30 2.30 1.21 
YPK_1167 
  
allophanate hydrolase 
subunit 1 -1.84 -1.21 1.49 
YPK_1252 
  
lytic transglycosylase 
catalytic -1.75 -1.45 -1.44 
YPK_1265 glyA glycine hydroxymethyltransferase 2.27 1.50 2.20 
YPK_1302 guaB inosine-5'-monophosphate dehydrogenase 3.45 1.34 1.75 
YPK_1429 cysK cysteine synthase A 1.84 1.32 1.40 
YPK_1558 alaA aminotransferase class I 
and II 1.80 1.08 1.84 
YPK_1737 
  
NAD(P)H quinone 
oxidoreductase, PIG3 
family 
2.47 1.96 1.72 
YPK_1849 sufC FeS assembly ATPase SufC 1.76 1.35 1.98 
YPK_1869 gloA lactoylglutathione lyase -2.91 -2.41 -1.76 
YPK_1950 ilvB 
acetolactate synthase, 
large subunit, biosynthetic 
type 
-1.41 2.89 1.21 
YPK_2069 oppB alkaline phosphatase 1.49 1.87 1.63 
YPK_2184 prsA ribose-phosphate pyrophosphokinase 1.84 1.27 1.59 
YPK_2225 astE succinylglutamate desuccinylase 1.87 1.79 1.34 
YPK_2226 astB succinylarginine dihydrolase 1.80 1.70 -1.23 
YPK_2228 astA arginine N-
succinyltransferase 1.83 1.83 -1.01 
YPK_2229 astC succinylornithine transaminase family 1.86 2.20 1.06 
YPK_2254 glsA glutaminase 1.86 -2.56 1.29 
YPK_2257 aspAT putative aminostransferase 1.06 -2.09 -1.15 
YPK_2442 ptrB oligopeptidase B 1.74 1.83 1.59 
YPK_2451 sdaA L-serine dehydratase 1 1.15 1.84 1.26 
YPK_2525 hisG ATP phosphoribosyltransferase 1.10 3.57 1.36 
YPK_2526 hisD histidinol dehydrogenase 1.43 4.77 1.55 
YPK_2527 hisC histidinol-phosphate 
aminotransferase 1.77 4.89 1.85 
YPK_2528 hisB histidinol-phosphatase 1.59 4.11 1.79 
YPK_2529 hisH 
imidazole glycerol 
phosphate synthase, 
glutamine 
amidotransferase subunit 
1.46 3.83 1.69 
YPK_2530 hisA 
phosphoribosylformimino-
5-aminoimidazole 
carboxamide ribotide 
isomerase 
1.36 3.84 1.25 
YPK_2531 hisF 
imidazoleglycerol 
phosphate synthase, 
cyclase subunit 
1.55 4.45 1.65 
YPK_2532 hisI phosphoribosyl-ATP diphosphatase 1.13 2.95 1.26 
YPK_2571 frmA, 
adhC 
S-
(hydroxymethyl)glutathione 
dehydrogenase/class III 
alcohol dehydrogenase 
1.25 1.72 1.90 
YPK_2670 aroA 3-phosphoshikimate 1-
carboxyvinyltransferase 1.60 2.16 1.68 
YPK_2703 poxB 
thiamine pyrophosphate 
protein TPP binding 
domain protein 
2.18 7.42 1.55 
YPK_2705 ltaA threonine aldolase 1.16 2.07 -1.09 
YPK_2709 pheA-1 chorismate mutase 2.06 4.36 1.02 
YPK_2746 
  
HAD-superfamily 
subfamily IB hydrolase, 
TIGR01490 
2.13 2.16 1.22 
YPK_2773 serA-2 
D-isomer specific 2-
hydroxyacid 
dehydrogenase NAD-
binding 
1.35 1.76 -1.07 
YPK_2867 ddc aromatic-L-amino-acid decarboxylase 3.43 1.31 1.23 
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YPK_2932 bioA 
adenosylmethionine-8-
amino-7-oxononanoate 
aminotransferase 
-1.95 -1.88 -1.34 
YPK_2949 aroG phospho-2-dehydro-3-deoxyheptonate aldolase 1.52 2.40 1.33 
YPK_3001 asnB asparagine synthase (glutamine-hydrolyzing) 1.97 2.08 1.54 
YPK_3273 brnQ 
branched-chain amino acid 
transport system II carrier 
protein 
-2.71 -1.15 -1.08 
YPK_3282 aroL shikimate kinase -2.13 -2.13 -1.36 
YPK_3357 aroF phospho-2-dehydro-3-deoxyheptonate aldolase -1.60 -1.96 1.18 
YPK_3436 cysD 
sulfate 
adenylyltransferase, small 
subunit 
-1.08 1.35 1.85 
YPK_3537 leuC 3-isopropylmalate dehydratase, large subunit 1.19 1.59 1.85 
YPK_3584 dapB dihydrodipicolinate 
reductase -1.58 -1.80 1.03 
YPK_3595 yaaH GPR1/FUN34/yaaH family protein -5.37 -4.08 -1.81 
YPK_3604 thrA aspartate kinase -2.03 -2.32 1.23 
YPK_3819 
  
lysine 2,3-aminomutase 
YodO family protein 2.14 1.44 1.44 
YPK_3825 aspA aspartate ammonia-lyase 1.61 2.67 1.43 
YPK_3853 tyrB aromatic-amino-acid transaminase 1.45 1.06 1.82 
YPK_3884 metF-1 methylenetetrahydrofolate 
reductase 2.50 -1.41 -1.56 
YPK_3952 metE 
5-
methyltetrahydropteroyltrig
lutamate--homocysteine S-
methyltransferase 
1.41 2.26 3.13 
YPK_3994 
ybhA, 
ybjI, yidA, 
yigL 
putative sugar 
phosphatase -1.94 -3.11 -1.74 
YPK_4057 ilvD dihydroxy-acid dehydratase 1.05 1.33 1.91 
YPK_4089 argC N-acetyl-gamma-glutamyl-phosphate reductase -1.52 -1.80 -1.11 
YPK_4094 metL aspartate kinase -2.04 1.27 1.27 
YPK_4095 metB O-succinylhomoserine (thiol)-lyase -1.90 -1.09 -1.18 
YPK_4096 metJ methionine repressor, MetJ -2.27 -1.89 -1.58 
YPK_4144 tdh L-threonine 3-dehydrogenase 1.20 2.67 1.16 
YPK_4214 asnA aspartate-ammonia ligase -2.81 -2.79 -1.13 
NUCLEOTIDE METABOLISM 
YPK_0356 purD phosphoribosylamine-glycine ligase -1.02 -1.14 1.83 
YPK_1118 nrdI NrdI protein 2.16 1.91 1.36 
YPK_1289 ndk nucleoside-diphosphate kinase -8.02 -2.40 -1.53 
YPK_1303 guaA GMP synthase, large 
subunit 2.35 -1.06 1.56 
YPK_1350 purN phosphoribosylglycinamide formyltransferase -1.37 -1.95 -1.18 
YPK_1351 purI phosphoribosylformylglycin
amidine cyclo-ligase -1.20 -1.83 1.10 
YPK_1364 purC 
phosphoribosylaminoimida
zole-succinocarboxamide 
synthase 
-1.10 -2.92 -1.22 
YPK_1675 pyrC dihydroorotase, homodimeric type 1.77 1.31 1.64 
YPK_1718 purB adenylosuccinate lyase 1.14 1.19 1.75 
YPK_2043 trpG 
glutamine 
amidotransferase of 
anthranilate synthase 
-2.30 -1.48 -1.23 
YPK_2080 purU formyltetrahydrofolate deformylase -1.43 -1.95 -1.28 
YPK_2447 purT phosphoribosylglycinamide formyltransferase 2 -1.85 -2.46 1.03 
YPK_2561 cdd cytidine deaminase -1.26 -1.04 5.56 
YPK_2644 pyrD dihydroorotate oxidase 1.83 2.79 1.36 
YPK_2669 cmk cytidylate kinase 2.54 2.12 1.42 
YPK_3155 purE 
phosphoribosylaminoimida
zole carboxylase, catalytic 
subunit 
-2.19 -2.06 -1.10 
YPK_3156 purK 
phosphoribosylaminoimida
zole carboxylase, ATPase 
subunit 
-1.98 -1.94 1.03 
YPK_3194 adk nucleoside-triphosphate-
adenylate kinase -2.14 -1.57 -1.07 
YPK_3291 gpt xanthine phosphoribosyltransferase -4.27 -4.28 -1.92 
YPK_3453 dgt deoxyguanosinetriphosphate triphosphohydrolase 1.66 2.30 1.20 
YPK_3501 guaC guanosine 
monophosphate reductase -2.11 -3.41 -1.58 
YPK_3624 deoD purine nucleoside phosphorylase 1.18 -1.94 1.52 
YPK_3626 deoA thymidine phosphorylase 2.22 1.20 2.52 
YPK_3627 deoC-2 deoxyribose-phosphate 
aldolase 2.81 1.16 3.83 
YPK_3950 udp uridine phosphorylase 1.10 -1.12 8.07 
YPK_4015 cyaA putative adenylate cyclase 1.96 -1.37 -1.08 
YPK_4157 dut 
deoxyuridine 5'-
triphosphate 
nucleotidohydrolase Dut 
-1.64 -1.84 -1.08 
YPK_4159 pyrE orotate phosphoribosyltransferase -1.75 -2.35 -1.22 
YPK_4182 xanP uracil-xanthine permease -2.07 -4.39 -1.07 
COENZYME METABOLISM 
 YPK_0328 coaA pantothenate kinase -3.31 -2.81 -1.93 
YPK_0342 thiH thiazole biosynthesis protein ThiH 1.25 1.37 2.02 
YPK_0343 thiG thiazole biosynthesis family protein 1.26 1.51 2.03 
YPK_0344 thiS thiamine biosynthesis protein ThiS 1.07 1.44 1.94 
YPK_0345 thiF UBA/THIF-type NAD/FAD binding protein 1.13 1.49 1.95 
YPK_0346 thiE thiamine-phosphate pyrophosphorylase 1.13 1.63 1.94 
YPK_0347 thiC thiamine biosynthesis protein ThiC 1.06 1.76 2.04 
YPK_0649 ribB 3,4-dihydroxy-2-butanone 4-phosphate synthase 1.75 1.49 1.32 
YPK_1261 nadE NAD+ synthetase 2.08 1.44 1.78 
YPK_1393 hemF coproporphyrinogen 
oxidase -1.71 -1.92 -1.47 
YPK_1532 folC FolC bifunctional protein 2.04 3.27 1.52 
YPK_1880 pdxH pyridoxamine 5'-phosphate 
oxidase 1.43 2.36 1.05 
YPK_2029 ribA GTP cyclohydrolase II -2.04 -2.55 -1.24 
YPK_2038 btuR cob(I)alamin 
adenosyltransferase 1.82 1.58 1.51 
YPK_2089 selD selenide, water dikinase -1.44 -1.90 -1.20 
YPK_2180 hemA glutamyl-tRNA reductase -1.35 -2.03 -1.41 
YPK_2930 bioF 8-amino-7-oxononanoate 
synthase -1.92 -1.67 -1.06 
YPK_2931 bioB biotin synthase -1.98 -1.66 -1.03 
YPK_2952 pnuC 
nicotinamide 
mononucleotide 
transporter PnuC 
-1.05 1.85 -1.09 
YPK_2953 nadA quinolinate synthetase 
complex, A subunit 1.11 2.19 1.44 
YPK_3252 ispA polyprenyl synthetase 1.78 1.34 1.63 
YPK_3369 gshA glutamate--cysteine ligase 1.85 1.41 1.54 
YPK_3437 cysG uroporphyrin-III C-
methyltransferase -2.39 -2.09 -1.02 
YPK_3443 ygcM queuosine biosynthesis protein QueD -4.33 -4.91 -1.81 
YPK_3474 panD aspartate 1-decarboxylase 1.88 -3.71 1.02 
YPK_3497 nadC nicotinate-nucleotide pyrophosphorylase -1.51 -2.08 -1.17 
YPK_3578 folA dihydrofolate reductase -2.95 -1.35 -1.85 
YPK_3758 ispB polyprenyl synthetase -1.28 -1.81 -1.15 
YPK_4145 kbl 2-amino-3-ketobutyrate 
coenzyme A ligase 1.01 2.70 1.22 
LIPID METABOLISM 
 
YPK_0447 
  
3-hydroxyisobutyrate 
dehydrogenase 1.79 1.52 -1.18 
YPK_1070 dxr 
1-deoxy-D-xylulose 5-
phosphate 
reductoisomerase 
1.94 2.82 1.26 
YPK_1082 accA 
acetyl-CoA carboxylase, 
carboxyl transferase, alpha 
subunit 
-2.54 -3.04 -1.48 
YPK_1193 acpS holo-acyl-carrier-protein 
synthase 2.00 1.08 1.40 
YPK_1324 yegS diacylglycerol kinase 
catalytic region 1.38 2.36 1.05 
YPK_1506 fadL 
membrane protein 
involved in aromatic 
hydrocarbon degradation 
-2.44 2.48 1.64 
YPK_1508 fadI acetyl-CoA C-
acyltransferase FadI -1.35 2.02 -1.07 
YPK_1509 fadJ 
fatty acid oxidation 
complex, alpha subunit 
FadJ 
1.27 3.03 1.12 
YPK_1924 acpD NAD(P)H dehydrogenase (quinone) 1.14 -1.94 -1.33 
YPK_2510 
  
short-chain 
dehydrogenase/reductase 
SDR 
2.55 2.36 1.17 
YPK_2636 fabF2 3-oxoacyl-(acyl-carrier-protein) synthase 2 1.88 1.88 1.53 
YPK_2735 
  membrane protein 1.46 1.90 1.21 
YPK_2736 
  
undecaprenyl-
diphosphatase 2.11 5.44 1.01 
YPK_3283 
  putative methyltransferase -1.16 2.49 -1.75 
YPK_3582 carB carbamoyl-phosphate 
synthase, large subunit -1.03 1.42 1.86 
YPK_3933 fadB fatty oxidation complex, 
alpha subunit FadB -2.91 2.69 -1.06 
YPK_3934 fadA acetyl-CoA C-
acyltransferase FadA -1.13 3.23 1.27 
SECONDARY METABOLITES BIOSYNTHESIS AND CATABOLISM 
YPK_0118 
  serralysin -1.09 3.11 1.22 
YPK_0261 tauD taurine dioxygenase -2.92 -1.40 -1.09 
YPK_0514 yrbD mammalian cell entry 
related domain protein 1.96 1.27 -1.02 
YPK_0515 yrbC toluene tolerance family protein 3.62 2.14 1.46 
YPK_0789 
  
intradiol ring-cleavage 
dioxygenase 5.30 1.29 -1.02 
YPK_1687 acpP acyl carrier protein -2.00 -4.07 -1.49 
YPK_1858 cfa cyclopropane-fatty-acyl-phospholipid synthase 3.61 1.50 1.18 
YPK_2472 rrmA rRNA (guanine-N(1)-)-
methyltransferase -2.46 -2.69 -1.65 
YPK_2509 
  
5-oxopent-3-ene-1,2,5-
tricarboxylate 1.62 1.97 -1.06 
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decarboxylase 
YPK_2658 smtA methyltransferase type 11 -1.81 1.21 -1.58 
YPK_2707 
  
NAD-dependent 
epimerase/dehydratase 1.23 1.89 1.30 
YPK_2929 bioC biotin biosynthesis protein BioC -1.77 -1.47 1.03 
YPK_3921 rcs acetate-CoA ligase 1.15 3.33 1.47 
YPK_3951 ysgA carboxymethylenebutenolidase 1.59 3.37 1.79 
YPK_4218 gidB methyltransferase GidB -2.84 -3.76 -1.63 
INORGANIC ION METABOLISM 
YPK_0136 gntK, idnK 
carbohydrate kinase, 
thermoresistant 
glucokinase family 
1.10 -1.86 -1.47 
YPK_0159 glpE rhodanese domain protein -2.29 -2.50 -1.45 
YPK_1001 cynT, can carbonic anhydrase -1.62 2.33 -1.36 
YPK_1355 yfgD arsenate reductase 2.26 1.81 1.74 
YPK_1386 napD NapD family protein 1.38 -2.01 1.15 
YPK_1492 phnA 
alkylphosphonate 
utilization operon protein 
PhnA 
-2.37 -1.60 -1.77 
YPK_1602 dps ferritin Dps family protein 1.73 1.30 -1.84 
YPK_1661 mdoG periplasmic glucan biosynthesis protein MdoG 2.31 2.91 1.45 
YPK_1914 qacE small multidrug resistance protein -1.77 -2.72 -1.62 
YPK_2364 efeB Dyp-type peroxidase family -1.09 -1.80 1.62 
YPK_2438 ftnA Ferroxidase 1.81 1.59 -2.23 
YPK_2743 metQ-2 NLPA lipoprotein -1.17 2.08 1.13 
YPK_2866 ynjE, 
sseA rhodanese domain protein 1.09 1.90 -1.06 
YPK_3205 ychN DsrE family protein -1.73 -1.58 -1.87 
YPK_3875 terB tellurite resistance TerB 1.42 2.81 1.76 
YPK_3888 hemP hemin uptake protein -2.97 -3.71 -1.15 
YPK_3890 hmuS haemin-degrading family protein 1.12 7.75 1.86 
YPK_4013 cyaY iron donor protein CyaY -1.54 -2.58 -1.46 
YPK_4140 
  rhodanese domain protein -1.83 -2.05 -1.36 
YPK_4245 trmE tRNA modification GTPase TrmE -1.13 -1.88 -1.27 
TRANSPORT 
  
 
 
YPK_0048 mdfA major facilitator 
superfamily MFS_1 -1.75 -1.34 -1.15 
YPK_0068 
fhuC-1, 
fepC-1, 
fecE-1 
ABC transporter related -1.44 -1.75 1.06 
YPK_0070 
fhuB-2, 
fepG-2, 
fecD-2 
transport system 
permease protein -1.41 -1.78 -1.11 
YPK_0083 uhpC phosphoglycerate transporter -1.63 13.74 -1.51 
YPK_0098 dctA sodium:dicarboxylate 
symporter -1.01 2.33 -1.18 
YPK_0122 pitA phosphate transporter -2.03 -2.26 -1.28 
YPK_0238 tsgA major facilitator 
superfamily MFS_1 1.45 -1.28 3.98 
YPK_0247 
  
integral membrane protein, 
YccS/YhfK family 1.82 -1.14 1.02 
YPK_0258 tauA-1 taurine ABC transporter, periplasmic binding protein -1.81 -1.08 1.20 
YPK_0259 tauB ABC transporter related -2.20 -1.35 -1.01 
YPK_0260 tauC 
binding-protein-dependent 
transport systems inner 
membrane component 
-3.04 -2.00 -1.30 
YPK_0378 malE extracellular solute-binding protein family 1 -1.02 2.57 1.31 
YPK_0380 malK ABC transporter related -1.89 1.87 1.38 
YPK_0381 lamB-1 porin LamB type -1.72 1.82 1.30 
YPK_0431 yphF-1, ytfQ-1 
carbohydrate uptake 
(CUT2 family) ABC 
transporter, periplasmic 
carbohydrate-binding 
protein 
-2.47 1.07 1.42 
YPK_0495 treB PTS system, trehalose-
specific IIBC subunit 2.72 1.51 1.18 
YPK_0507 lptA 
lipopolysaccharide 
transport periplasmic 
protein LptA 
1.53 1.80 1.20 
YPK_0512 mlaF ABC transporter related 2.16 1.34 1.03 
YPK_0513 mlaE putative ABC transporter 
system permease protein 1.81 1.20 1.04 
YPK_0698 fepB periplasmic binding protein 4.07 -1.13 1.14 
YPK_0748 abgT AbgT putative transporter 1.27 -4.70 1.56 
YPK_0968 cycB, ganO 
extracellular solute-binding 
protein family 1 -1.94 -1.42 1.22 
YPK_0975 lamB-2 porin LamB type -2.04 -1.47 1.01 
YPK_1094 metQ-1 lipoprotein, YaeC family -1.83 -1.10 -1.17 
YPK_1114 proW 
binding-protein-dependent 
transport systems inner 
membrane component 
1.20 1.82 1.13 
YPK_1125 ddpA-1 extracellular solute-binding protein family 5 2.26 1.86 1.23 
YPK_1128 ddpD-1 ABC transporter related 2.50 1.52 1.13 
YPK_1129 ddpF-1 ABC transporter related 1.84 1.25 1.08 
YPK_1157 kdpC potassium-transporting ATPase, C subunit 1.96 1.31 -1.05 
YPK_1158 kdpB K+-transporting ATPase, B 
subunit 1.96 1.52 1.06 
YPK_1159 kdpA potassium-transporting ATPase, A subunit 2.05 1.60 1.12 
YPK_1333 ydcT spermidine/putrescine ABC transporter ATPase 2.66 2.18 1.34 
subunit 
YPK_1375 afuA, fbpA 
extracellular solute-binding 
protein family 1 -1.28 6.37 2.68 
YPK_1376 afuB, fbpB 
binding-protein-dependent 
transport systems inner 
membrane component 
-1.23 3.85 1.70 
YPK_1377 afuC ABC transporter related -1.41 2.80 1.51 
YPK_1408 cysP 
sulfate ABC transporter, 
periplasmic sulfate-binding 
protein 
-1.79 -1.75 1.03 
YPK_1409 cysT sulfate ABC transporter, inner membrane subunit -1.77 -1.92 -1.18 
YPK_1410 cysW 
sulfate ABC transporter, 
inner membrane subunit 
CysW 
-1.89 -1.94 -1.19 
YPK_1428 ptsH 
phosphotransferase 
system, phosphocarrier 
protein HPr 
-2.53 1.04 1.47 
YPK_1430 cysZ putative sulfate transport protein CysZ -1.33 -1.81 -1.82 
YPK_1438 nupC1 nucleoside transporter 3.91 -2.61 3.43 
YPK_1538 hisJ 
cationic amino acid ABC 
transporter, periplasmic 
binding protein 
-1.22 2.01 1.44 
YPK_1546 ulaA putative sugar-specific permease SgaT/UlaA -5.09 -2.41 1.45 
YPK_1547 ulaB 
phosphotransferase 
system lactose/cellobiose-
specific IIB subunit 
-6.35 -2.91 1.26 
YPK_1548 ulaC 
putative PTS IIA-like 
nitrogen-regulatory protein 
PtsN 
-7.05 -3.83 -1.06 
YPK_1555 
  citrate transporter -1.19 -1.85 -1.64 
YPK_1598 glnQ ABC transporter related 2.17 2.71 1.54 
YPK_1599 glnP 
polar amino acid ABC 
transporter, inner 
membrane subunit 
2.19 2.92 1.18 
YPK_1600 glnH 
cationic amino acid ABC 
transporter, periplasmic 
binding protein 
1.22 1.78 -1.19 
YPK_1694 ptsG PTS system, glucose-
specific IIBC subunit -23.68 -1.86 1.03 
YPK_1744 mgtB magnesium-translocating P-type ATPase -1.25 -1.51 -2.02 
YPK_1791 yebQ major facilitator 
superfamily MFS_1 1.02 -3.08 -1.10 
YPK_1795 gltP sodium:dicarboxylate 
symporter -2.99 -2.58 1.10 
YPK_1886 tppB amino acid/peptide transporter -2.85 1.13 -1.24 
YPK_1906 mppA extracellular solute-binding protein family 5 2.03 1.94 1.14 
YPK_1939 arcD, lys1, lysP 
arginine/ornithine 
antiporter -1.78 -1.11 -1.39 
YPK_1949 ilvN amino acid-binding ACT domain protein -1.24 3.50 1.19 
YPK_1958 tauA-2 
ABC transporter, 
periplasmic substrate-
binding protein 
1.78 1.09 1.27 
YPK_1979 clcB chloride channel core 1.25 2.56 -1.03 
YPK_1983 ynfM major facilitator 
superfamily MFS_1 -1.07 1.76 -1.03 
YPK_2070 oppA extracellular solute-binding protein family 5 1.23 2.34 2.05 
YPK_2174 ychM sulfate transporter -1.02 5.43 -1.16 
YPK_2233 chaA calcium/proton exchanger -2.71 -1.81 -1.61 
YPK_2246 ybbA-2 ABC transporter related 1.92 1.31 1.44 
YPK_2252 efeU-1 iron permease FTR1 -1.62 -2.35 -1.30 
YPK_2253 
  
major facilitator 
superfamily MFS_1 2.18 -1.76 1.49 
YPK_2256 ansP amino acid permease-
associated region -1.47 3.33 1.10 
YPK_2367 putP sodium/proline symporter -3.32 1.65 1.32 
YPK_2376 fliY extracellular solute-binding protein family 3 -1.89 -1.49 1.03 
YPK_2463 yoaE Integral membrane protein TerC -1.86 -1.20 1.15 
YPK_2464 manX 
PTS system, 
mannose/fructose/sorbose 
family, IIB subunit 
-1.92 1.17 1.72 
YPK_2466 manZ 
PTS system, 
mannose/fructose/sorbose 
family, IID subunit 
-1.87 1.09 1.49 
YPK_2477 aroP amino acid permease-
associated region -1.81 -1.35 1.12 
YPK_2487 mdlA-2 ABC transporter related -1.54 -1.77 1.10 
YPK_2512 
  
major facilitator 
superfamily MFS_1 1.56 1.88 1.20 
YPK_2517 yeeF amino acid permease-
associated region -1.87 -1.93 1.33 
YPK_2556 yphF-3, ytfQ-3 
putative sugar ABC 
transporter -1.39 1.97 1.77 
YPK_2564 mglC monosaccharide-transporting ATPase -2.36 1.09 1.09 
YPK_2565 mglA ABC transporter related -2.86 1.30 1.17 
YPK_2566 mglB 
periplasmic binding 
protein/LacI transcriptional 
regulator 
-5.00 1.68 1.10 
YPK_2618 tusE sulfur relay protein, TusE/DsrC/DsvC family -1.84 -1.38 -1.45 
YPK_2676 focA formate/nitrite transporter -2.00 -1.69 -1.99 
YPK_2688 cydD ABC transporter, CydDC 
cysteine exporter (CydDC- 1.11 1.97 1.24 
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E) family, permease/ATP-
binding protein CydD 
YPK_2689 cydC 
ABC transporter, CydDC 
cysteine exporter (CydDC-
E) family, permease/ATP-
binding protein CydC 
1.22 2.68 -1.02 
YPK_2695 macB-2 ABC transporter related 1.17 2.32 1.00 
YPK_2710 artP ABC transporter related -3.72 1.57 -1.32 
YPK_2711 artI 
cationic amino acid ABC 
transporter, periplasmic 
binding protein 
-3.94 1.74 -1.18 
YPK_2712 artQ 
polar amino acid ABC 
transporter, inner 
membrane subunit 
-2.92 1.93 -1.00 
YPK_2713 artM 
polar amino acid ABC 
transporter, inner 
membrane subunit 
-2.53 1.76 1.01 
YPK_2724 artJ 
cationic amino acid ABC 
transporter, periplasmic 
binding protein 
-2.54 2.01 1.10 
YPK_2739 sdaC serine transporter -3.64 -1.12 -1.51 
YPK_2742 metN-2 ABC transporter related 1.09 2.24 1.41 
YPK_2749 
fhuC-2, 
fepC-2, 
fecE-2 
ABC transporter related -2.18 -1.70 -1.06 
YPK_2750 
fhuB-3, 
fepG-3, 
fecD-3 
transport system 
permease protein -1.85 -1.01 1.20 
YPK_2751 
fhuD-3, 
fepB-3, 
fecB-3 
periplasmic binding protein -2.30 -1.40 1.07 
YPK_2752 lysP amino acid permease-
associated region -3.19 -2.66 -1.07 
YPK_2764 fruB phosphocarrier,  HPr family -2.61 1.19 1.22 
YPK_2767 yphE-4, ytfR-4 ABC transporter related 1.35 1.76 -1.01 
YPK_2768 yphF-4, ytfQ-4 
ABC transporter, 
periplasmic sugar-binding 
protein 
1.44 1.80 1.15 
YPK_2789 yejF ABC transporter related 1.34 2.64 1.26 
YPK_2853 tyrP aromatic amino acid transporter -1.41 1.93 -1.24 
YPK_2862 opuBD-1 
binding-protein-dependent 
transport systems inner 
membrane component 
1.13 2.30 1.10 
YPK_2863 opuA ABC transporter related 1.32 2.74 1.05 
YPK_2864 opuBD-2 
binding-protein-dependent 
transport systems inner 
membrane component 
1.23 2.30 -1.05 
YPK_2865 opuC 
substrate-binding region of 
ABC-type glycine betaine 
transport system 
1.66 3.98 1.27 
YPK_2940 modF ABC transporter related -1.96 1.21 -1.39 
YPK_3010 ybeJ/gltI extracellular solute-binding protein family 3 -1.76 1.33 -1.29 
YPK_3158 ybbA-1 ABC transporter related -1.14 1.84 1.18 
YPK_3189 ddhC DegT/DnrJ/EryC1/StrS 
aminotransferase 1.19 1.75 1.28 
YPK_3190 ddhB CDP-glucose 4,6-dehydratase 1.70 2.64 1.90 
YPK_3272 proY amino acid permease-
associated region -2.21 1.01 -1.06 
YPK_3309 fadE acyl-CoA dehydrogenase 1.32 2.07 1.09 
YPK_3339 emrB 
drug resistance 
transporter, EmrB/QacA 
subfamily 
1.07 2.17 1.26 
YPK_3442 cysJ sulfite reductase (NADPH) flavoprotein, alpha chain -2.40 -2.08 -1.12 
YPK_3460 fhuB transport system permease protein -1.76 -2.46 -1.07 
YPK_3461 fhuD periplasmic binding protein -1.44 -2.26 -1.05 
YPK_3462 fhuC ABC transporter related -1.79 -2.74 -1.31 
YPK_3597 
  
major facilitator 
superfamily MFS_1 -1.35 -2.18 -1.13 
YPK_3618 yjjK ABC transporter related 1.81 1.48 1.77 
YPK_3686 ddpA-2 extracellular solute-binding protein family 5 1.82 1.11 1.26 
YPK_3688 ddpC-2 
binding-protein-dependent 
transport systems inner 
membrane component 
-1.74 -1.89 -1.30 
YPK_3874 terC integral membrane protein TerC 1.26 1.78 1.65 
YPK_3891 hmuT periplasmic binding protein 1.22 5.54 1.55 
YPK_3892 hmuU transport system permease protein -1.11 4.65 1.22 
YPK_3893 hmuV ABC transporter related -1.32 2.41 1.00 
YPK_3920 gltP sodium:dicarboxylate 
symporter -2.62 -1.82 -1.12 
YPK_3923 actP cation/acetate symporter ActP 1.15 2.85 1.10 
YPK_3954 madN carboxylate/amino 
acid/amine transporter -2.08 -2.97 -1.37 
YPK_3970 livF ABC transporter related 2.46 -1.06 1.25 
YPK_3971 livG ABC transporter related 2.61 -1.23 1.33 
YPK_3972 livM inner-membrane translocator 2.09 -1.23 1.23 
YPK_3973 livH inner-membrane translocator 3.08 1.00 1.57 
YPK_3974 livK extracellular ligand-binding 
receptor 3.15 -1.57 1.30 
YPK_4001 rarD RarD protein, DMT 
superfamily transporter -1.36 -1.92 -1.20 
YPK_4018 hemX putative uroporphyrinogen III C-methyltransferase 1.38 1.80 1.39 
YPK_4112 glpF MIP family channel protein -7.60 1.62 -1.47 
YPK_4125 sbp1 
sulfate ABC transporter, 
periplasmic sulfate-binding 
protein 
-2.91 -1.48 1.16 
YPK_4127 fieF cation diffusion facilitator family transporter -1.44 -2.19 -1.85 
YPK_4181 gltS sodium/glutamate 
symporter -3.37 1.55 1.00 
YPK_4231 pstS 
phosphate ABC 
transporter, periplasmic 
phosphate-binding protein 
2.61 1.44 1.07 
YPK_4237 
  
extracellular solute-binding 
protein family 3 -2.15 -1.04 1.27 
YPK_4238 
  
polar amino acid ABC 
transporter, inner 
membrane subunit 
-1.76 1.24 1.07 
YPK_4239 
  
polar amino acid ABC 
transporter, inner 
membrane subunit 
-2.77 -1.38 -1.62 
GENERAL MEMBRANE TRANSPORT, SECRETION AND STRUCTURAL 
PROTEINS 
YPK_0262 rafQ glycosyl transferase family 9 -2.20 -1.50 -1.42 
YPK_0312 mscL 
large conductance 
mechanosensitive channel 
protein 
-1.44 -3.26 -1.65 
YPK_0410 
  YD repeat protein 2.13 -1.04 1.15 
YPK_0654 tolC 
type I secretion outer 
membrane protein, TolC 
family 
1.75 1.93 1.62 
YPK_0673 exbD TonB system transport protein ExbD -1.12 -2.62 1.14 
YPK_0729 fliK-2 putative flagellar hook-length control protein 1.68 1.88 1.45 
YPK_0740 
  
putative integral 
membrane efflux protein -1.23 -1.87 -1.43 
YPK_1073 rscP membrane-associated zinc 
metalloprotease 1.24 1.85 1.00 
YPK_1074 yaeT 
outer membrane protein 
assembly complex, YaeT 
protein 
2.12 2.43 1.64 
YPK_1075 ompH outer membrane 
chaperone Skp (OmpH) 1.79 1.14 -1.17 
YPK_1090 cutF copper resistance lipoprotein NlpE 1.01 1.96 -1.49 
YPK_1533 dedD phosphogluconate dehydratase 1.70 2.61 1.30 
YPK_1641 mscM mechanosensitive ion 
channel MscS  1.60 1.88 1.42 
YPK_1662 mdoH glycosyl transferase family 2 1.87 2.73 1.09 
YPK_1665 htrB 
lipid A biosynthesis lauroyl 
(or palmitoleoyl) 
acyltransferase 
2.32 1.04 1.12 
YPK_1783 prc carboxyl-terminal protease 1.92 1.66 1.71 
YPK_2022 osmB osmotically inducible lipoprotein B precursor 1.11 2.50 -1.20 
YPK_2055 tonB TonB family protein -2.02 -2.66 -1.17 
YPK_2508 
  
mandelate 
racemase/muconate 
lactonizing protein 
2.42 1.74 1.15 
YPK_2630 ompA 
OmpA domain protein 
transmembrane region-
containing protein 
1.85 2.76 1.68 
YPK_2649 ompF porin Gram-negative type -2.34 -2.00 -1.29 
YPK_2678 
  
glycosyl transferase family 
25 -1.28 1.93 -1.27 
YPK_2684 lolA 
outer membrane 
lipoprotein carrier protein 
LolA 
1.06 2.07 -1.03 
YPK_2696 macA-2 efflux transporter, RND family, MFP subunit 1.31 3.56 1.37 
YPK_2740 dacC serine-type D-Ala-D-Ala 
carboxypeptidase 2.16 4.21 1.63 
YPK_2784 spr NLP/P60 protein -3.53 3.40 -1.09 
YPK_2839 ompC-2 porin Gram-negative type -1.12 3.72 -1.28 
YPK_2885 pbpG 
peptidase S11 D-alanyl-D-
alanine carboxypeptidase 
1 
-1.01 1.76 1.17 
YPK_2954 
  
tol-pal system protein 
YbgF 2.46 3.84 1.39 
YPK_2955 pal peptidoglycan-associated lipoprotein 1.99 3.05 -1.06 
YPK_2956 tolB 
Tol-Pal system beta 
propeller repeat protein 
TolB 
2.51 5.13 1.15 
YPK_3009 lnt apolipoprotein N-
acyltransferase 1.16 2.00 1.32 
YPK_3028 tatE 
twin-arginine translocation 
protein, TatA/E family 
subunit 
1.84 2.48 -1.09 
YPK_3182 fcl NAD-dependent 
epimerase/dehydratase 1.72 1.77 1.64 
YPK_3185 wzy O-antigen biosynthesis protein -2.24 -3.07 -1.91 
YPK_3187 
  
glycosyl transferase family 
2 -1.51 -2.22 -1.78 
YPK_3238 yajG uncharacterized lipoprotein -2.21 -2.31 -1.95 
YPK_3263 yajC preprotein translocase, YajC subunit -1.82 -1.68 -1.36 
YPK_3338 emrA efflux pump membrane 1.09 2.73 1.32 
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YPK_3463 mrcB penicillin-binding protein 1B 1.46 2.62 1.57 
YPK_3512 lpxC 
UDP-3-0-acyl N-
acetylglucosamine 
deacetylase 
1.93 1.66 1.14 
YPK_3521 mraY 
phospho-N-
acetylmuramoyl-
pentapeptide-transferase 
-1.23 -1.76 -1.24 
YPK_3613 slt lytic transglycosylase 
catalytic 1.04 2.06 1.36 
YPK_3632 osmY hyperosmotically inducible periplasmic protein 3.55 28.04 1.17 
YPK_3733 secG preprotein translocase, SecG subunit -2.42 -2.20 -1.26 
YPK_3779 ytfB opacity-associated protein A 1.36 -1.21 -1.13 
YPK_4028 rffH glucose-1-phosphate thymidylyltransferase 1.70 2.13 1.29 
YPK_4030 wecC nucleotide sugar dehydrogenase 1.53 2.26 1.31 
YPK_4031 rffE UDP-N-acetylglucosamine 2-epimerase 1.41 1.92 1.22 
YPK_4032 wzzE lipopolysaccharide biosynthesis protein 1.90 3.07 1.29 
YPK_4149 kdtA 
three-deoxy-D-manno-
octulosonic-acid 
transferase domain protein 
-1.47 -1.81 -1.40 
YPK_4229 glmS 
glucosamine-fructose-6-
phosphate 
aminotransferase, 
isomerizing 
2.34 -1.19 1.33 
DEFENSE MECHANISMS 
 
YPK_1644 cas-1 CRISPR-associated protein Cas1 1.00 2.98 -1.07 
YPK_1645 cas-3 CRISPR-associated helicase Cas3 family 1.06 1.92 -1.01 
YPK_1646 csy-1 CRISPR-associated protein, Csy1 family 1.34 2.50 1.51 
YPK_1647 csy-2 CRISPR-associated protein, Csy2 family 1.26 1.96 1.09 
YPK_1648 csy-3 CRISPR-associated protein, Csy3  family 1.43 2.59 1.09 
YPK_1649 csy-4 CRISPR-associated protein, Csy4 family 1.89 3.22 1.30 
YPK_1760 cwlA, 
xlyA, xlyB 
N-acetylmuramyl-L-alanine 
amidase, negative 
regulator of AmpC, AmpD 
2.97 3.21 -1.09 
YPK_2050 yciC protein of unknown function UPF0259 -1.47 -2.10 -1.38 
YPK_2836 ampH beta-lactamase 1.91 1.76 1.44 
YPK_3642 mexB acriflavin resistance protein 1.34 -2.44 1.08 
YPK_3665 
  
type I restriction-
modification system, M 
subunit 
-2.01 -2.42 -1.34 
YPK_3671 mcrC 
5-methylcytosine 
restriction system 
component 
-1.67 -2.00 -1.35 
YPK_3672 hsdM-2 
type I restriction-
modification system, M 
subunit 
-2.35 -2.83 1.21 
YPK_3674 hsdR 
type I site-specific 
deoxyribonuclease, HsdR 
family 
-1.80 -1.82 1.09 
OTHERS 
   
 
 pYV0019 
  putative transposase 1.92 1.46 1.43 
pYV0039 
  putative transposase -1.96 -1.85 -1.43 
pYV0046 
  
putative transposase 
remnant -1.76 -1.21 -1.21 
pYV0095 
  putative transposase 2.08 1.09 1.08 
YPK_0025 yiaF putative lipoprotein 3.89 -1.20 1.19 
YPK_0066 
  
transposase IS3/IS911 
family protein 1.75 1.17 1.16 
YPK_0067 
  integrase catalytic region 1.94 1.02 -1.07 
YPK_0080 eptB sulfatase -1.72 -1.84 -1.32 
YPK_0100 
  
peptidase M16 domain 
protein 1.67 2.19 1.36 
YPK_0106 yhjD ribonuclease 1.18 1.81 1.04 
YPK_0154 
  
protein of unknown 
function DUF943 -2.34 -1.75 -1.84 
YPK_0158 glpG rhomboid family protein -1.69 -2.11 -1.41 
YPK_0166 
  
protein of unknown 
function DUF1471 2.45 -1.15 -1.76 
YPK_0189 
  
DNA circulation family 
protein -1.27 -1.81 -1.51 
YPK_0311 arfA protein of unknown function DUF331 -1.08 -1.75 -1.41 
YPK_0353 yjaG protein of unknown function DUF416 -1.99 -1.17 -1.62 
YPK_0355 yjaH protein of unknown function DUF1481 1.38 1.86 1.37 
YPK_0375 yjbA phosphate-starvation-inducible E 1.12 -1.94 -1.27 
YPK_0406 
  
putative cytoplasmic 
protein 2.23 1.24 1.25 
YPK_0427 
  transposase mutator type 1.47 2.91 1.44 
YPK_0445 pcp 17 kDa surface antigen -1.17 -9.78 -1.57 
YPK_0456 yhdT protein of unknown function DUF997 -1.97 -1.29 -1.33 
YPK_0462 yedY oxidoreductase 
molybdopterin binding 2.10 -1.09 1.13 
YPK_0487 
  guanine-specific 2.17 1.23 1.06 
ribonuclease N1 and T1 
YPK_0502 yhbJ conserved hypothetical protein 1.57 1.77 1.26 
YPK_0508 yrbK protein of unknown function DUF1239 1.61 2.04 1.19 
YPK_0509 kdsC 
3-deoxy-D-manno-
octulosonate 8-phosphate 
phosphatase, YrbI family 
1.67 2.36 1.29 
YPK_0521 yhcB protein of unknown function DUF1043 -2.31 -1.93 -2.05 
YPK_0534 elbB ThiJ/PfpI domain protein 1.95 1.90 1.48 
YPK_0551 
  putative lipoprotein -1.44 -1.85 -1.34 
YPK_0602 
  YheO domain protein -1.84 -1.83 -1.45 
YPK_0613 xtmA putative phage terminase, 
small subunit 1.86 1.45 1.46 
YPK_0638 
  
protein of unknown 
function DUF205 -2.03 -2.59 -2.02 
YPK_0647 
  
protein of unknown 
function DUF526 -1.50 -2.42 -1.58 
YPK_0661 mdaB NAD(P)H dehydrogenase (quinone) -2.13 -4.10 -1.09 
YPK_0822 yggL protein of unknown function DUF469 -1.39 -1.82 -1.30 
YPK_0856 yggE protein of unknown function DUF541 3.29 18.46 1.58 
YPK_0861 zapA protein of unknown function DUF710 -1.60 -3.34 -1.74 
YPK_0885 
  
regulatory CII family 
protein -1.13 2.35 1.07 
YPK_0887 
  
gpB bacteriophage P2-like 
protein -1.80 2.38 -1.56 
YPK_0890 
  
putative replication 
initiation protein -1.63 3.48 -1.08 
YPK_0895 
  
transcriptional activator 
Ogr/delta -1.10 -1.73 -1.79 
YPK_0951 
  
filamentation induced by 
cAMP protein Fic 1.14 1.87 -1.23 
YPK_1020 
  
beta-lactamase domain 
protein 2.36 1.84 1.42 
YPK_1049 sufE 
cysteine desulfurase, 
sulfur acceptor subunit 
CsdE 
-1.16 -1.81 -1.56 
YPK_1058 syd Syd family protein -1.31 -2.01 -1.49 
YPK_1086 
  
transcriptional 
antiterminator, Rof -1.63 -2.46 -1.84 
YPK_1087 
  
protein of unknown 
function UPF0253 -1.75 -2.92 -1.95 
YPK_1088 
  YaeQ family protein 1.07 -1.16 1.01 
YPK_1177 yplB ankyrin 1.87 1.19 -1.14 
YPK_1200 
  
Arc domain protein DNA 
binding domain protein -1.95 -1.67 -1.33 
YPK_1296 yfgL outer membrane assembly lipoprotein YfgL 1.76 1.55 1.41 
YPK_1323 
  
inhibitor of vertebrate 
lysozyme 2.03 1.95 1.09 
YPK_1326 yegP protein of unknown function DUF1508 2.39 -1.03 -1.15 
YPK_1398 yfeY protein of unknown function DUF1131 1.51 2.24 1.19 
YPK_1451 
  
protein of unknown 
function DUF799 -1.35 -1.94 -1.01 
YPK_1512 
  Smr protein/MutS2 -1.58 -1.77 -1.59 
YPK_1530 dedA SNARE associated Golgi protein 1.40 1.98 1.34 
YPK_1557 yfbR metal dependent phosphohydrolase -1.09 -1.89 -1.24 
YPK_1577 
  
protein of unknown 
function DUF187 1.15 1.96 1.06 
YPK_1585 elaB protein of unknown function DUF883 ElaB 2.99 -1.58 -1.74 
YPK_1601 
  
protein of unknown 
function DUF218 -1.22 1.79 1.06 
YPK_1624 trp14A transposase IS3/IS911 family protein 2.07 -1.21 -1.04 
YPK_1676 
  
antibiotic biosynthesis 
monooxygenase -1.70 -2.52 -1.72 
YPK_1681 yceD protein of unknown function DUF177 -2.59 -2.75 -1.74 
YPK_1697 ycfL protein of unknown function DUF1425 1.82 2.15 1.65 
YPK_1741 
  DsrB protein -2.13 -3.34 -1.70 
YPK_1772 
  
protein of unknown 
function DUF1480 1.92 1.12 -2.05 
YPK_1776 
  
spore coat U domain 
protein 2.01 -1.07 1.01 
YPK_1778 
  
spore coat U domain 
protein 3.70 1.05 1.17 
YPK_1806 
  transposase mutator type 1.43 2.99 1.56 
YPK_1807 
  transposase 1.35 2.14 1.04 
YPK_1870 sepC Rhs family protein-like protein 2.76 1.55 1.28 
YPK_1885 
  
protein of unknown 
function DUF1282 4.04 1.94 -1.14 
YPK_1926 
  
protein of unknown 
function DUF891 1.71 2.54 1.14 
YPK_1951 
  
protein of unknown 
function DUF1460 2.06 2.31 -1.40 
YPK_1952 
  putative virulence factor -1.62 -2.15 1.06 
YPK_1977 
  
protein of unknown 
function DUF1283 1.42 3.17 1.26 
YPK_1978 
  
protein of unknown 
function DUF1161 2.39 16.59 -1.64 
YPK_1987 
  protein of unknown 1.90 4.12 1.46 
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YPK_1995 
  
oxidoreductase domain 
protein 1.87 1.04 1.10 
YPK_2048 
  transport-associated 4.42 2.66 -1.47 
YPK_2079 
  
SEC-C motif domain 
protein -1.11 -1.74 -1.26 
YPK_2102 yeaH protein of unknown function DUF444 2.57 2.20 -1.01 
YPK_2103 
  
protein of unknown 
function DUF6 
transmembrane 
2.19 1.13 -1.35 
YPK_2105 
  pirin domain protein -1.64 -2.14 -1.54 
YPK_2108 spoVR SpoVR family protein 2.60 1.83 1.40 
YPK_2120 
  
protein of unknown 
function DUF709 1.55 1.86 -1.08 
YPK_2146 
  
protein of unknown 
function DUF28 1.76 1.23 1.45 
YPK_2205 
  
Sel1 domain protein 
repeat-containing protein 1.13 1.82 1.16 
YPK_2260 
  amidohydrolase 2 9.21 -1.29 1.07 
YPK_2264 
  putative lipoprotein 1.79 -1.28 -1.28 
YPK_2291 
  transposase 1.22 1.89 1.18 
YPK_2292 
  transposase mutator type 1.29 2.00 1.12 
YPK_2358 ydgC, glpM GlpM family protein -1.48 -1.77 -1.81 
YPK_2388 doc death-on-curing family protein -1.04 -1.84 -1.74 
YPK_2444 yqfB protein of unknown function DUF437 3.75 1.53 -1.15 
YPK_2448 yoaH protein of unknown function UPF0181 -1.51 -2.53 -1.83 
YPK_2473 
  
protein of unknown 
function DUF152 2.19 1.32 1.15 
YPK_2488 
  
protein of unknown 
function RIO1 1.80 1.23 1.36 
YPK_2489 
  YCII-related 1.33 -1.98 -1.77 
YPK_2514 
  
protein of unknown 
function DUF496 -3.11 -3.67 -1.96 
YPK_2548 fhuF ferric iron reductase -1.98 -2.63 -1.55 
YPK_2559 yohJ LrgA family protein -1.93 -1.31 -1.71 
YPK_2572 frmB, fghA 
S-formylglutathione 
hydrolase -1.34 1.87 1.17 
YPK_2629 sulA cell division inhibitor SulA -1.85 1.21 -1.49 
YPK_2638 pqiB mammalian cell entry 
related domain protein 1.33 1.94 1.18 
YPK_2639 pqiA integral membrane protein, PqiA family 1.41 2.13 1.17 
YPK_2643 
  
protein of unknown 
function DUF1379 -1.40 -1.11 -1.94 
YPK_2652 
  
beta-lactamase domain 
protein 1.52 2.36 1.15 
YPK_2653 
  
protein of unknown 
function DUF882 1.53 2.64 1.25 
YPK_2661 
  
protein of unknown 
function DUF343 -1.79 -1.06 -1.75 
YPK_2666 comEC 
DNA internalization-related 
competence protein 
ComEC/Rec2 
1.09 1.85 -1.16 
YPK_2693 clpS 
ATP-dependent Clp 
protease adaptor protein 
ClpS 
1.28 1.81 1.03 
YPK_2708 
  putative lipoprotein 1.75 2.43 1.35 
YPK_2744 
  2OG-Fe(II) oxygenase -1.96 1.59 1.08 
YPK_2797 yejL protein of unknown function DUF1414 -1.61 -1.53 -1.92 
YPK_2802 
  Colicin D 1.18 2.44 -1.14 
YPK_2808 
  
tail assembly chaperone 
gp38 -2.24 2.06 -1.41 
YPK_2809 
  
putative bacteriophage tail 
fiber protein -1.80 2.28 1.04 
YPK_2810 
  
putative bacteriophage 
protein GP48 -1.17 2.90 -1.00 
YPK_2811 
  baseplate J family protein -1.25 2.10 -1.00 
YPK_2812 
  GP46 family protein -1.10 2.43 1.03 
YPK_2813 
  
phage baseplate assembly 
protein V -1.02 3.47 1.15 
YPK_2814 
  Mu P family protein -1.05 2.85 1.39 
YPK_2817 
  
putative bacteriophage 
protein -1.25 3.80 1.08 
YPK_2819 
  
Mu tail sheath family 
protein -1.24 3.97 1.39 
YPK_2820 
  
putative bacteriophage 
protein -1.32 3.62 1.11 
YPK_2827 
  
antitermination Q family 
protein -1.06 2.21 1.07 
YPK_2830 msgA DinI family protein -2.22 1.17 -1.42 
YPK_2854 
  YfaZ family protein 1.81 1.19 1.14 
YPK_2874 
  
protein of unknown 
function DUF1456 -2.76 -1.96 -1.99 
YPK_2918 
ybhL, 
ybhM, 
yccA 
protein of unknown 
function UPF0005 -2.08 -1.64 -2.06 
YPK_2947 psiF PsiF repeat protein 2.58 3.58 -1.14 
YPK_2961 
  cyd operon protein YbgE -1.90 -1.39 -1.67 
YPK_2962 
  cyd operon protein YbgT -1.96 -1.39 -1.58 
YPK_2978 
  
protein of unknown 
function UPF0125 1.29 1.83 1.06 
YPK_2989 
  
CopG domain protein 
DNA-binding domain 
protein 
-2.67 -2.15 -1.94 
YPK_3014 
  
protein of unknown 
function DUF1451 2.71 2.48 1.25 
YPK_3025 ybeD protein of unknown -1.89 -1.69 -1.71 
function DUF493 
YPK_3036 
  
antibiotic biosynthesis 
monooxygenase -2.40 -1.84 -1.76 
YPK_3075 dkgA-2 2,5-didehydrogluconate 
reductase 1.92 2.29 1.37 
YPK_3076 
  aldo/keto reductase 2.25 2.20 1.38 
YPK_3118 
  
phage-related membrane 
protein -1.35 -1.83 -1.69 
YPK_3122 
  
Mu tail sheath family 
protein 1.80 1.29 1.13 
YPK_3147 
  
tetratricopeptide TPR_2 
repeat protein -1.78 -2.09 -1.53 
YPK_3157 ybbP-3 protein of unknown function DUF214 1.09 2.05 1.18 
YPK_3166 
  GumN family protein 1.15 2.04 1.05 
YPK_3186 
  
LPS side chain defect: 
putative O-antigen 
transferase 
-1.70 -2.42 -1.81 
YPK_3216 ybaY putative lipoprotein -1.74 2.86 -1.70 
YPK_3228 ybaW thioesterase superfamily protein -1.24 1.94 -1.10 
YPK_3247 yajQ protein of unknown function DUF520 -2.07 -1.54 -1.22 
YPK_3281 yaiE protein of unknown function DUF1255 -1.76 -2.07 -1.52 
YPK_3317 mtnK 5-methylthioribose kinase -2.29 1.26 1.11 
YPK_3505 yacG protein of unknown function DUF329 -1.31 -2.49 -1.62 
YPK_3528 ygaW protein of unknown function DUF1144 1.84 1.38 -1.29 
YPK_3607 creA CreA family protein 1.22 -2.01 -1.65 
YPK_3619 
  
filamentation induced by 
cAMP protein Fic -1.89 -1.20 -1.24 
YPK_3623 smp putative membrane protein Smp -1.13 -1.76 -1.58 
YPK_3630 yjjU patatin 1.22 2.70 -1.13 
YPK_3631 
  
protein of unknown 
function DUF1328 3.79 22.04 1.19 
YPK_3663 
  
protein of unknown 
function DUF898 
transmembrane 
-1.83 -1.24 -1.04 
YPK_3668 
  integrase family protein -1.54 -1.78 -1.18 
YPK_3677 yjgQ permease YjgP/YjgQ family protein 1.17 2.31 1.03 
YPK_3678 yjgP permease YjgP/YjgQ family protein 1.01 1.96 -1.10 
YPK_3683 
  
protein of unknown 
function DUF1260 2.67 1.45 1.67 
YPK_3746 xtmA2 putative phage terminase, 
small subunit 1.93 1.36 1.51 
YPK_3763 yhcN protein of unknown function DUF1471 1.19 -1.79 2.71 
YPK_3768 
  AIG2 family protein -1.43 -2.16 -1.75 
YPK_3773 
  
protein of unknown 
function DUF1107 1.30 2.43 -1.50 
YPK_3838 insB IS1 transposase -1.40 -2.10 -1.64 
YPK_3922 
  
protein of unknown 
function DUF485 1.09 2.34 1.24 
YPK_3925 
  integrase catalytic region 2.05 -1.13 -1.19 
YPK_3983 
  
domain of unknown 
function DUF1820 -1.93 -2.27 -1.92 
YPK_3984 yhhN YhhN family protein -1.05 -2.23 -1.73 
YPK_4063 yifE protein of unknown function DUF413 -1.51 -2.04 -1.66 
YPK_4097 
  
YiaAB two helix domain 
protein -1.44 -2.57 -1.57 
YPK_4116 
  
protein of unknown 
function DUF805 -2.40 -2.93 -1.09 
YPK_4128 
  
transposase, IS4 family 
protein -1.41 -2.68 -1.94 
YPK_4164 
  
phage transcriptional 
regulator, AlpA -1.79 -1.40 -1.39 
YPK_4187 
yrfG-4, 
yigB-4, 
yihX-4 
HAD-superfamily 
hydrolase, subfamily IA, 
variant 3 
3.48 1.24 -1.32 
YPK_4247 yidD protein of unknown function DUF37 -1.84 -1.63 -1.05 
HYPOTHETICAL 
  
 
 pYV0010 
  hypothetical protein -2.04 -3.78 -1.17 
pYV0012 
  hypothetical protein -1.40 -3.27 1.09 
pYV0026 
  hypothetical protein 1.04 -2.49 -1.46 
pYV0027 
  hypothetical protein 1.07 -2.51 -1.45 
pYV0044 
  hypothetical protein -2.21 -2.04 -1.42 
pYV0077 yscA hypothetical protein -1.35 -2.96 -1.76 
pYV0078 
  hypothetical protein -1.11 -2.06 -1.40 
YPK_0006 
  
hypothetical protein 
YPK_0006 -1.99 -2.25 -1.37 
YPK_0030 yibL conserved hypothetical protein -2.75 -4.29 -2.10 
YPK_0031 
  
conserved hypothetical 
protein 1.78 1.08 1.34 
YPK_0044 
  
conserved hypothetical 
protein -3.93 -1.98 -2.24 
YPK_0046 
  
conserved hypothetical 
protein -2.12 1.60 -1.74 
YPK_0047 
  
conserved hypothetical 
protein -1.55 -1.83 -1.64 
YPK_0049 
  
hypothetical protein 
YPK_0049 -1.97 -2.19 -1.39 
YPK_0062 
  
conserved hypothetical 
protein -1.65 -1.96 -1.39 
YPK_0063 
  
hypothetical protein 
YPK_0063 -2.59 -3.74 -1.99 
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YPK_0132 
  
conserved hypothetical 
protein -1.68 -2.95 -1.19 
YPK_0153 
  
conserved hypothetical 
protein -1.74 -2.12 -1.32 
YPK_0156 
  
hypothetical protein 
YPK_0156 -1.95 -2.01 -1.36 
YPK_0250 
  
hypothetical protein 
YPK_0250 -1.89 2.08 -1.72 
YPK_0397 
  
conserved hypothetical 
protein 2.00 1.25 1.15 
YPK_0405 
  
hypothetical protein 
YPK_0405 1.77 1.25 1.23 
YPK_0411 
  
conserved hypothetical 
protein -1.21 -2.49 -1.41 
YPK_0441 
  
hypothetical protein 
YPK_0441 -1.51 -1.99 -1.55 
YPK_0457 
  
hypothetical protein 
YPK_0457 -4.11 -4.43 -2.05 
YPK_0497 
  
conserved hypothetical 
protein 8.64 1.84 1.47 
YPK_0522 
 
hypothetical protein 
YPK_0522 -1.46 -2.00 -1.49 
YPK_0528 
  
conserved hypothetical 
protein -1.05 1.88 -1.12 
YPK_0566 
  
conserved hypothetical 
protein 1.79 1.27 1.09 
YPK_0574 
  
hypothetical protein 
YPK_0574 -1.11 -1.79 -1.45 
YPK_0579 
  
conserved hypothetical 
protein 1.86 1.70 1.24 
YPK_0580 
  
hypothetical protein 
YPK_0580 1.22 1.83 -1.28 
YPK_0609 
  
conserved hypothetical 
protein -1.39 -2.10 -1.79 
YPK_0615 
  
hypothetical protein 
YPK_0615 -1.70 -2.10 -1.54 
YPK_0631 
  
hypothetical protein 
YPK_0631 -1.66 -3.26 -1.59 
YPK_0633 
  
hypothetical protein 
YPK_0633 -2.36 -5.11 -1.68 
YPK_0653 
  
conserved hypothetical 
protein -1.42 -2.19 -1.58 
YPK_0732 
  
conserved hypothetical 
protein -1.99 -1.13 -1.90 
YPK_0742 
  
conserved hypothetical 
protein -2.69 -3.57 -1.60 
YPK_0759 
  
conserved hypothetical 
protein -1.20 -1.81 -1.22 
YPK_0769 
  
hypothetical protein 
YPK_0769 -2.25 -1.31 -2.04 
YPK_0777 
  
conserved hypothetical 
protein -1.53 2.07 -1.40 
YPK_0840 
  
hypothetical protein 
YPK_0840 -2.10 -2.06 -1.41 
YPK_0870 
  
conserved hypothetical 
protein 2.00 1.61 -1.15 
YPK_0884 
  
conserved hypothetical 
protein -1.27 2.37 -1.04 
YPK_0886 
  
hypothetical protein 
YPK_0886 1.19 2.97 1.38 
YPK_0889 
  
conserved hypothetical 
protein -1.36 3.38 -1.19 
YPK_0894 
  
hypothetical protein 
YPK_0894 -2.03 -1.23 -1.85 
YPK_0946 
  
conserved hypothetical 
protein -1.40 2.14 -1.63 
YPK_0947 
  
conserved hypothetical 
protein -1.02 1.79 1.03 
YPK_0954 
  
conserved hypothetical 
protein 1.98 3.40 1.36 
YPK_0963 
  
conserved hypothetical 
protein -2.31 -1.48 -1.93 
YPK_0969 
  
hypothetical protein 
YPK_0969 -1.86 -1.44 1.26 
YPK_1030 
  
conserved hypothetical 
protein -1.47 -1.94 -1.53 
YPK_1051 
  
hypothetical protein 
YPK_1051 -1.46 -1.98 -1.37 
YPK_1056 ygdH conserved hypothetical protein 1.08 2.65 1.14 
YPK_1062 
  
conserved hypothetical 
protein -1.04 -2.31 -1.47 
YPK_1121 
  
conserved hypothetical 
protein 1.05 3.36 -1.42 
YPK_1150 
  
conserved hypothetical 
protein -2.04 -1.45 -1.45 
YPK_1160 
  
conserved hypothetical 
protein -1.19 -1.45 -2.30 
YPK_1178 
  
conserved hypothetical 
protein 1.78 1.13 -1.30 
YPK_1186 
  
conserved hypothetical 
protein 1.33 4.39 -1.32 
YPK_1216 
  
hypothetical protein 
YPK_1216 -1.75 -1.77 -1.76 
YPK_1244 
  
hypothetical protein 
YPK_1244 -1.46 -1.68 -2.17 
YPK_1256 
  
hypothetical protein 
YPK_1256 1.17 -2.22 -2.87 
YPK_1295 yfgM conserved hypothetical protein 1.90 1.64 1.48 
YPK_1369 
  
hypothetical protein 
YPK_1369 -1.36 -1.81 -1.19 
YPK_1397 ygiW conserved hypothetical 2.00 3.24 1.07 
protein 
YPK_1405 
  
conserved hypothetical 
protein -1.97 -1.96 -1.48 
YPK_1413 
  
conserved hypothetical 
protein -3.16 -3.00 -1.69 
YPK_1434 
  
conserved hypothetical 
protein -1.94 -2.62 -1.65 
YPK_1440 
  
conserved hypothetical 
protein 1.66 5.73 -1.23 
YPK_1457 
  
conserved hypothetical 
protein 1.05 5.19 -1.55 
YPK_1458 
  
hypothetical protein 
YPK_1458 -1.26 1.76 -1.07 
YPK_1507 
  
conserved hypothetical 
protein -1.49 -2.32 -1.68 
YPK_1537 
  
hypothetical protein 
YPK_1537 1.41 -1.22 -1.77 
YPK_1556 
  
conserved hypothetical 
protein 1.62 2.01 -1.72 
YPK_1587 
  
hypothetical protein 
YPK_1587 -1.18 1.39 -2.17 
YPK_1617 
  
conserved hypothetical 
protein -1.34 -1.90 -1.65 
YPK_1623 
  
conserved hypothetical 
protein -2.30 -2.39 -1.66 
YPK_1626 
  
conserved hypothetical 
protein -1.39 -1.09 -2.20 
YPK_1659 
  
conserved hypothetical 
protein -2.08 -2.70 -1.97 
YPK_1670 
  
conserved hypothetical 
protein -1.82 -1.06 -1.60 
YPK_1725 
  
conserved hypothetical 
protein -3.81 -3.72 -1.95 
YPK_1729 
  
conserved hypothetical 
protein -1.38 -2.33 -1.76 
YPK_1731 
  
conserved hypothetical 
protein -1.30 -3.69 -1.65 
YPK_1734 
  
hypothetical protein 
YPK_1734 -1.42 -2.06 -1.60 
YPK_1735 ylaC conserved hypothetical protein -1.49 -2.05 -1.76 
YPK_1738 
  
hypothetical protein 
YPK_1738 1.39 1.85 -1.49 
YPK_1762 
  
conserved hypothetical 
protein 2.83 1.06 1.13 
YPK_1763 
  
hypothetical protein 
YPK_1763 1.38 -2.16 -1.66 
YPK_1765 
  
conserved hypothetical 
protein 1.89 -1.17 -1.26 
YPK_1767 
  
conserved hypothetical 
protein -1.21 -2.11 -1.29 
YPK_1769 
  
conserved hypothetical 
protein -2.29 -1.44 -2.05 
YPK_1818 
  
conserved hypothetical 
protein -13.93 -1.85 -1.55 
YPK_1819 
  
conserved hypothetical 
protein -1.46 -2.79 -2.06 
YPK_1827 
  
conserved hypothetical 
protein 1.11 -2.26 -1.21 
YPK_1865 
  
conserved hypothetical 
protein -1.18 -2.29 -1.63 
YPK_1867 
  
hypothetical protein 
YPK_1867 -1.54 -1.88 -1.75 
YPK_1879 
  
conserved hypothetical 
protein 1.30 3.27 -1.36 
YPK_1887 
  
conserved hypothetical 
protein 1.06 2.01 1.42 
YPK_1899 ycjF conserved hypothetical protein 1.79 1.44 1.33 
YPK_1921 ydbL conserved hypothetical protein 2.01 1.43 1.45 
YPK_1938 
  
conserved hypothetical 
protein -1.24 -1.94 -1.81 
YPK_1954 
  
conserved hypothetical 
protein -6.28 -6.23 -1.10 
YPK_1989 
  
hypothetical protein 
YPK_1989 -7.00 1.21 -1.10 
YPK_1990 
  
conserved hypothetical 
protein -3.63 1.68 1.08 
YPK_2005 
  
conserved hypothetical 
protein -1.51 -2.22 -1.93 
YPK_2020 
  
conserved hypothetical 
protein -1.59 -3.77 -1.69 
YPK_2025 
  
conserved hypothetical 
protein -1.50 -2.84 -2.04 
YPK_2034 
  
conserved hypothetical 
protein -1.72 -2.65 -1.51 
YPK_2035 
  
conserved hypothetical 
protein -2.09 -3.80 -2.01 
YPK_2058 
  
conserved hypothetical 
protein 1.08 12.84 -1.64 
YPK_2059 
  
conserved hypothetical 
protein -2.99 -1.05 -1.19 
YPK_2062 
  
conserved hypothetical 
protein -1.57 -1.95 -1.58 
YPK_2065 
  
conserved hypothetical 
protein -2.95 -1.78 -1.71 
YPK_2082 
  
hypothetical protein 
YPK_2082 1.11 1.08 1.02 
YPK_2084 
  
conserved hypothetical 
protein -1.97 -1.49 -1.05 
YPK_2101 
  
hypothetical protein 
YPK_2101 2.55 1.92 1.07 
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YPK_2183 
  
hypothetical protein 
YPK_2183 1.92 1.18 1.37 
YPK_2185 
  
conserved hypothetical 
protein -1.13 2.08 -1.18 
YPK_2197 
  
conserved hypothetical 
protein 2.20 3.71 -1.05 
YPK_2198 
  
conserved hypothetical 
protein 2.19 3.26 1.04 
YPK_2199 
  
conserved hypothetical 
protein 2.91 3.91 -1.13 
YPK_2200 
  
hypothetical protein 
YPK_2200 21.47 7.16 -1.93 
YPK_2236 
  
conserved hypothetical 
protein 3.17 1.79 -1.04 
YPK_2251 
  
conserved hypothetical 
protein 1.26 -2.13 -1.16 
YPK_2263 
  
conserved hypothetical 
protein 1.77 -1.45 -1.12 
YPK_2298 
  
conserved hypothetical 
protein -1.73 2.76 -1.53 
YPK_2299 
  
conserved hypothetical 
protein -1.45 3.10 -1.56 
YPK_2308 
  
hypothetical protein 
YPK_2308 1.23 1.97 1.09 
YPK_2309 
  
conserved hypothetical 
protein 1.96 1.85 1.22 
YPK_2339 
  
conserved hypothetical 
protein 1.06 2.97 -1.32 
YPK_2357 
  
conserved hypothetical 
protein -2.38 -2.66 -2.05 
YPK_2359 
  
conserved hypothetical 
protein -1.53 -1.82 -1.95 
YPK_2368 
  
conserved hypothetical 
protein -3.47 1.31 1.19 
YPK_2379 
  
conserved hypothetical 
protein -4.41 -6.14 1.08 
YPK_2389 
  
conserved hypothetical 
protein -1.01 -2.22 -1.73 
YPK_2397 
  
conserved hypothetical 
protein -2.63 -2.80 1.13 
YPK_2405 
  
hypothetical protein 
YPK_2405 -1.59 -1.48 -2.16 
YPK_2433 
  
conserved hypothetical 
protein -1.03 2.28 1.09 
YPK_2441 
  
conserved hypothetical 
protein 2.12 -2.08 -1.88 
YPK_2443 
  
conserved hypothetical 
protein 3.64 1.70 -1.09 
YPK_2471 
  
conserved hypothetical 
protein -5.82 -5.33 -1.93 
YPK_2475 
  
conserved hypothetical 
protein -3.03 -3.43 -2.08 
YPK_2480 
  
conserved hypothetical 
protein -1.72 -2.65 -1.87 
YPK_2481 
  
conserved hypothetical 
protein 1.22 1.51 -1.89 
YPK_2482 
  
conserved hypothetical 
protein -2.07 -4.04 -1.84 
YPK_2483 
  
hypothetical protein 
YPK_2483 1.12 -1.92 -2.05 
YPK_2485 
  
conserved hypothetical 
protein -1.13 -3.51 -1.80 
YPK_2486 
  
conserved hypothetical 
protein -1.14 -4.74 -1.89 
YPK_2500 yaiL conserved hypothetical protein -1.46 -2.07 -1.63 
YPK_2501 
  
conserved hypothetical 
protein -1.37 -2.15 -1.40 
YPK_2507 
  
conserved hypothetical 
protein 2.21 1.84 1.09 
YPK_2522 
  
hypothetical protein 
YPK_2522 -1.46 -2.57 -1.40 
YPK_2523 
  
conserved hypothetical 
protein -1.29 -1.86 -1.28 
YPK_2623 
  
conserved hypothetical 
protein 1.22 2.02 1.12 
YPK_2726 
  
conserved hypothetical 
protein -2.61 -1.58 -1.61 
YPK_2731 
  
conserved hypothetical 
protein -3.04 -1.91 -1.69 
YPK_2745 
  
conserved hypothetical 
protein -3.44 1.08 -1.21 
YPK_2772 
  
conserved hypothetical 
protein 1.58 2.05 -1.12 
YPK_2781 
  
conserved hypothetical 
protein -8.43 5.22 -2.11 
YPK_2790 
  
conserved hypothetical 
protein -1.23 -1.19 -1.80 
YPK_2801 
  
conserved hypothetical 
protein 1.46 2.61 1.29 
YPK_2804 
  
conserved hypothetical 
protein -2.04 6.61 -1.55 
YPK_2806 
  
hypothetical protein 
YPK_2806 1.33 1.96 1.12 
YPK_2816 
  
conserved hypothetical 
protein 1.08 2.17 1.03 
YPK_2818 
  
conserved hypothetical 
protein -1.24 4.87 1.32 
YPK_2821 
  
conserved hypothetical 
protein 1.03 4.13 1.36 
YPK_2822 
  
conserved hypothetical 
protein -1.11 3.00 1.29 
YPK_2868 
  conserved hypothetical 2.45 1.08 -1.00 
protein 
YPK_2880 
  
conserved hypothetical 
protein 1.17 6.05 -1.02 
YPK_2892 
  
conserved hypothetical 
protein 1.51 1.87 1.35 
YPK_2984 
  
conserved hypothetical 
protein -1.94 -2.09 -1.73 
YPK_2988 
  
hypothetical protein 
YPK_2988 -2.26 -2.01 -1.84 
YPK_3035 
  
conserved hypothetical 
protein -11.46 -5.14 -2.17 
YPK_3038 
  
conserved hypothetical 
protein -1.57 -2.38 -1.86 
YPK_3061 
  
conserved hypothetical 
protein -1.23 2.04 -1.26 
YPK_3062 
  
conserved hypothetical 
protein -1.80 2.06 -1.53 
YPK_3070 
  
conserved hypothetical 
protein -1.26 2.00 -1.40 
YPK_3089 
  
conserved hypothetical 
protein 1.76 1.82 1.04 
YPK_3101 
  
hypothetical protein 
YPK_3101 -1.19 1.83 -1.16 
YPK_3121 
  
conserved hypothetical 
protein 1.86 1.56 1.25 
YPK_3123 
  
conserved hypothetical 
protein 1.80 -1.00 -1.20 
YPK_3138 
  
hypothetical protein 
YPK_3138 1.12 1.99 1.17 
YPK_3203 
  
conserved hypothetical 
protein -2.02 -1.21 -1.74 
YPK_3212 
  
conserved hypothetical 
protein -1.33 -2.15 -1.78 
YPK_3218 
  
hypothetical protein 
YPK_3218 -1.99 -1.94 -1.56 
YPK_3236 
  
conserved hypothetical 
protein -1.83 -1.27 -1.14 
YPK_3240 
  
conserved hypothetical 
protein -3.16 -1.86 -1.41 
YPK_3285 
  
conserved hypothetical 
protein -1.95 -2.70 -2.05 
YPK_3396 
  
conserved hypothetical 
protein -1.83 -1.38 -1.45 
YPK_3481 yacC conserved hypothetical protein -2.00 -2.25 -1.56 
YPK_3486 yacL conserved hypothetical protein 2.28 1.47 1.59 
YPK_3549 
  
conserved hypothetical 
protein 6.01 1.42 -1.11 
YPK_3554 
  
conserved hypothetical 
protein 7.92 3.05 1.79 
YPK_3555 
  
conserved hypothetical 
protein 6.25 2.62 1.80 
YPK_3567 
  
conserved hypothetical 
protein 4.33 -2.03 -1.20 
YPK_3576 
  
conserved hypothetical 
protein -2.01 -1.65 -1.57 
YPK_3608 
  
hypothetical protein 
YPK_3608 1.49 -2.06 -1.71 
YPK_3615 
  
conserved hypothetical 
protein -1.29 -1.88 -1.66 
YPK_3644 
  
conserved hypothetical 
protein 1.15 -2.64 -1.09 
YPK_3645 
  
hypothetical protein 
YPK_3645 -1.59 -2.16 -1.76 
YPK_3656 
  
conserved hypothetical 
protein 4.10 17.85 1.70 
YPK_3721 
  
hypothetical protein 
YPK_3721 -1.32 -1.92 -1.62 
YPK_3749 
  
hypothetical protein 
YPK_3749 -1.66 -1.31 -1.78 
YPK_3753 
  
hypothetical protein 
YPK_3753 -1.58 -2.27 -1.30 
YPK_3764 
  
hypothetical protein 
YPK_3764 -1.31 -1.88 -1.60 
YPK_3774 ytfJ conserved hypothetical protein 1.79 1.84 1.13 
YPK_3821 
  
conserved hypothetical 
protein -1.36 -1.83 -1.52 
YPK_3836 
  
hypothetical protein 
YPK_3836 -1.58 -4.87 -1.40 
YPK_3837 
  
conserved hypothetical 
protein -2.30 -2.99 -2.04 
YPK_3867 
  
conserved hypothetical 
protein 1.28 6.38 1.23 
YPK_3956 
  
conserved hypothetical 
protein -2.05 -2.05 -1.47 
YPK_3963 
  
conserved hypothetical 
protein -1.47 3.60 -1.66 
YPK_4014 
  
hypothetical protein 
YPK_4014 -1.29 -1.79 -1.76 
YPK_4039 
  
conserved hypothetical 
protein -1.94 -1.65 -1.58 
YPK_4053 
  
conserved hypothetical 
protein -4.88 -3.66 -2.21 
YPK_4092 
  
hypothetical protein 
YPK_4092 -1.95 -2.16 -1.30 
YPK_4107 
  
conserved hypothetical 
protein 6.05 -1.05 -1.05 
YPK_4108 
  
conserved hypothetical 
protein 2.16 2.30 -1.36 
YPK_4124 
  
hypothetical protein 
YPK_4124 -2.06 -1.45 1.12 
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YPK_4130 
  
hypothetical protein 
YPK_4130 -1.35 -1.80 -2.05 
YPK_4172 
  
hypothetical protein 
YPK_4172 -1.26 -1.91 -1.47 
YPK_4242 
  
conserved hypothetical 
protein -1.80 -1.75 -1.44 
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